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The ubiquitin proteasome system (UPS) maintains cellular homeostasis by controlling the 
turnover of important regulatory enzymes and by the removal of damaged or misfolded proteins. 
The UPS serves as the basic framework of many specific catabolic pathways, including the 
Endoplasmic Reticulum-Associated Degradation (ERAD) pathway, which in particular helps to 
maintain the homeostasis of the early secretory pathway. An important component of the ERAD 
pathway is a complex containing the AAA ATPase, Cdc48p. The Cdc48p complex couples ATP 
hydrolysis with the physical dislocation of ubiquitinated substrates from the endoplasmic 
reticulum prior to degradation by a multi-subunit catabolic protease known as the 26S 
proteasome. Here I show that the loss of a Cdc48p cofactor, VCP/Cdc48p-associated 
Mitochondrial Stress-responsive-1 (Vms1p), negatively affects the turnover of the model ERAD 
substrate, the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), but does not 
affect the ubiquitination of CFTR. Strains lacking both the VMS1 gene and other select Cdc48p 
cofactors, namely genes encoding members of the Ubiquitin Regulatory X and Ubiquitin Fusion 
Degradation families, are hypersensitive to certain chemical stressors, and also display additive 
ERAD defects for certain substrates. Curiously, VMS1 mutants show increased accumulation of 
ubiquitinated proteins in total cell extracts, and also in complex with Cdc48p. These data suggest 
that Vms1p functions after substrate ubiquitination. In support of this hypothesis, I found that 
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VMS1 mutants show a decrease in the amount of proteasome that handles ubiquitinated 
substrates and an increase in the amount of free, latent 20S proteasome holoenzyme. This 
phenomenon is not a result of the altered expression of proteasome components. Additionally, 
the restoration of ubiquitinated protein accumulation and the distribution of proteasome subtypes 
to near wild-type levels require the physical interaction between Vms1p and Cdc48p. 
Furthermore, Cdc48p may be important for recruitment of Vms1p to the proteasome. Using yeast 
genetics I provide supporting evidence that indicates that Vms1p does not appear to function 
with various proteasome assembly chaperones. Quantitative mass spectrometry indicates that 
Cdc48p-associated proteasome is unaffected by loss of VMS1. Together my data indicates that 
Vms1p functions with Cdc48p to regulate proteasome subtypes that are required to degrade 
ubiquitinated substrates. 
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1.0  INTRODUCTION TO THE UBIQUITIN PROTEASOME SYSTEM 
Life is a balance between anabolic and catabolic pathways. However, for much of the 1950s 
through the 1970s, research in biology was largely skewed towards the study of anabolic 
processes such as nucleic acid and protein production with little regard to how these 
biomolecules were turned over. It was thought that protein turnover was a generally non-specific 
process, and that degradation occurred within a specialized, acidic organelle known as the 
lysosome in mammals, or the vacuole in lower eukaryotes and plants. However, a series of 
discoveries from the mid to late 1970s changed the scientific view of protein catabolism - the 
process was energy dependent and highly regulated. In the last 30 or so years, a tremendous 
amount of work has been done on the ubiquitin proteasome system, and we now know that this 
system is as important to the birth of proteins as it is to their death. In this Chapter, I will 
introduce the basic components of the ubiquitin proteasome system followed by a description of 
a specialized branch of this system at the endoplasmic reticulum (ER).  
1.1 UBIQUITIN 
The ubiquitin proteasome system (UPS) is the major eukaryotic catabolic pathway tasked with 
regulating cellular enzymes and protecting the cell from damaged or misfolded proteins. The 
targets of the UPS are modified most commonly by the covalent attachment of a highly-
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conserved 76 amino acid protein known as ubiquitin via its carboxy-terminal glycine to the ε-
amino group of a lysine residue on a recipient protein (HERSHKO and CIECHANOVER 1998). The 
fate of a ubiquitinated substrate is largely dependent on whether the target is modified by one 
(monoubiquitination) or many ubiquitin (multiubiquitination and polyubiquitination) moieties 
(Figure 1) (HICKE 2001; HOCHSTRASSER 1996). The monoubiquitination of a substrate normally 
alters a protein’s function or localization and is well documented for processes such as gene 
transcription, DNA repair, membrane trafficking, and protein endocytosis (HAGLUND et al. 2003; 
HICKE 2001; OSLEY 2004). In contrast, substrate polyubiquitination is most commonly 
associated with substrate degradation by a multi-subunit ATP-dependent protease known as the 
26S proteasome (HOCHSTRASSER 1996). Polyubiquitination, however, has an additional and 
rather complex layer of regulation. The polyubiquitin polymer is formed by the successive 
linking of one ubiquitin to another ubiquitin via one of eight different linkages between the 
ubiquitin moieties (Figure 2) (WALCZAK et al. 2012). Seven of these linkages are based on 
internal lysine residues within ubiquitin while the eighth is an amino-terminal linkage that leads 
to the formation of a linear ubiquitin chain (WALCZAK et al. 2012). Of these eight possible 
linkages, two ubiquitin linkages are highly abundant and well characterized (HERSHKO and 
CIECHANOVER 1998). The lysine 48 (K48)-linked polyubiquitin chain is the most common type 
and leads to the most recognizable consequence of ubiquitination, substrate degradation by the 
26S proteasome (CHAU et al. 1989; VAN NOCKER and VIERSTRA 1993). The lysine 63 (K63)-
linkage, alternatively, directs proteins primarily to non-degradative fates (ARNASON and ELLISON 
1994; HOCHSTRASSER 2006; SPENCE et al. 1995). Not surprisingly, the structures of K48- and 
K63-linked chains are very different. K48-chains are compact while K63-chains appear 
extended, and these structures suggest that their recognition by ubiquitin-binding proteins is a 
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strong determinant of their fate (Figure 3) (KIM and RAO 2006; PICKART and FUSHMAN 2004; 
WICKLIFFE et al. 2011). There is also very compelling evidence indicating that all ubiquitin-
linkages, aside from linear and K63 chains are candidates for proteasome-mediated degradation 
(XU et al. 2009). Though some of these linkages are highly abundant (e.g., K11 and K63), they 
cannot rescue the inviability of strains lacking the K48 linkage (XU et al. 2009). Intriguingly, 
“atypical” ubiquitin chains with mixed linkages have been detected, some of which result from 
ubiquitin chain editing (BEN-SAADON et al. 2006; IKEDA and DIKIC 2008; KIM et al. 2007; 
NEWTON et al. 2008; WINBORN et al. 2008). One exciting possibility is that a ubiquitin chain of 
mixed linkages may couple temporal and spatial information for protein function prior to 
degradation. 
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Figure 1. Mono, multi, and polyubiquitination 
In monoubiquitination, a ubiquitin (red circle) peptide is attached to a substrate. 
Multiubiquitination is monoubiquitination, but at many different sites. Polyubiquitination 
describes the formation of a ubiquitin-ubiquitin chain on a substrate.  
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Figure 2. Conservation of Ubiquitin 
Pair-wise alignment of full-length ubiquitin from Homo sapiens and Saccharomyces 
cerevisiae using Vector NTI. Identical residues are highlighted in yellow and conserved changes 
are in green. Inverted arrowheads indicate residues used to forming linkages in a polyubiquitin 
chain.  
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Figure 3. The Structure of K48 and K63-linked diubiquitin 
Ribbon diagrams of K48- and K63-linked diubiquitin. K48 diubiquitin adopts a compact 
structure while K63 diubiquitin is extended. K48-linkage is a classic degradation signal. The 
K63-linkage is involved primarily in non-degradative fates (WICKLIFFE et al. 2011). 
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1.1.1 ENZYMES OF THE UBIQUITIN PROTEASOME SYSTEM 
The process leading to substrate ubiquitination occurs in a step-wise fashion (Figure 4), and 
starts with the initial formation of a ubiquitin-adenylate intermediate by the adenylation domains 
of the E1 activating enzyme (SCHULMAN and HARPER 2009). Next, a covalent thioester bond is 
formed between the terminal glycine of the ubiquitin-adenylate intermediate and the Second 
Catalytic Cysteine Half-domain (SCCH) of the E1-activating enzyme by attack from a cysteine 
residue found within this domain (SCHULMAN and HARPER 2009). Upon thioester bond 
formation, the E1 enzyme undergoes a conformational change that exposes E2-conjugating 
enzyme interaction surfaces in the Ubiquitin Fold Domain (HUANG et al. 2007; LEE and 
SCHINDELIN 2008). The ubiquitin in the E1-ubiquitin complex is next transferred to an E2-
conjugating enzyme by a transthioesterification reaction that is mediated by attack from a 
cysteine residue in the highly-conserved UBiquitin Conjugating (UBC) domain of the E2 
enzyme (LEE and SCHINDELIN 2008). The E2-ubiquitin complex then transfers its ubiquitin 
moiety to a substrate via one of two important families of E3 ubiquitin ligases whose 
mechanisms of action are distinct (FINLEY 2009) (see below).  
 
The three step process shown in Figure 4 is highly conserved with only a few variations; 
one example is the ability of select E2 enzymes to directly monoubiquitinate some ubiquitin 
binding proteins (HOELLER et al. 2007). The initial activation of an ubiquitin moiety by an E1 
enzyme occurs at a quicker rate than that of substrate ubiquitination, and for good reason: most 
eukaryotes possess a single E1 enzyme (MCGRATH et al. 1991). The fact that E1 enzymes are 
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efficient machines is in part because they can interact with two ubiquitin moieties: one at the 
active site cysteine in the SCCH and a second at the site of ubiquitin-adenylate intermediate 
formation (SCHULMAN and HARPER 2009). By comparison, E2-conjugating enzymes are more 
abundant than E1 enzymes, but are far less common than E3 ubiquitin ligases (PICKART 2001). 
In humans, there are two E1s, ~38 E2s, and greater than 600 E3 enzymes, while yeast has a 
single E1, 13 E2, and ~60 E3 enzymes (CREWS 2003; YE and RAPE 2009). Given the number of 
potential substrates, the functional hierarchy of the UPS, and the large number of E3 ubiquitin 
ligases, it is not a surprise that the E3 enzymes are largely responsible for selecting substrates.  
 
The two important families of E3 ubiquitin ligases are the Really Interesting New Gene 
(RING) zinc finger and Homologous to the E6-AP Carboxy Terminus (HECT) domain families 
(FREEMONT et al. 1991; HUIBREGTSE et al. 1995). The RING and HECT domain families differ 
in their mode of action. RING finger E3 ligases promote the attachment of ubiquitin to a 
substrate directly from an E2-ubiquitin complex, and never come in contact with the ubiquitin 
moiety itself (BAILLY et al. 1997; KWON et al. 1998). The RING-E3 ligases do this by acting as a 
molecular scaffold that brings the active site of the E2-ubiquitin spatially closer to a lysine on a 
substrate (DESHAIES and JOAZEIRO 2009). It is worth noting the existence of a minor subfamily 
of E3 ubiquitin ligases possessing a variation of the RING zinc finger, called a U-box domain. 
U-box E3 ligases, unlike the RING zinc finger domain E3s, do not contain the key cysteine 
residues needed for zinc ion coordination (HATAKEYAMA and NAKAYAMA 2003; PATTERSON 
2002). Interestingly, some U-box family members possess a ubiquitin-extending, or E4 activity 
(KOEGL et al. 1999; NAKATSUKASA et al. 2008). The mechanism of U-box ligase activity is 
similar to that of RING E3 ligases, and both require structural flexibility to place the charged E2 
 9 
in close proximity to a substrate for efficient polyubiquitination (QIAN et al. 2009). HECT E3 
ligases, on the other hand, directly form a thioester bond with the ubiquitin moiety prior to 
transferring the ubiquitin to a substrate (ROTIN and KUMAR 2009; SCHEFFNER et al. 1995). All 
HECT E3s have an invariant cysteine residue in the HECT domain that forms this bond, and the 
sequences surrounding the HECT domain are important for mediating interaction with E2s and 
substrate (LEE et al. 2009; ROTIN and KUMAR 2009). Like the RING domain E3s, HECT E3s are 
also structurally flexible (VERDECIA et al. 2003). While the domains that define an E3 ubiquitin 
ligase may be conserved, there can be variability in the surrounding sequences. These variable 
regions are likely determinants for E2 and substrate specificity (DESHAIES and JOAZEIRO 2009; 
ROTIN and KUMAR 2009).  
 
In a clever twist in E3 evolution, a very abundant group of RING-like domain E3 ligases 
has evolved structural flexibility by becoming entirely modular. This group of E3s is generically 
called the Skp1-Cullin-Fbox (SCF)-family of RING-like E3 ubiquitin ligases. SCF family E3s 
have both substrate recognition and E3 ligase activity in separate protein complexes that then 
assemble onto a scaffold protein (DESHAIES and JOAZEIRO 2009). In yeast, the scaffold (Cullin 
portion), substrate recognition protein (Fbox portion), and the RING E3 are encoded by the 
CDC53, CDC4, and HRT1 genes, respectively. A protein encoded by the SKP1 gene connects 
the substrate binding Fbox to the Cullin scaffold and an E2 conjugating enzyme, Cdc34p 
supplies the activated ubiquitin. SCF mediated protein degradation is particularly important for 
the regulation of the cell cycle (SKAAR and PAGANO 2009).  
 
 10 
The E3 ligases are processive enzymes and can successively add ubiquitin moieties to 
form the polyubiquitin chain on a substrate (DESHAIES and JOAZEIRO 2009; ROTIN and KUMAR 
2009). This feat can be accomplished by oligomerization of the E3s, or by repeated 
association/dissociation of the E2/E3 complex in addition to other mechanisms that have yet to 
be defined (CHENG et al. 2009; KLEIGER et al. 2009). In some instances, an entire polyubiquitin 
chain can be formed on an E3, or in solution, and at least in vitro can be added to a substrate by 
the E3 ligase (LI et al. 2007a; PARKER and ULRICH 2009; WANG and PICKART 2005). It is 
unknown if E3s add entire polyubiquitin chains en bloc in vivo, but this is a formal possibility 
since di-, tri-, and tetra-ubiquitin chains can exist as free entities in vivo.  
 
As introduced above, ubiquitin linkage is an important determinant of ubiquitinated 
substrate fate. There is compelling evidence that the formation of specific linkages is mediated 
primarily by the E2 enzyme in combination with an E3, but evidence also suggests that the 
determinants for linkage may lie within the E3 itself (KIM and HUIBREGTSE 2009; KIM et al. 
2007; MASTRANDREA et al. 1999; YOU and PICKART 2001). It is quite likely that there are many 
more factors involved in determining what type of ubiquitin linkage is formed, and we are only 
beginning to understand this.  
 
Aside from these enzymes, the cell possesses additional ubiquitin-specific enzymes that 
help to modify the outcome of ubiquitination. For example, deubiquitinating (DUB) enzymes are 
a large group of proteins that can 1) remove ubiquitin from substrates and prevent degradation, 
2) process ubiquitin precursors, 3) recycle ubiquitin, or 4) assist in editing the linkage of the 
ubiquitin chain on a protein (AMERIK and HOCHSTRASSER 2004; CROSAS et al. 2006; MAYER and 
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WILKINSON 1989; NEWTON et al. 2008; PAPA and HOCHSTRASSER 1993; PICKART and ROSE 
1985). DUB enzymes are classified either as papain-like cysteine or zinc-metalloproteases 
(REYES-TURCU et al. 2009). And, examples of select DUBs in yeast illustrate the varied roles of 
this enzyme class. Doa4p, for instance, is involved in recycling ubiquitin and is also important in 
the process of ubiquitin-mediated endocytosis (AMERIK et al. 2000; SWAMINATHAN et al. 1999). 
Another example, Otu1p, is involved in regulated turnover of ubiquitin-fusion degradation 
substrates associated with the ATPase, Cdc48p (RUMPF and JENTSCH 2006). Otu1p and a protein 
known as Ufd3p compete with Ufd2p for binding to Cdc48p. The Ufd2p protein belongs to a 
group of the aforementioned E4 polyubiquitin-extending enzymes and promotes the efficient 
degradation of various substrates by extending the polyubiquitin chain (HOPPE 2005; KOEGL et 
al. 1999; NAKATSUKASA et al. 2008; SHI et al. 2009). This “tug-of-war” battle between 
deubiquitination and polyubiquitin chain extension is also demonstrated for the DUB, Ubp6p and 
the E4 enzyme, Hul5p at the 26S proteasome (CROSAS et al. 2006). Ultimately, the regulated 
turnover of the vast majority of UPS substrates is governed by the balance between the addition, 
extension, and removal of ubiquitin. 
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Figure 4. Ubiquitin cascade 
Ubiquitin (red circle) is first activated by an E1-activating enzyme (yellow) in an ATP-
dependent process. The ubiquitin-E1 complex then passes the ubiquitin to an E2-conjugating 
enzyme (green). The E2-ubiquitin complex works with an E3-substrate (blue/grey) complex 
resulting in substrate ubiquitination. 
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1.1.2 UBIQUITIN INDEPENDENT DEGRADATION 
A chain of four ubiquitin moieties is minimally required for proteasomal degradation (THROWER 
et al. 2000). It is not entirely clear why an extended polyubiquitin chain is needed, but one can 
speculate that having a long chain of ubiquitins, with perhaps mixed linkages, can potentially 
serve as recruitment platform for a large number of processing factors. Interestingly, there are a 
select number of substrates that undergo proteasomal degradation without being ubiquitinated. 
For instance, the tumor suppressor p53 can be degraded by both ubiquitin-dependent and 
independent mechanisms, while ornithine decarboxylase is degraded by the proteasome in an 
entirely ubiquitin-independent manner (ASHER et al. 2005; HOYT et al. 2003). Some proteins that 
possess ubiquitin-like or -associated domains can also be degraded independent of ubiquitination 
(BAUGH et al. 2009). And, localization to the proteasome appears to be sufficient to trigger 
protein degradation independent of ubiquitin (JANSE et al. 2004). The proteasome has also been 
shown to retrotranslocate a non-ubiquitinated substrate for degradation from the ER (LEE et al. 
2004). 
1.2 THE 26S PROTEASOME 
The K48-linked polyubiquitinated substrate is the prototypical degradation substrate of the 26S 
proteasome. The 26S proteasome is a large multi-subunit ATP-dependent protease that is 
composed of two main parts, a 20S proteolytic core particle (20S core, or CP) and the 19S 
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regulatory particle (19S cap, PA700, or RP), which accepts and processes ubiquitinated 
substrates (LIU et al. 2002; PICKART and COHEN 2004; VOGES et al. 1999). In the cell, the 
proteasome exists as three major forms: the 20S core alone and the 20S core flanked by either 
one 19S cap (RPCP) or two 19S caps (RP2CP, Figure 5) (VOGES et al. 1999). Though it is 
unknown if there are functional distinctions between the RP1CP and RP2CP forms, both 
versions are considered to be active towards ubiquitinated substrates as they are readily 
detectable with artificial fluorogenic reporters (HOUGH et al. 1986; HOUGH et al. 1987). 
Conversely, the 20S core is considered inactive under normal circumstances and undetectable by 
fluorogenic reporter substrates unless low concentrations of detergent or fatty acids are added 
(ARRIBAS and CASTANO 1990; DAHLMANN et al. 1985; MCGUIRE et al. 1989). The 20S core is 
also a latent enzyme in the presence of cellular concentrations of select cations, such as 
potassium, further suggesting inactivity (KOHLER et al. 2001; WILK and ORLOWSKI 1983). 
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Figure 5. Three forms of the proteasome 
The proteasome exists in three dominant forms. The 20S core particle (CP, grey barrel) is 
composed of four-stacked seven member rings (αββα). The CP can be flanked by one “base” and 
“lid” subassembly (boxed in yellow, RPCP) or two subassemblies (RP2CP). 
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1.2.1 Proteasome localization 
The activation of the 20S by fatty acids is intriguing given the fact that the mammalian 26S 
proteasome is found associated with the ER – a major site of lipid and protein biosynthesis 
(ENENKEL et al. 1998; FRICKE et al. 2007; RIVETT et al. 1992). The ER/nucleus is postulated to 
be the site of the proteasome biogenesis (FRICKE et al. 2007; GORBEA et al. 2004; LEHMANN et 
al. 2002). In yeast, components of the 19S cap were shown to be more abundant at the ER than 
components of the 20S core (KALIES et al. 2005). The juxtanuclear quality control compartment, 
which is a major site of protein degradation in yeast and mammals, is situated near the ER 
(KAGANOVICH et al. 2008). In both yeast and mammals, the 26S proteasome is localized 
throughout the cytosol, nucleus, and at the surface of many endomembrane systems (RIVETT 
1998; WOJCIK and DEMARTINO 2003). Proteasomes are quite abundant in the nucleus where they 
are associated with both degradative and, surprisingly, non-degradative roles (VON MIKECZ 
2006). The roles of nuclear proteasomes include nucleotide excision repair and regulation of 
gene expression (GONZALEZ et al. 2002; RUSSELL et al. 1999). Intriguingly, a protein known as 
Sts1p may act as a proteasome receptor and aid in localizing proteasomes within the nucleus 
(CHEN et al. 2011). The localization of the proteasome has even been noted to change during 
different stages of the cell cycle (WOJCIK and DEMARTINO 2003). Overall, however, the 
regulation of proteasome localization and dynamics are currently poorly understood.  
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1.2.2 The 20S core particle  
The 20S core particle is a cylindrical, chambered protease that is composed of four-stacked 
heteroheptameric rings (GRZIWA et al. 1991; KOPP et al. 1986; LOWE et al. 1995). The two 
outer-most rings are largely structural and are composed of alpha subunits while the inner-most 
pair of rings contains the proteolytic activity and are composed of beta subunits (Figure 5). The 
chambered protease is an evolutionarily conserved structure. The 20S proteasome of 
archaebacteria, eubacteria, and eukaryotes all share this structure along with the unrelated 
chambered proteases of prokaryotes (PICKART and COHEN 2004). Although there is evidence 
suggesting that the free 20S core particle can process select types of substrates, the 20S is an 
inactive enzyme because the aperature leading into the barrel is closed by the amino-termini of 
the alpha subunits that serve as a gate (BAUGH et al. 2009; DAHLMANN et al. 1985; GROLL et al. 
1997; JUNG and GRUNE 2008). In Saccharomyces cerevisiae, the amino-terminus of the alpha3 
subunit plays an important role in 20S gating by coordinating the amino termini of other select 
alpha subunits (alpha1, 2, 6, 7) (GROLL et al. 2000; GROLL et al. 1997). Curiously, the yeast 
alpha3 subunit is the only non-essential subunit of the 20S core, and can be replaced by an 
additional alpha4 subunit (HILT and WOLF 1995; KUSMIERCZYK et al. 2008; VELICHUTINA et al. 
2004). As expected, this alternate version of the 20S core has increased basal 20S activity 
(VELICHUTINA et al. 2004). This paradigm is not uncommon as naturally-occurring alternative 
versions of select 20S subunits exist in higher eukaryotes, with some subunits being known to 
alter the proteolytic activity of the proteasome (DRISCOLL et al. 1993; GACZYNSKA et al. 1993; 
VELICHUTINA et al. 2004).  
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The constitutive catalytic subunits of the 20S core are the beta1, beta2, and beta5 
subunits, and each subunit possesses an evolutionarily-conserved but distinct proteolytic activity. 
The beta1, beta2, and beta5 subunits contain: 1) peptidylglutamyl peptide hydrolyzing, 2) 
trypsin-like and 3) chymotrypsin-like activities which cleave after: 1) acidic, 2) basic and 3) 
hydrophobic residues, respectively. In addition to these three subunits, humans have a group of 
inducible beta subunits known as beta1i, beta2i, and beta5i, which are expressed by many cell 
types in response to interferon-gamma signaling and are incorporated into the proteasome. This 
results in the formation of the immunoproteasome, or i-proteasome (DRISCOLL et al. 1993; 
GACZYNSKA et al. 1993). The i-proteasome helps process host and pathogen proteins for display 
by the Major Histocompatibility Complex I (MHCI), but also has a major function in the 
degradation of the defective ribosomal products that can occur as a result of increased protein 
translation (KINCAID et al. 2012; SEIFERT et al. 2010). As expected, the i-proteasome subunits 
confer enhanced proteolytic activity to the 26S and 20S proteasome (DRISCOLL et al. 1993; 
GACZYNSKA et al. 1993).  
1.2.3 The 19S cap and accessory complexes 
The 20S core particle can be flanked by any number of accessory complexes (HOFFMAN et al. 
1992). The accessory complex associated with ubiquitinated protein degradation, and also the 
most recognizable is the 19S cap. The highly-conserved 19S cap is composed of two main parts, 
the base and lid (Figure 5) (GLICKMAN et al. 1998a). In yeast, the base of the cap is composed of 
a heterohexameric ring of ATPases (Rpt1p-6p), which drives a deubiquitinated substrate into the 
20S core barrel, and a quartet of proteins that are involved in stabilizing the 19S cap structure 
and ubiquitin-substrate binding (Rpn1p, 2p, 10p, 13p) (ELSASSER et al. 2002; GLICKMAN et al. 
 19 
1998a; GLICKMAN et al. 1998b; HUSNJAK et al. 2008; VAN NOCKER et al. 1996). Rpn10p, in 
particular has been proposed to be important in stabilizing the complete 19S cap structure, and 
recent cryo-electron microscopy studies of yeast 26S proteasomes with and without the Rpn10p 
and Rpn13p suggest that these two ubiquitin receptors determine the requirement of 
tetraubiquitin as a degradation signal  (GLICKMAN et al. 1998a; LANDER et al. 2012; SAKATA et 
al. 2012; THROWER et al. 2000). The base subassembly sits on top of the 20S core particle, 
forming contacts between the ATPase ring and the alpha subunits (PETERS et al. 1993; WALZ et 
al. 1998). The ring of ATPases contributes to the opening of the 20S gate via an evolutionarily-
conserved “hydrophobic-tyrosine-X” (HbYX) motif at the carboxy terminus (KOHLER et al. 
2001; SMITH et al. 2007). Many other factors also contribute to the opening of the 20S core, 
possibly by binding to and modulating the activity of the ATPase ring, or affecting the assembly 
of the 19S-20S subunits (BECH-OTSCHIR et al. 2009; LI and DEMARTINO 2009; PETH et al. 2009).  
 
Traditionally, the base subassembly was thought to be positioned below the lid 
subassembly. However, recent cryo-electron microscopy studies indicate that the lid components 
are on the side of the base and even contact the 20S core (LANDER et al. 2012). Nevertheless, the 
lid subassembly in yeast is composed of nine proteins, Rpn3p, 5p-9p, 11p, 12p, and Sem1p 
(FUNAKOSHI et al. 2004; GLICKMAN et al. 1998b; SONE et al. 2004). Many lid components (e.g., 
Rpn3p, 5p, 6p, 7p, 9p, 11p, 12p, and Sem1p) appear to be necessary for the biogenesis and 
stability of the 19S lid structure, and the 26S proteasome (CHANDRA et al. 2010; FUKUNAGA et 
al. 2010; FUNAKOSHI et al. 2004; ISONO et al. 2004; ISONO et al. 2005; JOSHI et al. 2011; 
PATHARE et al. 2012; SONE et al. 2004; TOMKO and HOCHSTRASSER 2011; YU et al. 2011). One 
structural component, Rpn11p, however, contains a specific activity. Rpn11p is one of two DUB 
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enzymes associated with the proteasome in yeast; the other is Ubp6p (see above) (GUTERMAN 
and GLICKMAN 2004; LEGGETT et al. 2002; VERMA et al. 2002; VERMA et al. 2000; YAO and 
COHEN 2002). As a core component of the 19S lid, Rpn11p is required for the stability of the 19S 
cap and as a DUB enzyme can remove ubiquitin en bloc from a substrate (LANDER et al. 2012). 
Ubp6p, on the other hand, has a processive ubiquitin trimming activity, and also a DUB-
independent function that modulates the activity and assembly of the proteasome (HANNA et al. 
2006; PETH et al. 2009; SAKATA et al. 2011). Cryo-electron microscopy of the 19S indicates that 
Rpn11p is well-positioned between the two ubiquitin receptors and nearest the entrance of the 
ATPase base subassembly, a position where the en bloc removal of an entire ubiquitin chain is 
important (LANDER et al. 2012). On the other hand, Ubp6 is at the periphery of the 19S which is 
consistent with its involvement in ubiquitin chain trimming and thus rescuing substrates from 
degradation (Figure 5) (CROSAS et al. 2006; LANDER et al. 2012).  
 
In addition to the 19S cap, the 20S core can be flanked by other accessory complexes, of 
which many seem to increase the proteolytic activity of the 20S core (HOFFMAN et al. 1992; MA 
et al. 1992; SCHMIDT et al. 2005). For example, the yeast Blm10 protein promotes the efficient 
degradation of a number of protein substrates by gating the proteasome in a manner similar to 
that of the HbYX motif of the 19S base (DANGE et al. 2011; LOPEZ et al. 2011). Interestingly, 
there are other proteins that possess this HbYX motif, most notably the multifunctional 
hexameric ATPase, p97, which is the mammalian homolog of yeast Cdc48p (see below, Dave 
Smith, West Virginia University, personal communication). Indeed it does appear that Cdc48 
and 20S form a stable and functional complex (BARTHELME and SAUER 2012). It will be 
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interesting to find out if other HbYX motif-ATPase complexes modulate the activity of this 
important protease.     
1.2.4 Proteasome assembly 
The multitude of proteasomal accessory complexes, cofactors, and alternate proteasomal 
subunits suggests that there are specialized assembly pathways. Additionally, the composition of 
the proteasome is known to change under certain stress conditions (HANNA et al. 2007; WANG et 
al. 2010; XIE and VARSHAVSKY 2001). Early hints of a proteasome assembly pathway were 
demonstrated in reconstitution experiments that originally aimed to prove that the 20S core was a 
component of the 26S proteasome (DRISCOLL and GOLDBERG 1990; EYTAN et al. 1989; GANOTH 
et al. 1988; HOFFMAN et al. 1992; ORINO et al. 1991). These experiments showed that the 19S 
cap was composed of two chief parts, the lid and base, that when mixed together with the third 
fraction containing the 20S formed the 26S particle (DRISCOLL and GOLDBERG 1990; EYTAN et 
al. 1989; HOFFMAN et al. 1992; ORINO et al. 1991). Preincubating these three fractions with ATP 
to promote assembly prevented a delay in model substrate degradation (GANOTH et al. 1988). 
Work from the late 1990s has since uncovered a host of dedicated assembly chaperones for the 
assembly of both the 20S core and 19S cap.  
 
The assembly of the 20S core particle is well-defined and evolutionarily-conserved 
between man and yeast (MURATA et al. 2009). In yeast, five different chaperones contribute to 
different stages of 20S core formation. Two heterodimeric complexes, Pba1p-Pba2p and Pba3p-
Pba4p, cooperate to form the alpha ring which then serves as a template for subsequent 
chaperone-assisted incorporation of the beta subunits (LE TALLEC et al. 2007; LI et al. 2007b). 
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This alpha and the partially-complete beta ring pair is known as the “half-mer” (Figure 6). It is 
worth noting that the Pba1p-Pba2p and Pba3p-Pba4p chaperones appear to have specific 
functions in the formation of the half-mer. For instance, Pba1p-Pba2p mutants have a specific 
defect in chymotryptic-like (beta5) activity, suggesting a specific role in beta ring formation (LI 
et al. 2007b; SCOTT et al. 2007). Pba4p mutants lead to the incorporation of the alpha4 subunit in 
place of the alpha3 subunit, suggesting a role in alpha ring formation (KUSMIERCZYK et al. 2008; 
MURATA et al. 2009). Intriguingly, Pba3p-Pba4p mutants form the alternate 20S proteasome that 
is observed when alpha3 is deleted (see above). It is still not clear if this alternative, more active 
20S core exists naturally in yeast. As mentioned, the half-mer is incomplete, and in yeast, the 
beta7 subunit is not incorporated until the dimerization of two half-mers to form the 20S core 
(Figure 7) (LI et al. 2007b; MARQUES et al. 2007). The incorporation of beta subunits and 
dimerization of the two half-mers is assisted by a fifth chaperone, Ump1p (RAMOS et al. 1998). 
Half-mer dimerization results in the encapsulation and degradation of Ump1p after the 
processing of the catalytic beta subunit propeptides, as well as the noncatalytic beta6 and beta7 
subunits (CHEN and HOCHSTRASSER 1996; HEINEMEYER et al. 1997; RAMOS et al. 1998; 
SEEMULLER et al. 1996).  
 
Interestingly, mutations in the genes-encoding Pba3p, Pba4p, Ump1p, and alpha3 lead to 
the accumulation of 19S cap precursors, suggesting that the 20S core particle can serve a scaffold 
for 19S cap formation (HENDIL et al. 2009; KUSMIERCZYK et al. 2008). Like the 20S core, the 
19S cap is also assembled by chaperone-like proteins (Figure 8). The assembly of the base of the 
19S has only been recently described. Here, four proteasome-dedicated chaperones, Nas2p, 
Nas6p, Hsm3p, and Rpn14p bind different Rpt-Rpn subunits of the 19S base to facilitate their 
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assembly (FUNAKOSHI et al. 2009; KANEKO et al. 2009; LE TALLEC et al. 2009; PARK et al. 
2009; ROELOFS et al. 2009; SAEKI et al. 2009). These chaperones bind near the carboxy terminus 
of their respective Rpt subunits, and are displaced by the presence of the 20S core particle 
(ROELOFS et al. 2009). The binding of the chaperone probably prevents the premature proteolytic 
activation by the formation of a stable complex between an unregulated, base assembly and the 
20S core particle (BESCHE et al. 2009b; HENDIL et al. 2002; KRIEGENBURG et al. 2008). 
Surprisingly, the simultaneous deletion of all four chaperones does not completely abolish the 
formation of the 26S proteasome (SAEKI et al. 2009). These data indicate that there are 
alternative back-up methods to assemble this essential protease.  
 
The assembly of the lid is very poorly characterized, and no dedicated chaperones have 
been identified thus far. However, analyses of the lid intermediates that accumulate in various lid 
mutants have identified two main lid modules, one containing Rpn5p, 6p, 8p, 9p, 11p and a 
second consisting of Rpn3p, 7p and Sem1p (FUKUNAGA et al. 2010; ISONO et al. 2004). This 
provides evidence that Rpn12p is the last lid component to incorporate when these two modules 
form (Figure 9) (FUKUNAGA et al. 2010; ISONO et al. 2004). This conclusion is supported by the 
finding that mutations in the Rpn12p carboxy terminus accumulate the entire lid subassembly 
without Rpn12p (TOMKO and HOCHSTRASSER 2011). In vitro reconstitution experiments indicate 
that the carboxy terminus of Rpn12p drives the association of the lid and base subassemblies in 
the presence of 20S core particles (TOMKO and HOCHSTRASSER 2011). 
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Figure 6. Assembly of the 20S half-mer 
Two chaperones, Pba1p and Pba2p, facilitate the assembly of the alpha ring. The 
assembled alpha ring then serves as a template for beta ring assembly. Beta ring assembly is 
assisted by the Pba3p, Pba4p and Ump1p chaperones and is incomplete as the beta7 subunit is 
not incorporated. This incomplete structure is called the “half-mer”. 
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Figure 7. Assembly of the 20S core 
Two half-mers are joined together and incorporate two copies of the beta 7 subunit. This 
encapsulates Ump1p which is then degraded after catalytic subunit propeptide maturation and 
formation of the 20S core particle. 
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Figure 8. Assembly of the 19S base 
Hsm3p , Nas2p, and the Rpn14p/Nas6p pair facilitate the assembly of the base. Hsm3p 
interacts with Rpt1p (T1), Rpt2p (T2), Rpn1p (1) and Ubp6p. Nas6p interacts with Rpt5p (T5) 
and Rpt4p (T4). Rpn14p and Nas6p interact with Rpt6p (T6) and Rpt3p (T3), respectively. 
White indicates proteasome chaperone, red indicates deubiquitinating enzyme, blue indicates 
ubiquitin receptor, orange indicates non-ATPase subunit and yellow indicates ATPase subunit.  
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Figure 9. Assembly of the 19S lid 
Two intermediates of the 19S lid subassembly 1) Rpn3p (3) and Rpn7p (7), and 2) Rpn5p 
(5), Rpn6p (6), Rpn8p (8), and Rpn11p (11) are joined together by Rpn12p (12). This 
subassembly is then joined to the 19S base by Rpn10p (10). Red indicates deubiquitinating 
enzyme, blue indicates ubiquitin receptor, orange indicates non-ATPase subunit and yellow 
indicates ATPase subunit.  
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1.2.5 Additional Factors 
Other factors also appear to be involved in the assembly and function of the proteasome. For 
instance, yeast Hsp90 mutants or Hsp90 inhibitor treatment (geldanamycin) has been reported to 
reduce the levels of 26S proteasome (IMAI et al. 2003). Ubiquitinated substrates have been 
shown to promote the stability of the 26S proteasome, and ATP hydrolysis may destabilize the 
yeast proteasome (BABBITT et al. 2005; KLEIJNEN et al. 2007). Specific proteins such as 
Ecm29p, Not4p, and Nob1p have partially characterized roles in proteasome biology (LEHMANN 
et al. 2010; PANASENKO and COLLART 2011; TONE and TOH 2002; WANG et al. 2010). For 
example, Ecm29p is involved in the joining of the 19S cap and 20S core, and binds to both 19S 
cap and 20S core particles (LEHMANN et al. 2010). Ecm29p also serves as a quality control 
checkpoint and appears to inhibit improperly assembled proteasomes (LEE et al. 2011). This 
implies that there is some assembly of the proteasome can occur after the 19S and 20S particles 
are joined. The proteasome is also subject to environmental factors. For instance, ubiquitin 
depletion promotes the expression of the DUB, Ubp6p, which is then loaded onto the 26S 
proteasome to promote the recycling of ubiquitin (HANNA et al. 2007). Hydrogen peroxide, or 
reactive oxygen species-triggered stress promotes the disassembly of the proteasome (WANG et 
al. 2010). Organelle stress, such as that from misfolded proteins at the ER leads to changes in the 
expression of the proteasome, which is mediated by the proteasomal transcription factor Rpn4p 
(METZGER and MICHAELIS 2009; XIE and VARSHAVSKY 2001). The proteasomal stress response 
is generally conserved, but the equivalent of Rpn4p in mammals, Nrf1, has only recently been 
identified (RADHAKRISHNAN et al. 2010). 
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1.2.6 Chemical targeting of the Proteasome 
Chemical modulation of the proteolytic activity of the proteasome has received considerable 
interest since it was discovered to have positive effects in the treatment of certain cancers 
(ADAMS and KAUFFMAN 2004; TAN et al. 2006). Currently, there are five proteasomal inhibitors 
in clinical trial, and one (Bortezomib/Velcade) is FDA-approved for use as a frontline cancer 
treatment for certain types of cancers, such as multiple myeloma and some types of lymphoma 
(MOLINEAUX 2012). These inhibitors are either natural beta-lactones or protected peptides with 
groups that are reactive towards the proteasome active site (MOLINEAUX 2012). These inhibitors 
take advantage of the fact that these cancers are caused by professional secretory cells that are 
under high levels of ER stress; therefore reducing proteasomal activity pushes these cells 
towards apoptosis (KISSELEV et al. 2012).  
1.3 ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION (ERAD) 
The function of the UPS underlies many cellular protein degradation pathways. These pathways 
are largely defined by specific E2, E3, DUB and E4 enzyme combinations in addition to other 
specific adaptor proteins. Some of these pathways are further divided depending on the location 
(e.g., cytoplasmic versus intraorganellar) and nature (e.g., misfolded protein versus a naturally 
regulated substrate) of a given substrate. One of the most thoroughly examined models of UPS-
mediated protein degradation is with regard to misfolded protein substrates in the ER.  
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The ER is the site of protein synthesis and folding for both transmembrane and secreted 
proteins in eukaryotes. The volume of protein traffic that enters the ER, and thus the early 
secretory pathway is very large and accounts for 20-30% of the total proteome (GHAEMMAGHAMI 
et al. 2003; LANDER et al. 2001). Proteins enter the secretory pathway by one of two modes, co-
translationally or post-translationally, both of which utilize the highly-conserved Sec61 
translocation channel complex (RAPOPORT et al. 1999). The yeast Sec61p translocation channel 
is a membrane-spanning multi-protein complex that contains two additional proteins, Sbh1p and 
Sss1p and is the docking site of the translating ribosome (ROMISCH 1999). The central pore of 
Sec61p is gated closed by the molecular chaperone, BiP/Kar2p, which allows the environment of 
the secretory pathway to be different from that found in the cytoplasm (HAMMAN et al. 1998). 
Proteins that enter the secretory gateway can be subject to: 1) proteolytic cleavage of the ER-
targeting signal sequence, 2) Asparagine-linked (Asn or N-linked) glycosylation, 3) disulfide 
bond formation, 4) chaperone-assisted protein folding and 5) propeptide processing (BRODSKY 
and SKACH 2011).  
 
The environment of the ER differs from the cytoplasm in a number of ways. For example, the 
ER is an oxidizing environment that allows the formation of disulfide bonds, and is a major site 
of lipid metabolism and calcium storage (CSALA et al. 2006; RAINA and MISSIAKAS 1997). The 
ER also acts as a protein concentrating organelle prior to secretory protein transport (MIZUNO 
and SINGER 1993). These factors can present a hurdle to proper protein folding, especially if the 
protein is mutated or damaged. Fortunately, the early secretory pathway is protected from 
misfolded proteins by a protein quality-control/processing pathway known as Endoplasmic 
Reticulum-Associated Degradation (ERAD) (MCCRACKEN and BRODSKY 1996; VEMBAR and 
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BRODSKY 2008). The ERAD pathway is composed of a cooperating set of sequential events: 
substrate recognition and targeting, ubiquitination by membrane-anchored E3 ubiquitin ligases, 
substrate retrotranslocation, and finally degradation by the 26S proteasome. Substrate 
recognition is the starting point for the ERAD surveillance pathway and is based largely on the 
location of the offending lesion (ISMAIL and NG 2006; SMITH et al. 2011; VASHIST and NG 2004; 
VEMBAR and BRODSKY 2008). 
1.3.1 ERAD-Lumenal (ERAD-L) 
Misfolded proteins inside the ER are recognized by a specific set of molecular chaperones, and 
are targeted to the protein degradation machinery that comprises the ERAD-Lumenal (ERAD-L) 
pathway (Figure 10) (BUCK et al. 2007; CARVALHO et al. 2006; DENIC et al. 2006; VASHIST and 
NG 2004). The primary ERAD-L chaperone is a 72 KDa protein known as BiP, or Kar2p in 
yeast. Kar2p is a member of the abundant Heat Shock Protein 70 (HSP70) family and couples 
ATP hydrolysis with protein binding. The ATPase activity of HSP70 proteins, as well as their 
substrate binding ability can be modulated by cofactors such as HSP40 co-chaperones (BRODSKY 
2007). The activity of HSPs can be either pro-folding or pro-degradation. In addition, chaperone-
like lectins such as Yos9p and Htm1p monitor the status of the N-linked glycosylation signals on 
ERAD-L substrates (BHAMIDIPATI et al. 2005; KIM et al. 2005; NAKATSUKASA et al. 2001; 
SZATHMARY et al. 2005). N-linked glycosylation occurs on proteins that possess the Asn-X-
Ser/Thr (NXS/T) consensus motif inside the ER lumen (HELENIUS and AEBI 2004). The N-linked 
glycosylation signal serves a dynamic timer of substrate folding and is based on the removal and 
addition of glucose residues (by glucosidases and glycosyl transferases, respectively), and the 
trimming of mannoses from the parent oligosaccharide (N-acetylglucosamine2 - mannose9 - 
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glucose3) (HELENIUS and AEBI 2004). Molecular chaperones and these lectins target misfolded 
ERAD-L substrates to the ER membrane via physical interactions with the transmembrane 
ubiquitin ligase complex. Here, they are presented to the catalytic portion of the E3 ubiquitin 
ligase found on the cytosolic side of the ER by a “retrotranslocation” mechanism that is poorly 
understood.  
 
The ubiquitin ligase of the yeast ERAD-L pathway is a transmembrane RING E3 known 
as Hrd1p (Figure 10) (BAYS et al. 2001a; HAMPTON et al. 1996). Hrd1p interacts with a number 
of different proteins to form a multi-protein complex that appears to regulate its ubiquitin ligase 
activity (CARVALHO et al. 2010; GARDNER et al. 2000). One key interactor with the Hrd1p E3 
enzyme is Cue1p, a transmembrane tether for the cytosolic E2-conjugating enzyme, Ubc7p 
(BIEDERER et al. 1997). Cue1p is part of a larger and poorly-characterized family of proteins 
defined by the monoubiquitin-binding CUE domain (SHIH et al. 2003). The ERAD-L pathway is 
defined by this particular E2 (Ubc7p) -E3 (Hrd1p) pairing. Hrd1p receives substrates via a 
physical interaction with second key partner, Hrd3p, which is a transmembrane receptor for the 
lumenal lectin-like chaperone and chaperone Yos9p and Kar2p/BiP, respectively (CARVALHO et 
al. 2006; DENIC et al. 2006; GARDNER et al. 2000; GAUSS et al. 2006). Hrd1p substrates are then 
linked to the cytosolic protein degradation machinery by a Hrd1p interaction with the 
transmembrane protein, Ubx2p (CARVALHO et al. 2006; DENIC et al. 2006; SCHUBERTH et al. 
2004). Ubx2p possesses a Ubiquitin Regulatory X (UBX) domain that is needed to recruit an 
abundant hexameric ATPase complex that contains Cdc48p (see below) (BUCHBERGER et al. 
2001; NEUBER et al. 2005; SCHUBERTH and BUCHBERGER 2005; SCHUBERTH et al. 2004; 
WILSON et al. 2006). The Cdc48p hexamer and Npl4p/Ufd1p cofactors provide the specificity 
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and mechanical force needed to retrotranslocate a substrate from the ER (see below) (BAYS et al. 
2001a; HITCHCOCK et al. 2001; JAROSCH et al. 2002; RABINOVICH et al. 2002; YE et al. 2001). 
This simplified ERAD-L model indicates that the Hrd1p complex serves as a central hub for 
receiving, ubiquitinating and recruiting the necessary cytosolic factors for substrate 
retrotranslocation from the ER.  
 
The Hrd1p protein has additional interaction partners that have incompletely characterized roles 
in the ERAD-L complex and pathway. For instance, Hrd1p interacts with Der1p, which from 
studies of the mammalian homolog Derlin-1 was proposed to be part of an undefined 
proteinaceous channel that allows substrates to pass from inside the ER to the cytosol (LILLEY 
and PLOEGH 2004; YE et al. 2004). While data supporting the Derlin-1/Der1p translocation 
channel model in yeast (and mammals) are lacking, yeast Der1p mutants have a rather significant 
protein degradation defect for many ERAD-L substrates, indicating an important and conserved 
role for this protein (HORN et al. 2009; KNOP et al. 1996; PLEMPER et al. 1999; SATO and 
HAMPTON 2006). Recently, the human Derlin-1 protein, which bears a resemblance to the 
rhomboid protease family, has been linked to ERAD, although the catalytic residue in Derlin-1 is 
mutated (GREENBLATT et al. 2011; ZETTL et al. 2011). The interaction between Hrd1p and Der1p 
is mediated by Usa1p, a transmembrane protein that contains a Ubiquitin-Like (UBL) domain 
(Horn 09). In the absence of Hrd3p, Hrd1p self-ubiquitination occurs in trans through a Usa1p-
mediated oligomerization of Hrd1p (CARROLL and HAMPTON 2010; GARDNER et al. 2000). The 
self-ubiquitination of Hrd1p ultimately leads to degradation but is largely independent of Der1p 
(CARROLL and HAMPTON 2010; HORN et al. 2009). In yeast, Dfm1p is a Der1p homolog which 
itself is an unstable protein that depends on Usa1p (HITT and WOLF 2004; STOLZ et al. 2010). 
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Unlike Der1p, Dfm1p mutants do not show defects in the ERAD-L pathway, but, conflictingly, 
may show a defect for a model, mutated transmembrane substrate (HITT and WOLF 2004; SATO 
and HAMPTON 2006; STOLZ et al. 2010). Genetic interaction studies suggest that Dfm1p may 
also function in a non-ERAD process that involves Cdc48p (SATO and HAMPTON 2006). And 
Dfm1p, but not Der1p genetically interacts with Cdc48p (SATO and HAMPTON 2006). While 
Hrd1p is best known for its role in the ERAD-L pathway, it was originally discovered as a 
protein required for the degradation of the transmembrane protein, Hmg2p (HAMPTON et al. 
1996). This example is not isolated, as Hrd1p is necessary for the degradation of other 
transmembrane proteins such as a mutated versions of the translocation channel, Sec61p, and the 
multi-drug resistance pump, Pdr5p (BIEDERER et al. 1997; PLEMPER et al. 1998). While there is 
still confusion about the roles of Hrd1p interaction partners, the simplest model is that the Hrd1p 
complex plays two roles in ERAD that are both mediated by Usa1p: a Der1p-dependent ERAD-
L, and a Der1p-independent ERAD-Membrane (ERAD-M) pathway (CARROLL and HAMPTON 
2010; HORN et al. 2009; SATO and HAMPTON 2006). In general, transmembrane proteins 
represent a complex class of ERAD substrates as they can have misfolded protein signatures on 
either side, or even within the lipid bilayer of the ER membrane. 
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Figure 10. The ERAD-L and ERAD-C Complexes 
The ERAD-L surveillance complex is composed of the chaperones Kar2p and Yos9p 
(grey), their receptor Hrd3p (orange), the ubiquitination machinery Hrd1p, Cue1p, and Ubc7p 
(dark blue, green, and light blue), and the retrotranslocation machinery, Cdc48p-Npl4p-Ufd1p 
and its receptor Ubx2p (yellow and magenta). The ERAD-C complex is composed of the 
chaperones of the HSP70 family (grey), the ubiquitination machinery Doa10p, Cue1p, and 
Ubc7p (black, green, and light blue, respectively), and the retrotranslocation machinery Cdc48p-
Npl4p-Ufd1p (yellow). In both cases, chaperones bring substrates to the ubiquitination 
machinery. Ubiquitinated substrates are then retrotranslocated into the cytosol for degradation by 
the 26S proteasome.  
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1.3.2 ERAD-Cytosol (ERAD-C) 
Proteins with offending lesions on the cytosolic side of the ER are targeted to the ERAD-Cytosol 
(ERAD-C) pathway. The ERAD-C pathway is quite similar in design to the ERAD-L pathway 
(Figure 10) (ISMAIL and NG 2006). In yeast, ERAD-C substrates are first recognized by 
cytosolic molecular chaperones (BUCK et al. 2007; HUYER et al. 2004; VASHIST and NG 2004). 
These chaperones include small HSPs, HSP70 (Ssa1p) and the Heat Shock Cognate 70 (HSC70) 
families of molecular chaperones (BRODSKY 2007). These cytosolic chaperones facilitate the 
interaction of the substrate with a second ER E3 ubiquitin ligase complex known as the Doa10p 
complex (HAN et al. 2007; NAKATSUKASA et al. 2008; SWANSON et al. 2001). It is unknown if 
there is a chaperone receptor analogous to Hrd3p, but given the location of ERAD-C substrates 
and their known interactions with chaperones, there may not be a requirement for such. 
Regardless, the Doa10p RING E3 ligase is linked to the E2-conjugating enzymes Ubc7p 
(through Cue1p), and to a transmembrane E2 known as Ubc6p (CARVALHO et al. 2006; 
SWANSON et al. 2001). Doa10p interacts with Ubx2p and Dfm1p, both of which are known to 
recruit the retrotranslocating ATPase, Cdc48p (SCHUBERTH and BUCHBERGER 2005; STOLZ et al. 
2010). Interestingly, some substrates appear to teeter between the ERAD-C and ERAD-L 
pathways. For instance, complicated transmembrane proteins such as the 12-transmembrane pass 
Ste6p and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) show dependence on 
both Hrd1p and Doa10p, and on Ubc6p and Ubc7p (GNANN et al. 2004; HUYER et al. 2004; 
VASHIST and NG 2004; ZHANG et al. 2001). Regardless of which ERAD pathway is used, 
ubiquitinated substrates are removed from the ER for degradation by the homohexameric 
Cdc48p ATPase complex. 
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1.4 CELL DIVISION CYCLE 48 (CDC48) 
The yeast Cdc48p protein is an evolutionarily-conserved ATPase of the ATPases Associated 
with various cellular Activities (AAA) family. CDC48 was first identified in a yeast screen for 
temperature-sensitive mutants of the cell cycle (MOIR et al. 1982). In mammals, a 25-amino acid 
peptide known as Valosin was identified from porcine intestine (SCHMIDT et al. 1985). Valosin 
was later discovered to be a proteolytic artifact, as its sequence corresponded to the second 
AAA-ATPase domain of a larger, 97 KDa protein called, Valosin-Containing Protein (VCP) 
(KOLLER and BROWNSTEIN 1987). The Cdc48p and p97/VCP proteins were identified as 
homologs in 1991, and both were found to form a homohexameric ring structure (FROHLICH et 
al. 1991; KOLLER and BROWNSTEIN 1987). Cdc48p is an extremely abundant protein, with some 
estimates of its abundance at over 1% of total cellular protein (LATTERICH et al. 1995).  The 
cellular functions of Cdc48p/p97/VCP are also incredibly diverse and include cell division, DNA 
repair, RNA transcription, protein translation, nuclear envelope/ER reformation, vesicle fusion, 
protein transport, endosome size formation, cell-wall integrity, autophagy, and protein quality 
control at both the ER (ERAD) and mitochondria (CAO et al. 2003; FROHLICH et al. 1991; FUJII 
et al. 2012; HETZER et al. 2001; HITCHCOCK et al. 2001; HSIEH and CHEN 2011; JAROSCH et al. 
2002; JU et al. 2009; KRICK et al. 2010; LATTERICH et al. 1995; MEERANG et al. 2011; MIYACHI 
et al. 2004; MOIR et al. 1982; PLEASURE et al. 1993; RAMADAN et al. 2007; RAPE et al. 2001; 
TRESSE et al. 2010; UCHIYAMA et al. 2006; VERMA et al. 2011; YE et al. 2001). The common 
theme in all these processes is ubiquitinated-protein processing. 
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1.4.1 The medical relevance of Cdc48p/p97/VCP 
The human p97/VCP is of considerable medical interest. For instance, the upregulation of 
p97/VCP mRNA and protein is associated with negative outcomes in many cancers (BERTRAM et 
al. 2008; VALLE et al. 2011; YAMAMOTO et al. 2003). Mutations in p97/VCP are known to 
directly cause two muscle-related diseases: Inclusion Body Myopathy associated with Paget’s 
disease of bone and Frontotemporal Dementia (IBMPFD) and a subtype of familial Amyotrophic 
Lateral Sclerosis (ALS) (JOHNSON et al. 2010; WATTS et al. 2004). Both diseases have 
overlapping molecular phenotypes, such ubiquitin-positive inclusions and the aggregation of 
TAR DNA binding Protein-43 (TDP-43) (GUINTO et al. 2007; JOHNSON et al. 2010; SCHYMICK 
et al. 2007). The mutations that cause IBMPFD and ALS are also commonly found the amino 
terminus or the first of two AAA-ATPase domains (see below, Figure 11) in p97/VCP 
(HALAWANI et al. 2009). In fact, some IBMPFD and ALS mutations are exactly the same (e.g., 
R155H and R191Q), strongly suggesting the presence of additional phenotype-modifying genetic 
loci (HALAWANI et al. 2009; JOHNSON et al. 2010; WATTS et al. 2004). The R191Q mutation in 
p97/VCP has also been recently linked to a third muscular disorder called Facioscapulohumeral 
Muscular Dystrophy-1 (SACCONI et al. 2012). Neuromuscular dysfunction seems to be a 
commonality of disease-causing p97/VCP mutations and suggests a shared molecular 
mechanism. IBMPFD may ultimately result from defects in autophagy and ERAD (JU et al. 
2009; WEIHL et al. 2006).  
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Figure 11. Domain map of Cdc48p 
Cdc48p is composed of three domains, the N-domain (blue) and two-AAA ATPase 
domains (red). The location of IBMPFD mutations are marked by upward-pointing arrowheads 
(light blue) and mutations found in the commonly used CDC48 allele, cdc48-3, are marked by 
the downward pointing arrowheads (purple).  
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1.4.2 Cdc48p/p97/VCP ATPase activity 
Each monomer of yeast Cdc48p and mammalian p97/VCP contains: 1) a cofactor binding 
amino-terminal domain (termed N domain), 2) two AAA-ATPase domains (termed D1 and D2) 
and 3) a carboxy terminal end that can also bind select cofactors (Figure 12). The AAA-ATPase 
domains each contain a Walker A and a Walker B motif which coordinate the binding and 
hydrolysis of ATP, respectively (HANSON and WHITEHEART 2005). ATP hydrolysis occurs at 
both ATPase domains, and is most extensively studied using the mammalian p97/VCP as a 
model (PYE et al. 2006). The purification of p97/VCP hexamers for structural studies, however, 
indicates that the D1 domain remains tightly bound to ADP while the D2 domain can be empty, 
or bound to ADP or to transition state analogs (PYE et al. 2006). This finding has been validated 
by biochemical and genetic experiments supporting the idea that the bulk of p97/VCP ATPase 
activity comes from the D2 ATPase domain (SONG et al. 2003; WANG et al. 2003; YE et al. 
2003). The D1 ATPase domain is believed to be mainly involved in some aspect of 
Cdc48p/p97/VCP hexamerization (SONG et al. 2003; WANG et al. 2003; YE et al. 2003). 
Structural data indicate that these two ATPase domains do not function in isolation, and that 
ATPase hydrolysis in one domain contributes to structural changes in the other domain within 
the same protomer and also between neighboring protomers (DELABARRE and BRUNGER 2003; 
LI et al. 2012). ATPase activity also contributes to conformational changes in the cofactor-
binding amino-terminal N domain (NIWA et al. 2012; PYE et al. 2006; ROUILLER et al. 2002). 
This is an attractive way of converting ATP hydrolysis to mechanical work on a substrate. 
Indeed, Cdc48p/p97/VCP has been suggested to aid in protein unfolding, possibly by funneling 
proteins through the central pore of the hexamer (DELABARRE et al. 2006). Definitive evidence 
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for this is still lacking, and the reality is we still have very little idea as to how Cdc48p/p97/VCP 
acts to retrotranslocate a substrate during ERAD. Interestingly, all IBMPFD mutants tested by 
Niwa and colleagues (2012) showed increased D2 domain ATPase activity, and in at least one 
known mutant (A232E), the increased ATPase activity required the presence of the N domain. 
The carboxy terminus was also required for D2 ATPase. In addition, in Arabidopsis, a Ubiquitin-
Regulatory X (UBX) domain protein known as AtPUX1 was shown to down-regulate ATPase 
activity and promote hexamer disassembly (PARK et al. 2007; RANCOUR et al. 2004). Similarly, 
the mammalian UBX protein TUG down-regulates p97/VCP ATPase activity and promotes 
hexamer disassembly (ORME and BOGAN 2012). Other mammalian UBX protein such as p47 and 
SAKS1 have also been shown to negatively regulate p97/VCP vesicle formation and ERAD 
function, respectively, but it is unknown if either affects hexamer stability (BRUDERER et al. 
2004; LALONDE and BRETSCHER 2011; MEYER et al. 1998). Only one example of cofactor 
binding increases ATPase activity: Synaptotagmin, which is a tramsmembrane protein involved 
in vesicle fusion, may increase the ATPase activity of p97/VCP, but the relevance of this 
phenomena is not currently understood (DELABARRE et al. 2006; MARTENS et al. 2007). Finally, 
cofactor binding to p97 has also been demonstrated to induce major conformational changes and 
likely modulates the activity of either the D1 or D2 ATPase domain (BEURON et al. 2006).  
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Figure 12. Cdc48p cofactors 
An abbreviated list of cofactors and their functional domains. Ubiquitin interacting 
domains (yellow) include Ubiquitin-Associated (UBA), Ubiquitin Interacting Motif (UIM), 
PLAA family ubiquitin binding domain (PFU), and Ubiquitin Fusion Degradation domain 
(UFD). Cdc48p interaction domains (pink) include Ubiquitin Regulatory X (UBX) and UBX-like 
(UBX-L), PLAP, UFD3 and Lub1 (PUL), and VCP/p97 Interacting Motif (VIM). 
Uncharacterized domains (grey) include Shp1, Eyc and p47 (SEP) and UAS. E3 or DUB 
domains (light blue) include the Ovarian Tunor (OUT) and Ubox modified ring finger (UBOX). 
Scaffold domains (dark grey) include WD-40 and the Ankyrin repeat. The C2H2 zinc finger 
motif is in green. Adapted from (SCHUBERTH and BUCHBERGER 2008).  
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1.4.3 Cdc48p/p97/VCP cofactors 
While Cdc48p has an innate ability to recognize unfolded proteins, the overwhelming majority of 
Cdc48p/p97/VCP-associated functions relies on its interaction partners (THOMS 2002; YEUNG et 
al. 2008). In this section, I will focus primarily on yeast Cdc48p interaction partners that are 
relevant to the ERAD pathway, and highlight examples from higher organisms as necessary. 
1.4.3.1 UBX-domain cofactors 
The UBX domain family of proteins represents the most abundant group of Cdc48p cofactors 
(see above, Figure 12) (SCHUBERTH and BUCHBERGER 2008). The UBX domain is an 80 amino 
acid motif that structurally resembles ubiquitin (BUCHBERGER et al. 2001). Seven UBX domain-
containing proteins exist in S. cerevisiae (UBX1-7), but only two are functionally characterized. 
The first, Ubx1p (also known as Shp1p), was originally isolated as a suppressor of lethality 
caused by the overexpression of the phosphatase Glc7p (ZHANG et al. 1995). Insights into Ubx1p 
function came from studies of the mammalian version of Ubx1p, p47 (see above) and showed 
that a complex of p97 and p47 regulated Golgi-vesicle membrane fusion (KONDO et al. 1997). In 
yeast, Ubx1p was found to be involved in the vacuolar degradation of fructose-1,6-
bisphosphatase and regulated autophagosome formation (CUI et al. 2004; KRICK et al. 2010). 
One of the earliest discovered roles for yeast Cdc48p was homotypic ER membrane fusion 
(LATTERICH et al. 1995). In addition, Ubx1p is required for the degradation of model ubiquitin-
fusion degradation substrates, the UV-response mediated degradation of RNA Polymerase II, 
and the degradation of a classic ERAD-L substrate (SCHUBERTH et al. 2004; TRAN et al. 2011; 
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VERMA et al. 2011). Ubx2p was also first characterized as being involved in ubiquitin-fusion 
substrate degradation (SCHUBERTH et al. 2004). A series of papers in 2005 and 2006 showed that 
Ubx2p is a transmembrane protein that acts as a recruitment factor for Cdc48p (NEUBER et al. 
2005; SCHUBERTH and BUCHBERGER 2005; WILSON et al. 2006). Ubx2p was found as an 
associated component of the ER E3 ubiquitin ligases, Hrd1p and Doa10p, and is required for the 
retrotranslocation of select ERAD substrates (see above) (CARVALHO et al. 2006; DENIC et al. 
2006; GARZA et al. 2009). Recent data suggest that Ubx2p, and the human homolog, UBXD8, 
are involved in ERAD substrate retrotranslocation through lipid droplets – an organelle that 
provides both storage and metabolic functions (FARESE and WALTHER 2009; SUZUKI et al. 2012; 
WANG and LEE 2012).  
 
In contrast to these two UBX proteins, relatively little is known about the yeast Ubx3p-7p 
proteins. Some data suggest that Ubx4p is involved in protein degradation either on its own or 
with other cofactors such as the UBX proteins, Ubx6p and Ubx7p (ALBERTS et al. 2009; 
DECOTTIGNIES et al. 2004; TRAN et al. 2011). Ubx4p is the yeast version of TUG (see above), a 
protein linked to the trafficking of GLUT4 upon insulin stimulation (BOGAN et al. 2003). 
Additionally, the mammalian version of Ubx7p, Erasin/UBXD2 localizes to the ER, is found in 
complex with ERAD components, and affects the degradation of a model substrate (LIANG et al. 
2006; LIM et al. 2009). The mammalian version of Ubx5p, UBXD7, has recently been linked to 
SCF-RING mediated protein degradation (ALEXANDRU et al. 2008). In addition, one study 
suggests that Ubx5p-7p plays a role in DNA damage response (LIS and ROMESBERG 2006). 
Overall, UBX domain-containing proteins contribute significantly to Cdc48p/p97/VCP 
functional diversity. 
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1.4.3.2 Ubiquitin Fusion Degradation (UFD) cofactors 
The Ubiquitin Fusion Degradation (UFD) group of cofactors was originally identified in a screen 
for mutants that stabilized a normally short-lived version of beta-galactosidase (JOHNSON et al. 
1995). A majority of UFD genes encoded for Cdc48p interaction partners, but not all. For 
instance, Ufd4p and Ufd5p are linked to proteasome function. Ufd4p is an E3 ligase associated 
with the 19S base of the proteasome and Ufd5p is Rpn4p, the transcription factor responsible for 
controlling proteasome levels (see section 1.2.6.) (XIE and VARSHAVSKY 2000; XIE and 
VARSHAVSKY 2001). Ufd1p, Ufd2p, and Ufd3p have since been identified as Cdc48p interaction 
partners (Figure 12).  
 
The UFD3 gene was found to be identical to the “Degradation of Alpha 1” (DOA1) gene, 
and encodes a WD-40 repeat protein that appears to be involved in regulating ubiquitin 
homeostasis (GHISLAIN et al. 1996; JOHNSON et al. 1995). Most recently, Ufd3p was implicated 
in the bulk degradation of ribosomes (ribophagy), DNA damage response, and the sorting of 
ubiquitinated plasma membrane proteins (LIS and ROMESBERG 2006; OSSAREH-NAZARI et al. 
2010; REN et al. 2008). Ufd3p does not seem to play a role in ERAD (MULLALLY et al. 2006). 
While the exact function of Ufd3p remains unclear, Ufd3p is one of the few Cdc48p cofactors 
that binds at the carboxy terminus, via a PLAP, UFD3 and Lub1, or PUL domain (ZHAO et al. 
2009). The Ufd3p-Cdc48p complex can bind the DUB, Otu1p (see above) and excludes the 
binding of a second PUL-domain containing protein, Ufd2p (RUMPF and JENTSCH 2006). This 
competitive binding occurs at the same site in the Cdc48p carboxy terminus, and leads to a 
Cdc48p complex that can either remove or add ubiquitin moieties to a substrate (BOHM et al. 
2011; RUMPF and JENTSCH 2006). Ufd2p is a U-box containing protein that extends K48 
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polyubiquitin chains and was discussed briefly in section 1.1.2 (KOEGL et al. 1999; 
NAKATSUKASA et al. 2008; SAEKI et al. 2004). UFD2 mutants, alone or when deleted with other 
Cdc48p cofactors, stabilize select ubiquitin proteasome substrates (LIU et al. 2011; 
NAKATSUKASA et al. 2008; TRAN et al. 2011). The mammalian version of Ufd2p, UBE4B, is 
involved in the degradation of the tumor suppressor p53 and in the pathology of certain 
neurological conditions (CONFORTI et al. 2000; WU et al. 2011). 
 
Perhaps the most recognizable UFD group member is Ufd1p. Ufd1p is an essential 
protein that forms a heterodimeric complex with Npl4p (JOHNSON et al. 1995; MEYER et al. 
2000). This heterodimeric complex binds to the N-domain of Cdc48p and can directly bind to 
ubiquitinated substrates (MEYER et al. 2000; MEYER et al. 2002; YE et al. 2001). Ufd1p and 
Npl4p mutants were initially linked to the proteasomal activation of ER-bound transcription 
factors, Spt23p/Mga2p (HITCHCOCK et al. 2001; HOPPE et al. 2000). A series of papers in 2001 
and 2002 further connected the Cdc48p-Npl4p-Ufd1p complex to the retrotranslocation of 
ubiquitinated ERAD substrate (BAYS et al. 2001b; HITCHCOCK et al. 2001; JAROSCH et al. 2002; 
RABINOVICH et al. 2002; YE et al. 2001). It is clear that these proteins, in complex with Cdc48p, 
are important for many ubiquitin-dependent processes in addition to ERAD (see above). 
Moreover, the Cdc48p complex is proposed to have the ability to separate ubiquitinated 
substrates from unmodified proteins, and probably reflects the segregase activity of the complex 
(BRAUN et al. 2002; SHCHERBIK and HAINES 2007). 
1.4.3.3 Additional Cofactors that function with Cdc48p 
During ERAD, UBX proteins, such as Ubx2p, can recruit the Cdc48p-Npl4p/Ufd1p to sites of 
protein ubiquitination. In this model, the Cdc48p-Npl4p-Ufd1p complex can then 
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retrotranslocate the ubiquitinated substrate and the presence of additional cofactors like Ufd2p 
can further extend the polyubiquitin chain (NAKATSUKASA et al. 2008). Nevertheless, a 
polyubiquitinated substrate that has been retrotranslocated requires additional proteins to 
facilitate proteasomal degradation. This is surprising given the fact that the proteasome has 
receptors for ubiquitin itself (see above). Moreover, the Cdc48p complex can be found 
associated with the proteasome (VERMA et al. 2000). Three proteins that fit this role are Rad23p, 
Dsk2p, and Ddi1p. All three proteins possess a Ubiquitin-Like (UBL) domain that mediates 
interaction with the 26S proteasome and a Ubiquitin-Associated (UBA) domain for interaction 
with ubiquitinated substrate (DANTUMA et al. 2009). Rad23p was originally described as a DNA 
repair protein and was the first of these proteins linked to the 26S proteasome (SCHAUBER et al. 
1998). Rad23p and Dsk2p were found as a complex that could bind to ubiquitinated substrates 
and to the Rpn1p subunit of the proteasome (ELSASSER et al. 2002; RAO and SASTRY 2002; 
SAEKI et al. 2002). Rad23p-Dsk2p could also be purified with Ufd2p and competitive binding 
experiments suggested that Rpn1p competes with Ufd2p for Rad23p (KIM et al. 2004; RICHLY et 
al. 2005). A complex of Cdc48p-Rad23p-Ufd2p was also isolated (RICHLY et al. 2005). 
Interestingly, Rad23p was also found in complex with Png1p, a cytosolic enzyme that can 
deglycosylate a misfolded protein (KIM et al. 2006). Relevant to this discussion, Rad23p-Dsk2p 
mutants showed an ERAD defect (MEDICHERLA et al. 2004; RICHLY et al. 2005). These data 
ultimately suggest a model in which the substrate has its polyubiquitin chain extended by 
Cdc48p-Ufd2p, possibly in complex with Rad23p-Dsk2p. This is followed by Rpn1p 
competition, leading to the loss of Ufd2p and proteasomal degradation of the substrate. 
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Table 1. Relevant factors of the ERAD pathway 
Yeast Human Function 
CDC48 VCP Multifunctional AAA ATPase, forms hexamer. 
NPL4 NPLOC4 Dimerizes with Ufd1p/UFD1L. 
UFD1 UFD1L Dimerizes with Npl4p/NPLOC4. 
UFD2 UBE4A & UBE4B E4 polyubiquitin extending enzyme. 
UFD3/DOA1 PLAA Involved in regulating ubiquitin levels. WD40 repeat protein. 
UFD4 TRIP12 E3 ubiquitin ligase associated with the proteasome. 
UBX1/SHP1 NSFL1C UBX domain protein. Involved in homotypic vesicle fusion 
UBX2 UBXD8/ETEA UBX domain protein. Recruits Cdc48p to the Endoplasmic Reticulum 
UBX3 - UBX domain protein. Transmembrane. 
UBX4 TUG/ASPL UBX domain protein. Potentially involved in ERAD. 
UBX5 UBXD7 UBX domain protein. 
UBX6 - UBX domain protein. Potential role in ubiquitin-mediated proteolysis 
UBX7 UBXD2/Erasin UBX domain protein. Potential role in ubiquitin-mediated proteolysis 
VMS1 ANKZF1 Cdc48p/VCP cofactor. Involved in ubiquitin-mediated proteolysis. 
HRD1 SYVN1 E3 ubiquitin ligase of the Endoplasmic Reticulum. 
HRD3 SEL1L 
Protein of the Endoplasmic Reticulum, involved in ERAD. Part of the Hrd1p 
complex. 
USA1 - 
Protein of the Endoplasmic Reticulum, involved in ERAD. Part of the Hrd1p 
complex. 
YOS9 OS9 Lectin of the ER lumen. Part of the Hrd1p complex. 
DOA10 MARCH VI E3 ubiquitin ligase of the Endoplasmic Reticulum. 
UBC6 UBE2J2 E2 ubiquitin conjugating enzyme. Involved in ERAD. 
UBC7 UBE2G2 E2 ubiquitin conjugating enzyme. Involved in ERAD. 
DER1 DER2L, DER3L Protein of the Endoplasmic Reticulum. Involved in ERAD. 
CUE1 - Protein of the Endoplasmic Reticulum. Involved in ERAD. 
RPT1 PSMC2 AAA ATPase subunit of the 19S base. 
RPT2 PSMC1 AAA ATPase subunit of the 19S base. 
RPT3 PSMC4 AAA ATPase subunit of the 19S base. 
RPT4 PSMC6 AAA ATPase subunit of the 19S base. 
RPT5 PSMC3 AAA ATPase subunit of the 19S base. Candidte ubiquitin receptor.  
RPT6 PSMC5 AAA ATPase subunit of the 19S base. 
RPN1 PSMD2 Non-ATPase component of 19S base. Candidate ubiquitin receptor. 
RPN2 PSMD1 Non-ATPase component of 19S base. Binds to Rpn13 
RPN10 PSMD4 Non-ATPase component of 19S base. Ubiquitin receptor.  
RPN3 PSMD3 Non-ATPase component of 19S basse. 
RPN5 PSMD12 Component of the 19S lid. 
RPN6 PSMD11 Component of the 19S lid. 
RPN7 PSMD6 Component of the 19S lid. 
RPN8 PSMD7 Component of the 19S lid. 
RPN9 PSMD13 Component of the 19S lid. 
RPN11 PSMD14 Component of the 19S lid. Deubiquitinating enzyme. 
RPN12 PSMD8 Component of the 19S lid. 
RPN13 ADRM1 Component of the 19S lid. Deubiquitinating enzyme. 
RPN14 PAAF1 Chaperone of the 19S Regulatory Particle. 
RPN15/SEM1 SHFM1 Non-ATPase component of 19S base. 
HSM3 PSMD5 Chaperone of the 19S Regulatory Particle. 
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NAS2 PSMD9 Chaperone of the 19S Regulatory Particle. 
NAS6 PSMD10 Chaperone of the 19S Regulatory Particle. 
RAD23 RAD23A/RAD23B Ubiquitinated substrate escort factor. Also involved in DNA damage repair. 
DSK2 UBQLN1 Ubiquitinated substrate escort factor.  
DDI1 DDI1/DDI2 Possible ubiquitinated substrate escort factor. DNA damage inducible.  
PBA1 PSMG1 Chaperone of the 20S core particle. 
PBA2 PSMG2 Chaperone of the 20S core particle. 
PBA3 PSMG3 Chaperone of the 20S core particle. 
PBA4 PSMG4 Chaperone of the 20S core particle. 
UMP1 POMP1 Chaperone of the 20S core particle. 
ECM29 ECM29 Stabilizer of the proteasome. 
BLM10 PSME4 Activator of the proteasome. Human version also called PA200. 
UFD5/RPN4 - 
Transcription factor regulating proteasome levels. Functional homolog is 
NRF1. 
SCL1 PSMA6 20S core subunit alpha 1. 
PRE8 PSMA2 20S core subunit alpha 2. 
PRE9 PSMA4 20S core subunit alpha 3. 
PRE6 PSMA7 20S core subunit alpha 4. 
PUP2 PSMA5 20S core subunit alpha 5. 
PRE5 PSMA1 20S core subunit alpha 6. 
PRE10 PSMA3 20S core subunit alpha 7. 
PRE3 PSMB6 20S core subunit beta 1. 
PUP1 PSMB7 20S core subunit beta 2. 
PUP3 PSMB3 20S core subunit beta 3. 
PRE10 PSMB2 20S core subunit beta 4. 
PRE2 PSMB5 20S core subunit beta 5. 
PRE7 PSMB1 20S core subunit beta 6. 
PRE4 PSMB4 20S core subunit beta 7. 
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1.5 PREVIEW OF CHAPTERS 2 THROUGH 4 
While our view of the ERAD pathway is becoming more and more complete, there are still 
lingering questions concerning the role of Cdc48p during ERAD. For instance, Cdc48p/p97/VCP 
has been found in a stable complex with the 26S proteasome, which is counter to the processive 
and transient nature of protein degradation (BESCHE et al. 2009a; DAI et al. 1998; DUBIEL et al. 
1995; VERMA et al. 2000). Additionally, Cdc48p is known to bind to many cofactors, most of 
which are uncharacterized (KROGAN et al. 2006). One of these cofactors, encoded by the 
YDR049W gene, was isolated from a gene expression profile study of yeast expressing a model 
misfolded substrate (AHNER et al. 2007). Ydr049p was found in a large multi-protein complex 
with Cdc48p and was also linked to the DOA pathway, which includes the ERAD-C E3 ligase 
Doa10p (KROGAN et al. 2006; RAVID et al. 2006). The Ydr049p protein contains a C2H2-type 
zinc finger, an Ankyrin repeat, and a “VCP/p97-Interacting Motif” (VIM). In Chapter 2, I will 
present data indicating that Ydr049p functions at a post-ubiquitination step in the ERAD 
pathway. I specifically found that deleting the yeast YDR049W gene leads to a modest defect in 
the ERAD of a model substrate, the Cystic Fibrosis Transmembrane Conductance Regulator. I 
will also present data indicating that Ydr049p plays a redundant role with other Cdc48p 
cofactors. And finally, I show that loss of YDR049W does not affect ERAD substrate 
ubiquitination, and leads to accumulation of Cdc48p-associated ubiquitinated proteins. During 
the course of my work, an independent group led by Dr. Jared Rutter from the University of Utah 
discovered that the Ydr049 protein was involved in Cdc48p-dependent mitochondrial protein 
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degradation (HEO et al. 2010). They termed the YDR049W gene, VCP/Cdc48-associated 
Mitochondrial Stress-responsive, or VMS1. From this point on, I shall use their nomenclature for 
this gene. In Chapter 3, I will present data that indicates that Vms1p functions in proteasome 
biology. First I demonstrate that VMS1 deletion causes an increased accumulation of 
ubiquitinated proteins in total cell extracts. Second, VMS1 deletion changes the distribution of 
proteasome subtypes. Specifically, there is an increase in free latent 20S core particle and a 
decrease in the ubiquitin-processing capped forms of the proteasome. Both of these phenomena 
can be restored to near wild-type conditions with a version of Vms1p that maintains its 
interaction with Cdc48p. I also provide evidence indicating that Cdc48p recruits Vms1p to the 
proteasome, and that Vms1p does not function with select proteasome chaperones. Finally, I 
present data that Cdc48p interaction with the proteasome is preserved in VMS1 mutants. 
Cumulatively, this work suggests that Cdc48p-Vms1p aids in the efficient turnover of 
ubiquitinated proteins by promoting the stability of ubiquitin substrate-competent proteasomes. 
In Chapter 4, I will summarize my finding and detail some potential future goals. 
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2.0  VMS1 FUNCTIONS AT A POSTUBIQUITINATION STEP IN THE ERAD 
PATHWAY 
Endoplasmic Reticulum-Associated Degradation (ERAD) clears the early secretory pathway of 
misfolded proteins, and can be sub-divided into distinct stages of substrate recognition and 
membrane targeting, retrotranslocation from the ER into the cytoplasm, ubiquitination, and 
degradation by the 26S proteasome (VEMBAR and BRODSKY 2008). Given the volume and 
diversity of protein traffic through the ER, it is not surprising that the cell has evolved unique 
ERAD pathways (e.g., ERAD-L, ERAD-C, and ERAD-M) that handle substrates based on the 
location of the offending lesion (SMITH et al. 2011; VASHIST and NG 2004; VEMBAR and 
BRODSKY 2008). Irrespective of the ERAD pathway employed, the retrotranslocation of most 
substrates relies upon the Cdc48p complex, which consists of the homohexameric Cdc48p ring 
and two adaptor proteins, Npl4p and Ufd1p  (BAYS et al. 2001b; HITCHCOCK et al. 2001; 
JAROSCH et al. 2002; RABINOVICH et al. 2002; YE et al. 2001). Cdc48p, the yeast homolog of 
p97/Valosin Containing Protein (p97/VCP), is a multifunctional member of the ATPases 
Associated with various Activities (AAA) family. This family also includes the ATPase ring of 
the 26S proteasome and the MCM complex, which is involved in DNA replication. Like other 
AAA proteins, Cdc48p is thought to couple ATP hydrolysis with changes in the conformation of 
its targets (NIWA et al. 2012; PYE et al. 2006; ROUILLER et al. 2002). The specificity of Cdc48p 
function relies on the cofactors to which it binds (BUCHBERGER et al. 2010).  
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While many Cdc48p cofactors have been identified in recent years, very few of these are 
functionally characterized. Of the ones that are, it is not uncommon to find that the cofactor 
functions in many different processes. For example, Ubx1p, also known as Shp1p, was originally 
isolated as a suppressor of phosphoprotein phosphatase 1 overexpression, but was later found to 
participate in Golgi vesicle fusion, ubiquitin-mediated degradation of select substrates, and 
autophagy (CUI et al. 2004; KONDO et al. 1997; KRICK et al. 2010; SCHUBERTH et al. 2004; 
TRAN et al. 2011; ZHANG et al. 1995).  Ubx1p is one member of a larger group of generally 
uncharacterized UBX-domain containing proteins (BUCHBERGER et al. 2010). The UBX domain 
mediates binding to Cdc48p, and its tertiary structure resembles ubiquitin (BUCHBERGER et al. 
2001). Other members of the UBX family have also been linked to ubiquitin-mediated protein 
degradation. For example, Ubx2p recruits the Cdc48p-Npl4p-Ufd1p complex to the ER 
membrane and ubx2Δ yeast exhibit ERAD defects (NEUBER et al. 2005; SCHUBERTH and 
BUCHBERGER 2005; WILSON et al. 2006).   
 
Another group of Cdc48p-associated proteins were first isolated as mutants that impaired 
the degradation of Ubiquitin Fusion Degradation (UFD) substrates (JOHNSON et al. 1995).  As 
noted above, Ufd1p is a Cdc48p partner and is required for ERAD.  Ufd2p is a Cdc48p-
associated ubiquitin chain assembly factor, catalyzing the extension of ubiquitin chains (KOEGL 
et al. 1999; NAKATSUKASA et al. 2008). Additionally, a deubiquitinating enzyme (DUB), known 
as Otu1p, binds the Cdc48p complex and antagonistic interactions amongst Ufd2p, and Ufd3p-
Otu1p have been observed (RUMPF and JENTSCH 2006).  Nevertheless, it is unknown how 
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Cdc48p’s function during ERAD is altered by most of these partners, and whether additional, ill-
characterized partners of Cdc48p also impact ERAD. 
 
In this Chapter, I report on the characterization of a new Cdc48p cofactor that is encoded 
by the VMS1/YDR049W open reading frame in the yeast, Saccharomyces cerevisiae.  Large-scale 
yeast proteomic studies uncovered Vms1p in a multi-protein complex that contains Cdc48p 
(KROGAN et al. 2006).  Deletion of VMS1 was also observed to exhibit mild synthetic growth 
defects in yeast compromised for the Degradation of Alpha (DOA) pathway (RAVID et al. 2006).  
Moreover, yeast lacking VMS1 were reported to exhibit synthetic interactions in karmellae-
forming yeast, suggesting a role in ER membrane homeostasis (WRIGHT et al. 2003).  Here, I 
demonstrate that VMS1 deletion affects the ERAD of a model transmembrane substrate, the 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and that VMS1 exhibits genetic 
interactions with select members of the UBX and UFD pathway. In some cases, the genetic 
interaction is supported by increased sensitivity to ER- and oxidative stressors and in other cases 
by synergistic ERAD defects. Finally, I show that increased levels of ubiquitinated species are 
associated with Cdc48p in vms1Δ yeast. 
2.1 EXPERIMENTAL PROCEDURES 
2.1.1 Yeast strains, plasmids, and growth assays 
Most yeast strains employed in this study (Table 2) were in the BY4742 background, and were 
obtained from Open Biosystems (Thermo Scientific, USA) or were made by disrupting the gene 
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by homologous recombination using resistance marker cassettes amplified from the plasmids 
pRS400 (KanMX4) or pFA6-His3MX (His3MX) (54,55). Synthetic primers used to construct 
linear DNA strands for gene disruption contained 50-100bp of sequence homology as well as 
sequences to amplify the cassette. A complete list of primers used to make the strains in this 
study is provided in Table 3.  Yeast harboring multiple gene deletions were made by standard 
genetic techniques (ADAMS 1997). In brief, strains were mated on rich media (YPD: 1% yeast 
extract, 2% peptone, 2% dextrose), and after 4-6 h at 30ºC diploids were selected on synthetic 
complete (SC) media lacking both lysine and histidine. Diploids were nitrogen-starved for 3-7 d 
in sporulation media (1% KOAc, 0.1% Bacto yeast extract, 0.05% dextrose) prior to tetrad 
dissection. The resulting germinated spores were screened on the appropriate media and 
deletions were confirmed by PCR. To introduce the cdc48-3 allele into the BY background, a 
cdc48-3 strain (MATa, his4-619, leu2,3,-112, ura3, pep4Δ::URA3, cdc48-3) in a S288C 
background was crossed against a BY strain of the opposite mating type. The resulting cdc48-3 
strain from this genetic cross was backcrossed three additional times against the BY background. 
The cdc48-3 strain derived from these backcrosses was then used.   
 
The plasmids used in the study (Table 4) were described previously, or created by PCR 
amplification and cloned as follows. For the construction of C-terminal HA- or myc-tagged 
Cdc48p constructs, two-PCR fragments were generated and ligated together into the desired 
plasmid. The first fragment was amplified with the forward primer: 5’-
TTGCGGCCGCGGTGGCCAGCCCAAGAAACGGA and the reverse primer: 5’-
ACGGATCCACTATACAAATCATCATCTTCC. These primers were synthesized with a NotI 
restriction site in the forward primer and a BamHI restriction site in the reverse primer 
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(underlined). The resulting PCR product started 437bp upstream of the ORF and contained the 
entire CDC48 ORF minus the termination codon. The second fragment was PCR amplified in a 
reaction with either the forward primer: 5’ACGGATCCTACCCATACGACGTCCCA 
GACTACGCTTAGTAGTTATATGCCAGGTATATTTTTATTTTAAATCG for the HA-
tagged constructs (the HA tag sequence is in boldface), or the forward primer 5’-
ACGGATCCGAACAAAAACTCATCTCAGAAGAGGATCTGTAGTAGTTATATGCCAG
GTATATTTTTATTTTAAATCG for myc-tagged constructs (the myc tag sequence is in 
boldface), paired with the reverse primer 5’-AGCTCGAGACGACCGAGGTCCTACAGCCT. 
Both forward primers contained a BamHI site while the reverse primer contained an XhoI site 
(underlined). The resulting PCR fragments encoded either a single in-frame copy of the HA or 
myc epitope tag followed by the termination codon in duplicate, and 221bp of the 3’ intergenic 
sequence. The PCR fragments were restriction digested and gel extracted prior to ligation into a 
pRS315 plasmid that was similarly digested with NotI and XhoI (SIKORSKI and HIETER 1989). 
Sequence verified constructs were used to create a library of expression vectors in the pRS316, 
pRS425 and pRS426 backbones (CHRISTIANSON et al. 1992; SIKORSKI and HIETER 1989).  
To generate plasmids for the expression of an untagged form of Cdc48p, the forward 
primer: 5’-TTGCGGCCGCGGTGGCCAGCCCAAGAAACGGA and the reverse primer 5’-
AGCTCGAGACGACCGAGGTCCTACAGCCT were used in a PCR reaction. The PCR 
fragment, which contained the full-length, untagged CDC48 gene, was digested with NotI and 
XhoI (underlined) and cloned into pRS315 (SIKORSKI and HIETER 1989). Sequence verified 
constructs were used to create a library of expression vectors in the pRS316, pRS425, and 
pRS426 backbones (CHRISTIANSON et al. 1992; SIKORSKI and HIETER 1989). A similar ligation 
strategy was used to clone the tagged and untagged versions of VMS1. The first fragment was 
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amplified using the forward primer: 5’-CTGCGGCCGCTTCTTGGAGGAGTGCCACAG and 
the reverse primer: 5’-ACGGATCCGTATTTCTTTTTCATCCTTTCTTCTGCG. The forward 
primer contains a NotI site while the reverse primer contains a BamHI site (underlined). This 
PCR fragment contains 341bp upstream of the ORF and the entire VMS1 ORF except the 
termination codon. For the second fragment, either the forward primer: 5’-
ACGGATCCTACCCATACGACGTCCCAGACTACGCTTGATGAGGAATATCTCATAT
TCAAATTTTTAGG for the HA-tagged construct (in boldface) or the forward primer: 5’-
ACGGATCCGAACAAAAACTCATCTCAGAAGAGGATCTGTGATGAGGAATATCTCA
TATTCAAATTTTTAGG for the myc-tagged construct (in boldface) was used in a PCR reaction 
with the reverse primer: 5’- CGGTCGACGGCGTCATTTTCGCGTTGAG. Both forward 
primers contained BamHI sites (underlined) while the reverse primer contained a SalI restriction 
site (underlined). The resulting PCR fragment contained the HA or Myc-tag followed by a 
termination codon in duplicate and 227bp of the 3’ intergenic sequence. For untagged VMS1 
constructs, the forward primer: 5’-CTGCGGCCGCTTCTTGGAGGAGTGCCACAG and the 
reverse primer: 5’- CGGTCGACGGCGTCATTTTCGCGTTGAG were paired in the PCR 
reaction. The primers contained a NotI and SalI restriction site, respectively. Cloning was done 
as described for the tagged and untagged forms of CDC48.  
 
To examine the growth of yeast under various conditions, log-phase cells grown at 26ºC were 
harvested and resuspended in sterile water to a final A600 of 1.0. Ten-fold serial dilutions were 
spot plated on the indicated media and grown for 2 to 6 d at 30° or 38°C. 
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Table 2. List of strains used in this study 
All strains were in the BY4742 background. 
Strain  Genotype Reference 
   
BY4742 MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15 Open Biosystems 
vms1Δ::HIS3 MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3 This study 
vms1Δ::KanMX MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::KanMX Open Biosystems 
vms1Δ MATα/A, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::KanMX, vms1Δ::HIS3 This study 
ufd2Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::KanMX Open Biosystems 
ufd2Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ufd2Δ::KanMX This study 
ufd3Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd3Δ::KanMX Open Biosystems 
ufd3Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ufd3Δ::KanMX This study 
ubx1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx1Δ::KanMX Open Biosystems 
ubx1Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx1Δ::KanMX This study 
ubx2Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx2Δ::KanMX Open Biosystems 
ubx2Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx2Δ::KanMX This study 
ubx3Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx3Δ::KanMX Open Biosystems 
ubx3Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx3Δ::KanMX This study 
ubx4Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx4Δ::KanMX Open Biosystems 
ubx4Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx4Δ::KanMX This study 
ubx5Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx5Δ::KanMX Open Biosystems 
ubx5Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx5Δ::KanMX This study 
ubx6Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx6Δ::KanMX Open Biosystems 
ubx6Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx6Δ::KanMX This study 
ubx7Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx7Δ::KanMX Open Biosystems 
ubx7Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx7Δ::KanMX This study 
cdc48-3 MATα, his3Δ1, leu2, ura3, lys2Δ0, MET15, cdc48-3 This study 
cdc48-3 vms1Δ MATα, his3Δ1, leu2, ura3, lys2Δ0, MET15, cdc48-3, vms1Δ::KanMX This study 
pdr5Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, pdr5Δ::KanMX Open Biosystems 
pdr5Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, pdr5Δ::KanMX This study 
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Table 3. List of oligonucleotide primers used in this study 
Restriction enzyme recognition sites are underlined and the sequences encoding epitope 
tags are in bold. 
Oligo Sequence 
  
vms1Δ::KanMX-F ggattttcaaaagatctgcacgcctgttgacaagcttccaatagcatctgtgcggtatttcacaccg 
vms1Δ::KanMX-R gcaaatgctaagaaaaatcctaaaaatttgaatatgagatattccagattgtactgagagtgcac 
vms1Δ::HIS3-F ggattttcaaaagatctgcacgcctgttgacaagcttccaatagcatcggatccccgggttaattaa 
vms1Δ::HIS3-R gcaaatgctaagaaaaatcctaaaaatttgaatatgagatattccgaattcgagctcgtttaaac 
VMS1 screen-F ttcttggaggagtgccacag 
VMS1 screen-R ggcgtcattttcgcgttgag 
ufd2Δ::His3-F ccaatagaaaggtaaagttgaccacaagttgtttaaggggaaaagttaactttgaaagtagaaccctcattccatagatccggatccccgggttaattaa 
ufd2Δ::His3-R aaatataagacacattgagcgatgaaataagccttatttgattagggtcaattttgcaatttattctatcacttattcatgaattcgagctcgtttaaac 
UFD2 screen-F ccagtttcgagaatctagtgctg 
UFD2 screen-R gaagcaaatcgctttcccacaa 
UBX1 screen-F gtagtgacaaacatgcctctggat 
UBX1 screen-R gcagcagttattcatgatgctggt 
UBX2 screen-F tggctgaggattgccgccaagctg 
UBX2 screen-R actataaaggtaggccccagctcc 
UBX3 screen-F agaccgcctaattggatcatcg 
UBX3 screen-R aaactgatgcacgtgacactt 
UBX4 screen-F aagatagcgggcgcctcaaccgct 
UBX4 screen-R gtacaagttacggaaggcggagct 
UBX5 screen-F ctcgatgtctctgcagaagcga 
UBX5 screen-R caacagcggcagatgcatcgct 
UBX6 screen-F ggatttacctctagcgcgtcaacc 
UBX6 screen-R aaccaggatttgcacgagcca 
UBX7 screen-F gtgctgcccatatacagcaactt 
UBX7 screen-R gctgagttcttttgcggtgat 
CDC48-NotI-F1 ttgcggccgcggtggccagcccaagaaacgga 
CDC48-XhoI-R1 agctcgagacgaccgaggtcctacagcct 
CDC48-Cterm-BamHI-R1 acggatccactatacaaatcatcatcttcc 
CDC48-Myc-BamHI-F1 acggatccgaacaaaaactcatctcagaagaggatctgtagtagttatatgccaggtatatttttattttaaatcg 
CDC48-HA-BamHI-F1 acggatcctacccatacgacgtcccagactacgcttagtagttatatgccaggtatatttttattttaaatcg 
vms1-NotI-F ctgcggccgcttcttggaggagtgccacag  
vms1-SalI-R tcggtcgacggcgtcattttcgcgttgag 
vms1-Cterm-BamHI-R1 acggatccgtatttctttttcatcctttcttctgcg 
vms1-Myc-BamHI-F1 acggatccgaacaaaaactcatctcagaagaggatctgtgatgaggaatatctcatattcaaatttttagg 
vms1-HA-BamHI-F1 acggatcctacccatacgacgtcccagactacgcttgatgaggaatatctcatattcaaatttttagg 
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Table 4. Plasmids used in the study 
Unless referenced, all plasmids were constructed by PCR amplification and cloning as 
detailed in the Materials and Methods section. 
Plasmid name Description Reference 
   
pSM1152 PGK1 promoter, CFTR-HA expression plasmid, 2 micron Zhang, et al., 2002 
pSM1911 PGK1 promoter, Ste6p*-HA expression plasmid, 2 micron Huyer, et al., 2006 
CPY*-3xHA Endogenous promoter, CPY* 3xHA expression plasmid, CEN Bhamidipati, et al., 2005 
pRS316-CDC48 Endogenous promoter, untagged CDC48, CEN This study 
pRS426-CDC48 Endogenous promoter, untagged CDC48, 2 micron This study 
pRS316-CDC48myc Endogenous promoter, c-terminal 1xmyc CDC48, CEN This study 
pRS316-CDC48HA Endogenous promoter, c-terminal 1xHA tagged CDC48, CEN This study 
pRS426-CDC48myc Endogenous promoter, c-terminal 1xmyc tagged CDC48, 2 micron This study 
pRS426-VMS1 Endogenous promoter, untagged VMS1, CEN This study 
pRS315-VMS1HA Endogenous promoter, c-terminal 1xHA tagged VMS1, CEN This study 
pRS316-VMS1HA Endogenous promoter, c-terminal 1xHA tagged VMS1, CEN This study 
pRS426-VMS1HA Endogenous promoter, c-terminal 1xHA tagged VMS1, 2 micron This study 
pRS426-UFD2 Endogenous promoter, untagged UFD2, 2 micron This study 
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2.1.2 Assays for ER-associated degradation (ERAD) and the degradation of other 
substrates 
To assess the rate of CFTR and Ste6p* degradation, the appropriately transformed strains were 
grown to log-phase (A600=0.5-1.5) in selective media at 26°C. The cells were then harvested and 
resuspended to a final A600 of 1.0. One ml of cells was taken as the zero time point. Next, 
cycloheximide was added to a final concentration of 100-200μg/ml and cells were incubated at 
30°C for Ste6p* or 40°C for CFTR (NAKATSUKASA et al. 2008; ZHANG et al. 2002). Aliquots 
were removed at the indicated time points. Samples were mixed with NaN3 (final concentration, 
10μM) and the cells were centrifuged at 16,000g for 1 min. The resulting supernatant was 
aspirated and the pellet was snap frozen in liquid nitrogen and stored at -80°C until use. Total 
protein was extracted from cell according to a previously established protocol (ZHANG et al. 
2002). Briefly, aliquots were thawed and resuspended in 1ml of freshly prepared alkaline lysis 
solution (0.2M NaOH, 0.11M beta-mercaptoethanol). The mixture was agitated briefly on a 
Vortex mixer and incubated on ice for 10 min. Next, 150μl of 50% TCA was added, agitated on 
a Vortex mixer and incubated on ice for an additional 10 min. The mixture was then centrifuged 
at 16,000g for 10 min. The supernatant was carefully aspirated and the pellet washed with 500μl 
of ice-cold acetone. The pellet was resuspended in SDS-PAGE sample buffer (80mM Tris-HCl 
pH 8.0, 8mM EDTA, 3.5% SDS, 15% glycerol, 0.08% Tris base, 0.01% bromophenol blue) 
containing freshly added DTT (100mM) to a final concentration of 10 OD/ml. The samples were 
solubilized by grinding with a Kontes mini-hand-held pestle. Samples were resolved by SDS-
PAGE, transferred to a nitrocellulose membrane, and detected by western blotting with the 
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appropriate antibodies. Data were quantified using ImageJ v1.42q software (ABRAMOFF et al. 
2004). The degradation of an HA epitope tagged form of CPY* (BHAMIDIPATI et al. 2005) was 
also assessed by cycloheximide chase analysis, as described above, except that the cells were 
incubated at 30°C during the chase. 
 
The pulse chase analysis of CFTR-HA was performed as previously described (GNANN et 
al. 2004). Briefly, 30 ml of cells were grown overnight to log-phase, harvested, and resuspended 
in media lacking methionine and cysteine to a final A600 of 6/ml. Cells were labeled for 1 h with 
35
S-labeled methionine (New England Nuclear, USA) at a final concentration of 100μCi/ml. A 
zero time point was then taken, and cells were chased with cold methionine and cysteine. Cells 
were disrupted by glass-bead lysis and the crude lysate was solubilized in 12.5mM Tris-HCl, pH 
7.5, 150mM NaCl, 1% SDS. The lysate was then diluted with IP buffer (50mM Tris-HCl, pH 
7.5, 150mM NaCl, 1% deoxycholic acid, 1% Triton X-100) so that the final concentration of 
SDS was 0.1%. CFTR-HA was immunoprecipitated from the solubilized lysate with anti-HA 
agarose (Roche, USA) and immunoprecipitated material was separated by SDS-PAGE and 
subject to autoradiography.  
 
The degradation of a galactose-inducible version of a ubiquitin-proline β-galactosidase 
chimera was measured by pulse-chase analysis as previously described (BACHMAIR et al. 1986). 
In brief, cells were grown to saturation, harvested, and resuspended to an A600 of ~3/ml in media 
lacking methionine. Next, 
35
S-labeled methionine (New England Nuclear, USA) was added to a 
final concentration of 11μCi/μl and total protein was labeled for 15 min at 30°C.  Cycloheximide 
was added to a final concentration of 500μg/ml, aliquots were removed at the indicated time 
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points, and samples were processed. The precipitated chimeric protein was visualized by 
phosphorimager analysis on a Fujifilm BAS-2500 and the data were quantified using ImageJ 
v1.42q software (ABRAMOFF et al. 2004). The degradation of a Deg1-β-galactosidase fusion was 
assessed by cycloheximide chase analysis, as published (HOCHSTRASSER and VARSHAVSKY 
1990). 
2.1.3 Preparation of yeast subcellular fractions and indirect immunofluorescence 
microscopy 
Yeast cytosol was prepared by liquid nitrogen lysis as described previously (MCCRACKEN and 
BRODSKY 1996).  In brief, 4-6 l of cells were grown to log-phase, harvested, and resuspended in 
Buffer 88 (20mM HEPES pH 6.8, 150mM KOAc, 250mM sorbitol, 5mM MgOAc). The 
suspension was then poured into liquid nitrogen and pulverized in a Waring blender for 10 min. 
The resulting mixture was thawed and clarified by centrifugation at 300,000g. The final 
concentration of cytosol was ~20-30mg/ml and was stored at -80°C. Yeast microsomes were 
prepared as previously described from 1-2 l of log-phase cells that were spheroplasted, lysed in a 
Potter-Elvehjem homogenizer, and isolated by differential centrifugation (BRODSKY and 
SCHEKMAN 1993; DESHAIES and SCHEKMAN 1989; NAKATSUKASA et al. 2008). The ER-enriched 
microsomes were resuspended in Buffer 88 to a final A280 of 40 (as measured in 2% SDS) and 
stored at -80°C. 
 
The subcellular localization of Vms1p was determined by a previously reported method 
(KABANI et al. 2002) in which log-phase cells were harvested, washed, and lysed with glass 
beads.  After unbroken cells were removed by centrifugation at 3,000g for 5 min, a crude 
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membrane fraction was obtained as the pellet after a 16,000g centrifugation for 15 min and the 
supernatant constituted a crude cytosolic fraction. The crude cytosolic fraction was clarified by 
centrifugation at 150,000g for 15 min. Ten microliters of total lysate and each membrane and 
cytosol fraction was subject to SDS-PAGE and western blotting with the indicated antibodies.  
 
The subcellular residence of Vms1p was also determined by indirect immunofluorescence 
microscopy, as previously described (COUGHLAN et al. 2004). Diploid strains lacking VMS1 and 
expressing an HA-tagged form of Vms1p from an episomal CEN plasmid were grown to log-
phase. Cells were fixed by adding a 1/10th volume of 37% formaldehyde and incubation at room 
temperature for 60 min. Cells were harvested and washed twice with Solution A (1.2M sorbitol, 
50mM KPO4, pH 7.0) and were then treated with 2μg/ml of Zymolyase 20T (MP Biomedicals, 
USA) resuspended in Solution A for 30-40 min. Following treatment, cells were pelleted and 
washed twice with Solution A and resuspended in 200μl of Solution A. A total of 25-30μl of 
cells were pipetted onto polylysine-treated slides and allowed to adhere for 30 min at room 
temperature. Loose cells were aspirated and the slides were washed once with PBS, 0.1% BSA, 
followed by two washes with PBS, 0.1% BSA, 0.1% NP-40. The samples were incubated 
overnight at 4ºC with primary antibodies against yeast BiP/Kar2p (1:2000) and the HA epitope 
tag (1:500) that were resuspended in PBS, 0.1% BSA.  Next, the samples were washed one time 
each with PBS, 0.1% BSA and PBS, 0.1% BSA, 0.1% NP-40. Samples were then incubated with 
a 1:2000 dilution of Alexa-Fluor-conjugated secondary antibodies (Invitrogen, USA, goat anti-
rabbit, 594 and goat anti-mouse, 488) resuspended in PBS, 0.1% BSA, for 1-2 h at room 
temperature. The slides were then washed once with PBS, 0.1% BSA, twice, with PBS, 0.1% 
BSA, 0.1% NP-40, and once with PBS, 0.1% BSA. Anti-fade mounting medium plus DAPI 
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(Invitrogen, USA) was laid on top of each sample before applying a coverslip that was sealed 
with nail polish. Images were captured by QED software using a Hamamamatsu camera attached 
to an Olympus BX-60 microscope (Olympus, Japan). Images were analyzed using ImageJ 
v1.42q (ABRAMOFF et al. 2004). 
2.1.4 Measurements of substrate ubiquitination 
In vitro ubiquitination reactions were performed as previously described (NAKATSUKASA et al. 
2008).  In brief, microsomes, cytosol, an ATP regenerating system and 
125
I-labeled ubiquitin 
were mixed and incubated at room temperature for 1 h. Yeast membranes were then solubilized 
with detergent and the ERAD substrate was immunoprecipitated with a mixture of anti-HA 
antibody and protein-A sepharose (GE Healthcare, USA). The precipitated material was washed 
with 50mM Tris-HCl, pH 7.4, 150mM NaCl, 5mM EDTA, 1% Triton X-100, 0.2% SDS, and 
then released from the beads with SDS-PAGE sample buffer (80mM Tris-HCl, pH 8.0, 8mM 
EDTA, 3.5% SDS, 15% glycerol, 0.08% Tris base, 0.01% bromophenol blue) containing freshly 
added DTT (100mM) and heating at 37°C for 30 min. The resulting 
125
I-ubiquitinated material 
was resolved on a 6% SDS-polyacrylamide gel and was detected by phosphorimager analysis, as 
described above. Unmodified CFTR was visualized by western blotting using anti-HA antibody. 
Data were quantified using Image Gauge v4.0 or ImageJ v1.42q (ABRAMOFF et al. 2004). 
 
The immunoprecipitation and detection of in vivo ubiquitinated CFTR was carried-out as 
previously described (AHNER et al. 2007). A total of 100ml of cells were grown overnight to log-
phase and were harvested and disrupted by glass bead lysis. Unbroken cells were sedimented by 
low-speed centrifugation, and membranes were sedimented at 18,000g for 20 min in a 
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refrigerated table top centrifuge and resuspended in Buffer 88 to an A280 of 40 as measured in 
2% SDS. Membranes were solubilized in 1% SDS at 37ºC for 30 min, and the solubilized ERAD 
substrate was immunoprecipitated with anti-HA-conjugated agarose (Roche, USA). The 
immunoprecipitated substrate was released with SDS-PAGE sample buffer containing freshly 
added DTT and heating at 37°C for 30 min.  The protein was then resolved by SDS-PAGE, and 
transferred to nitrocellulose as in a standard western blot except with the following modification.  
After the transfer to nitrocellulose was complete, the nitrocellulose membrane was sandwiched 
between two sheets of Whatmann filter paper and placed in a boiling water bath for 45 min.  The 
sandwiched blot was allowed to cool to room temperature and after blocking, the ubiquitinated 
species were detected using anti-ubiquitin antibody. 
2.1.5 Immunoprecipitation of Cdc48p and detection of Cdc48p-associated ubiquitinated 
proteins 
To monitor the association between Cdc48p and Vms1p, cells lacking VMS1 were transformed 
with CEN plasmids containing a C-terminal Myc-tagged version of Cdc48p and/or a C-terminal 
HA-tagged version of Vms1p (Table 4), or the vectors lacking an insert. The transformed cells 
were grown in selective media to log-phase, harvested by low-speed centrifugation, resuspended 
in Buffer 88—which was supplemented with 1mM PMSF, 1μg/ml leupeptin, 0.5μg/ml pepstatin 
A, and 10mM NEM—and then disrupted with glass beads by vigorous agitation on a Vortex 
mixer 10 times for 30 sec, followed by a 30 sec incubation on ice.  The extract was removed and 
reserved, and the beads were washed with an equal volume of Buffer 88, which was then pooled 
with the reserved extract.  Unbroken cells were removed by centrifugation at 1,500g for 5 min at 
4°C.  A portion of the resulting supernatant represented the total lysate, and the protein 
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concentration was estimated by adjusting the A280 in 2% SDS such that the absorbance was 40 
(i.e., a protein concentration of ~10 mg/ml).  To separate membrane and cytosolic fractions, the 
total lysate was centrifuged at 150,000g for 20 min at 4ºC.  The resulting membrane fraction was 
washed one time with Buffer 88 and then resuspended in Buffer 88 such that the final A280 in 2% 
SDS was 40 (i.e., a protein concentration of ~10 mg/ml). The protein concentration of the 
cytosol was estimated using the BioRad protein assay kit.  To immunoprecipitate the tagged 
proteins, 200μg of lysate, cytosol, and membrane proteins were treated as follows: The total and 
membrane fractions were solubilized on ice for 30 min in Buffer A (20mM HEPES, pH 7.4, 
150mM NaCl, 1% Triton X-100). Then, an equal amount of Buffer B (20mM HEPES, pH 7.4, 
150mM NaCl) was added so that the final concentration of Triton X-100 was 0.5%. For 
consistency the cytosolic extract was treated on ice for 30 min by adding Triton X-100 to a final 
concentration of 0.5%.  For each fraction, insoluble material was removed by centrifugation at 
16,000g for 10 min at 4°C and the volume was brought-up to 500μl with Buffer C (20mM 
HEPES, pH 7.4, 150mM NaCl, 0.5% Triton X-100) prior to immunoprecipitation with anti-HA- 
or anti-Myc-conjugated agarose The immunoprecipitate was washed once with Buffer C, and 
three times with Buffer D (20mM HEPES, pH 7.4, 300mM NaCl, 0.5% Triton X-100), and the 
bound proteins were released with SDS-PAGE sample buffer, as described above. 
 
To examine Cdc48p association with ubiquitinated proteins, yeast cultures containing 
100ml of log-phase cells harboring the Cdc48p-HA expression vector or a vector control either 
were left untreated or treated with 50μM MG132 for 1 h. Cell disruption was performed using 
the medium-scale preparation, as described previously (NAKATSUKASA et al. 2008), and all 
buffers, including SDS-PAGE sample buffer were supplemented with 1mM PMSF, 1μg/ml 
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leupeptin, 0.5 μg/ml pepstatin A, and 10 mM NEM. The cells were harvested, disrupted with 
glass-beads, and following the removal of unbroken cells the crude extract was loaded onto a 
1.0M sucrose cushion and the mixture was centrifuged at 6,900g in a Sorvall HB-6 swinging 
bucket rotor for 10 min at 4°C.  The material residing above the cushion is enriched for ER-
microsomes and this was collected by centrifugation at 20,200g for 10 min at 4°C in a Sorvall 
SS-34 rotor.  The microsomes were washed and resuspended in Buffer 88 to a final A280 
(measured in 2% SDS) of 40. To immunoprecipitate epitope-tagged Cdc48p, 20μl of membranes 
were solubilized with 1% Triton X-100 in Buffer A (see above) for 30 min on ice. The 
solubilized material was then diluted with Buffer B (see above) so that the final concentration of 
Triton X-100 was 0.5%. Insoluble material was pelleted by centrifugation at 16,000g for 10 min 
at 4°C and the clarified, soluble material was brought to a final volume of 500μl with Buffer C 
(see above) prior to immunoprecipitation with anti-HA agarose (Roche, USA). The 
immunoprecipitate was washed three times with Buffer C, and the bound proteins were eluted 
with SDS-PAGE sample buffer, as described above.  After SDS-PAGE, the resolved proteins 
were transferred to a nitrocellulose membrane, and the membrane was treated as described 
above. 
2.1.6 Assays to measure autophagy 
The effect of VMS1 deletion on autophagy was assessed by two established methods (CHEONG 
and KLIONSKY 2008). In the first method, the processing of Ape1p/Lap4p was measured by 
western blot analysis. Wild-type and vms1Δ yeast were grown in 5ml YPD (1% yeast extract, 2% 
peptone, 2% dextrose) cultures to log-phase at 30°C. An aliquot (1ml) of the log-phase culture 
was taken and mixed with sodium azide (final concentration 10mM). This aliquot was 
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centrifuged at 16,000g for 1 min in a refrigerated centrifuge to pellet the cells. The supernatant 
was next aspirated and the remaining pellet was snap frozen in liquid nitrogen and stored at -
80°C until use. The remaining 4ml culture was centrifuged at 1,000g for 5 min in a clinical 
centrifuge. The media was decanted and the cells were washed with and resuspended in an equal 
volume of SC-N (1.7% Yeast nitrogen base without ammonium sulfate, 2% glucose). The final 
resuspension was placed at 30°C and grown for 4 h to induced starvation. At 4 h an aliquot (1ml) 
was taken and processed as described above in section 2.2.2.  
 
In the second method, the processing of GFP-Atg8p was measured. Wild-type and vms1Δ 
yeast expressing GFP-Atg8p were grown to log-phase. An aliquot (1ml) was taken and processed 
as described for the Ape1p/Lap4p assay. The remaining log-phase culture was centrifuged at 
1,000g for 5 min in a clinical centrifuge. The media was decanted and the cells were washed 
with and resuspended in an equal volume of SC-N. The final resuspension was placed at 30°C 
and grown for 2 h to induced starvation. Aliquots of 1ml were taken at the 1 and 2 h time points. 
The aliquots were processed as described in section 2.2.2. 
2.1.7 Antibodies and western oblot analysis  
Antibodies used in this study included: Anti-HA (Roche, USA), anti-Myc (Santa Cruz, USA), 
anti-Ubiquitin (Santa Cruz, USA), anti-GFP (Roche, USA), anti-Cdc48p (S. pombe, a kind gift 
from Dr. Rasmus Hartmann-Petersen), anti-Cdc48p (S. cerevisiae), Ufd2p, Ufd3p, Ubx1p, 
Ubx2p (a kind gift from Dr. Alexander Buchberger), anti-Otu1p, Ufd1p (a kind gift from Dr. 
Stefan Jentsch), anti-Ufd1p (a kind gift from Dr. Claire Moore), anti-Ape1p (a kind gift from Dr. 
Daniel Klionsky), and monoclonal anti-yeast BiP/Kar2p (a kind gift from Dr. Mark Rose). 
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Western blots were decorated with the indicated primary antibodies and appropriate HRP-
conjugated anti-mouse or anti-rabbit IgG secondary antibodies. The HRP-chemiluminescent 
signal was visualized by enhanced chemiluminescence (Pierce, USA). Images were captured on 
a Kodak Image Station 440CF (Kodak, USA) and were analyzed using ImageJ v1.42q 
(ABRAMOFF et al. 2004). 
2.2 RESULTS 
2.2.1 Vms1p resides primarily in the cytoplasm 
To probe the localization of Vms1p in yeast during normal cell growth, I constructed a C-
terminal, HA-epitope-tagged version of Vms1p. The protein’s expression was controlled by the 
endogenous promoter and the gene was maintained on a low-copy CEN plasmid.  By taking 
advantage of the fact that yeast lacking VMS1 are cycloheximide sensitive (Parsons AB Boone 
C 04), I established that Vms1p-HA was functional since it rescued the growth of vms1Δ cells in 
the presence of cycloheximide (Figure 13A). Next, I used differential centrifugation to assess 
the localization of Vms1p. As shown in Figure 13B, Vms1p appears to reside in both 
membrane-associated and soluble fractions, but is predominantly a cytosolic protein. In this 
experiment, I also monitored the localization of Sec61p, which is an ER membrane protein 
(STIRLING et al. 1992), and Sse1p, which like Vms1p is primarily a cytosolic protein but exhibits 
partial membrane residence (GOECKELER et al. 2002). To further analyze Vms1p's residence, I 
performed indirect immunofluorescence microscopy with the help of a colleague, Dr. 
Christopher Guerriero. As seen in Figure 13C, Vms1p-associated fluorescence was primarily 
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cytoplasmic and in some cases enriched in large intracellular punctae. In some cells these bodies 
appeared to reside just at the periphery of the ER, as evidenced by the signal corresponding to 
yeast BiP, Kar2p. These bodies did not colocalize with mitochondrial-derived DAPI staining 
(Figure 13C). As assessed by indirect immunofluorescence, the localization of Cdc48p is also 
primarily cytosolic - except in late G1 - and can also be visualized in large bodies that reside 
periphery to the ER in some cells (MADEO et al. 1998). 
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Figure 13. Vms1p is found in the cytoplasm and at the membrane 
A. Wild-type and vms1Δ yeast cells harboring an empty vector, or a construct designed to 
express VMS1 or a VMS1-HA under its endogenous promoter were tested for cycloheximide 
sensitivity. Cells were spot tested as 10-fold serial dilution on either YPD, or YPD + 0.1μg/ml 
cycloheximide. The plates were incubated at 30ºC for 4 d. B. VMS1 encodes a cytosolic protein 
with limited membrane association.  Yeast cells deleted for VMS1 were transformed with a low-
copy VMS1-HA expression vector whose expression is under the control of the endogenous 
promoter. Yeast cells were disrupted and lysates were processed for SDS-PAGE and western 
blot analysis.  The ER membrane protein, Sec61p, and the cytosolic chaperone, Sse1p, served as 
controls. “T” represents total lysate, “P1” is the membrane pellet after a 16,000g centrifugation, 
“S1” is the supernatant after 16,000g, “P2” is the membrane pellet derived from “S1” after 
160,000g, and “S2” is the supernatant derived from “S1” after the 160,000g spin. A total of 10μl 
of each fraction was analyzed. C. Yeast cells were fixed and decorated with anti-HA antibody to 
detect Vms1p and anti-BiP (Kar2p), an ER resident protein, and the appropriate secondary 
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fluorescent-conjugated antibodies. DAPI staining was used to detect nuclear and mitochondrial 
DNA. 
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2.2.2 Vms1p is associated with Cdc48p in both cytosol and membrane fractions 
Large-scale proteomic studies identified Vms1p as a component of a multi-protein complex that 
included Cdc48p (KROGAN et al. 2006). Because false-positives can arise from proteomic 
analyses, experiments were designed to determine if Vms1p and Cdc48p can be co-precipitated. 
I therefore performed reciprocal co-immunoprecipitations with a C-terminal Myc-tagged version 
of Cdc48p and the HA-tagged form of Vms1p. Expression of the epitope tagged version of 
Cdc48p rescued the growth of cdc48-3 yeast at a non-permissive temperature (Figure 14A), 
indicating that Cdc48p-Myc is active. I then isolated cytosolic and membrane fractions from 
cells grown in the absence of stress to determine whether Cdc48p and Vms1p co-precipitate. As 
shown in Figure 14B, Vms1p and Cdc48p can be co-precipitated when a total yeast lysate is 
examined (T), and when both membrane (M) and cytosolic (C) fractions are examined. As 
controls for this experiment, co-precipitation was absent when cells expressed untagged versions 
of either protein. I also noted that significantly more Cdc48p resided in the cytosol than at the 
membrane, and that the amount of Vms1p associated with Cdc48p reflected this distribution 
(Figure 14B, top). In contrast, when Vms1p was precipitated (Figure 14B, bottom), 
approximately equal amounts of the protein resided at the membrane and in the cytosol, but in 
both cases again Cdc48p co-precipitated with Vms1p. Further evidence for the functional 
significance of Vms1p-Cdc48p interaction is provided by a synthetic growth phenotype in 
vms1Δ yeast that simultaneously harbor a temperature sensitive allele of CDC48 (Figure 14C). 
Given that Vms1p can localize and associate with the Cdc48p complex at the mitochondrial 
membrane in the presence of mitochondrial and oxidative stressors (HEO et al. 2010), I also 
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tested directly whether Vms1p associates with the Cdc48p complex at the ER membrane. To this 
end, Vms1p-HA was immunoprecipitated from highly enriched ER membranes and the resulting 
precipitate was blotted for Cdc48p. As shown in Figure 14D, Cdc48p was 
coimmunoprecipitated with Vms1p-HA from ER-enriched membranes but not from strains that 
contained an untagged version of Vms1p. Because Vms1p contains a VCP/p97 Interacting Motif 
(VIM) domain (HEO et al. 2010), which is known to mediate direct interactions with VCP/p97 
(BALLAR et al. 2006), it is likely that Vms1p and Cdc48p directly associate. I also observed 
reproducible interactions between Vms1p-HA and Ubx2p and Ufd3p, which are known Cdc48p 
partners (see Chapter 1) (Figure 15). Together, these data indicate that that Vms1p is a 
component of a Cdc48p complex that exists in both the cytosol and at the ER membrane. 
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Figure 14. Vms1p co-immunoprecipitates with Cdc48p 
A. The classic temperature sensitive mutant, cdc48-3, was transformed with an empty 
vector, or a vector designed to express CDC48 or CDC48-Myc from its endogenous promoter. 
Strains were streaked onto selective media and incubated at 30 or 38°C to test for the rescue of 
the conditional allele. B. VMS1-deleted cells were transformed with a plasmid engineered for the 
expression of a functional, Myc-tagged version of Cdc48p and/or with the HA-tagged version of 
Vms1p. As controls, untagged versions of each protein were introduced into each strain. The 
resulting transformants were disrupted and a portion of the total lysate (T), the membrane 
fraction (M), and the cytosolic fraction (C) were subject to immunoprecipitation with anti-Myc 
or anti-HA antibodies. The immunoprecipitated proteins were resolved by SDS-PAGE and 
subjected to western blot analysis with the indicated antibodies. C. To test for a genetic 
interaction between VMS1 and cdc48-3, the individual strains were mated on rich media 
followed by sporulation in nutrient poor media. The genotypic results of tetrad dissection are 
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shown in the circles beneath the image. White is wild-type, grey is vms1Δ, black is cdc48-3, and 
red is cdc48-3vms1Δ. D. VMS1 deleted cells were transformed with a plasmid engineered for the 
expression of untagged or HA-tagged versions of Vms1p. ER-microsomes were enriched 
through sucrose gradient and Vms1p was immunoprecipitated with anti-HA resin. The 
immunoprecipitate was resolved by SDS and subject to western blot analysis with anti-Cdc48p 
and anti-HA. 
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Figure 15. Vms1p physically associates with other members of the Cdc48p complex 
Total lysate (T), membrane (M), and cytosolic (C), fractions were prepared from cells expressing 
Vms1p-HA from a 2μ plasmid the under control of its endogenous promoter.  Vms1p-HA was 
immunoprecipitated with anti-HA agarose and Cdc48p-Myc was immunoprecipitated with anti-
Myc agarose. A mock control using protein-A sepharose was included. The immunoprecipitated 
material was eluted with SDS-PAGE sample buffer, resolved by SDS-PAGE and followed by 
western blot analysis with the indicated antibodies.     
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2.2.3 Yeast lacking VMS1 exhibit slowed degradation of CFTR, an integral membrane 
ERAD substrate 
As described in Section 2.1, Cdc48p plays a well-defined role during ERAD. To test if Vms1p 
function is also important for ERAD, I performed degradation assays with a panel of well-
established ERAD substrates. I found first that CFTR degradation was modestly slowed in 
vms1Δ yeast (Figure 16A, compare filled versus unfilled squares), and that the CFTR 
degradation defect was fully recoverable when an extrachromosomal copy of VMS1 was 
introduced (Figure 16A, gray squares). The CFTR degradation defect caused by VMS1 loss was 
reproducible by pulse-chase analysis, which unlike cycloheximide chase follows the degradation 
of a newly synthesized subpopulation of CFTR (Figure 16B).  Interestingly, vms1Δ yeast 
proficiently degraded several other ERAD substrates, including Ste6p* and CPY* (Figure 17A 
and B). Moreover, the degradation of an N-end rule substrate, the ubiquitin-proline β-
galactosidase chimera, and the DOA pathway substrate, Deg1-β-galactosidase, were unaffected 
(Figure 17C and D). Based on these results, I conclude that loss of VMS1 modestly affects the 
ERAD of select substrates. 
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Figure 16. Loss of VMS1 results in compromised ERAD efficiency of the model substrate, CFTR 
A. The degradation of the model substrate CFTR was assessed by cycloheximide chase 
assay. Each cell type was transformed with a CFTR-HA expression plasmid and was co-
transformed with either an empty vector, or a plasmid containing VMS1 driven by its endogenous 
promoter. Wild-type cells containing the empty vector control are represented by black squares, 
vms1Δ cells containing an empty vector are represented by white squares, and vms1Δ yeast 
containing the extrachromosomal copy of VMS1 are represented by gray squares. Data represent 
the means of 6 independent experiments, +SE. T-test statistic is p < 0.01 for the 120 min time 
point, and p < 0.05 for the 60 min time point when comparing the extent of degradation between 
wild type and vms1Δ strains. A representative set of images corresponding to this experiment are 
shown in the bottom panels. B. Loss of VMS1 affects the ERAD of CFTR as assessed by pulse-
chase analysis. Wild type and vms1Δ cells expressing CFTR-HA were radio-labeled for 1 hour 
with 
35
S-methionine and cysteine and chased with unlabeled amino acids. Aliquots were taken at 
the indicated time points, the cells were lysed and CFTR-HA was immunoprecipitated with anti-
HA agarose. The immunoprecipitate was resolved SDS-PAGE and subject to radiography. Data 
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were quantitated relative to the zero time point. n = 10, +SEM. Wild-type (WT) cells are denoted 
by the filled squares and vms1Δ cells are represented by the unfilled squares. 
 82 
 
Figure 17. Loss of VMS1 has no effect on the degradation of two model ERAD and two model non-
ERAD substrates 
A., B. The degradation of the classic ERAD-C substrate, Ste6p* and the classic ERAD-L 
substrate, CPY* were assessed by cycloheximide chase in both wild-type and vms1Δ. C., D. The 
degradation of the N-end rule pathway substrate, Ub-pro-beta-gal, and the DOA pathway 
substrate, Deg1-LacZ were assessed by pulse- and cycloheximide chase, respectively. In all 
cases, the wild-type is represented by filled squares and vms1Δ is represented by open squares. 
Representative images are shown below the graphs.  
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2.2.4 Autophagy is unaffected in yeast lacking VMS1 
Cdc48p function was recently linked to autophagy (JU et al. 2009; KRICK et al. 2010; TRESSE et 
al. 2010). To rule out the possibility that the degradation defects were a result of other catabolic 
mechanisms such as autophagy, I looked at the processing of Ape1p/Lap4p and GFP-Atg8p as a 
measure of Cytoplasmic to Vacuole Transport (CVT) and autophagic induction, respectively 
(CHEONG and KLIONSKY 2008). As seen in Figure 18A, Ape1p/Lap4p processing was apparent 
in both wild-type and vms1Δ cells and under both optimal growth and nitrogen-starved 
conditions. As anticipated, processing was absent in a strain lacking ATG8. Thus, it appears that 
the CVT pathway is not affected by the loss of VMS1. When a GFP-Atg8p reporter was used to 
measure autophagic induction, I observed no obvious impairment in the vms1Δ background. As 
expected, atg14Δ, was unable to process GFP-Atg8p (Figure 18B). I conclude that vms1Δ has 
no obvious role in autophagy.  
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Figure 18. Strains lacking VMS1 do not exhibit a defect in the Cytoplasmic-to-Vacuole Transport 
(CVT) or autophagic pathways 
A. Wild-type (WT), vms1Δ, and atg8Δ cells were grown in rich medium (YPD) and then 
shifted to nitrogen-poor medium (-N) for four hours. Total lysates were prepared by TCA 
precipitation, and equal amounts of lysate were resolved by SDS-PAGE for western blotting with 
a marker of CVT activity, anti-Ape1p. Autophagic induction increases the amount of processed 
Ape1p. Sec61p was analyzed as a loading control. B. Wild-type, vms1Δ, and atg14Δ were 
transformed with a reporter expressing GFP-Atg8p, which is processed during the early steps of 
autophagy. Cell were grown in rich media and then shifted to nitrogen-poor media for the 
indicated times. Total protein was prepared by TCA precipitation, resolved by SDS-PAGE, and 
the western blotted with anti-GFP. Induction of autophagy by nitrogen starvation results in the 
processing of the GFP-Atg8p. In both experiments, the * denotes the unprocessed formed and the 
** denotes the processed form. 
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2.2.5 VMS1 genetically interacts with members of the UBX and UFD gene families during 
ERAD 
Cdc48p is a multifunctional protein that physically interacts with a large number of cofactors. It 
is unlikely that all of these cofactors are bound simultaneously to Cdc48p (SCHUBERTH and 
BUCHBERGER 2008). Indeed, evidence indicates competition between distinct cofactors (RUMPF 
and JENTSCH 2006). However, the many complex genetic interactions between Cdc48p partners 
have not been fully explored. 
 
Based on the data presented above, I hypothesized that Vms1p might act in parallel 
and/or complementary with established Cdc48p partners during ERAD and in the presence of 
specific stress-inducing agents. Therefore, Lauren Tomsic (undergraduate, University of 
Pittsburgh) and I performed genetic crosses between vms1Δ yeast and strains lacking the genes 
encoding select Cdc48p cofactors (Table 5). I focused on UBX-domain containing proteins since 
yeast lacking the genes encoding some members of the UBX (UBX1 and UBX4) family share 
phenotypes with vms1Δ (e.g., cycloheximide and rapamycin sensitivity) and because most of the 
UBX and UFD proteins have not been examined for their roles during ERAD. Therefore, the 
resulting tetratype progeny were first screened for growth on tunicamycin and cadmium-
containing media, which respectively induce ER and heavy metal stress.  Under each condition, 
an exaggerated requirement for the protein quality control machinery is evident. In these assays, 
yeast deleted for IRE1, which is required to induce the unfolded protein response (COX et al. 
1993), were used as a positive control for sensitivity on tunicamycin, and yeast deleted for 
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RPN4, which is required for the induction of genes encoding proteasome subunits (XIE and 
VARSHAVSKY 2001), were used as a positive control for sensitivity on cadmium. Consistent with 
previous data, I observed that yeast deleted for UBX1 were sensitive to tunicamycin (PARSONS et 
al. 2006), but I also noted that deletion of VMS1 exacerbated the growth defect (see Table 5; 
growth defects are denoted by a “+”, and a heightened defect is denoted by a “++”; also see 
Figure 19A for select examples of synergistic growth defects). This result suggests that Ubx1p, 
which is the yeast homolog of the p97 partner, p47, may contribute to ER homeostasis (see 
below). In addition, I discovered that VMS1 interacted genetically with other genes encoding 
Cdc48p cofactors, including UBX2, UBX3, UBX4, and UFD3, when growth was assessed in the 
presence of cadmium (Table 5, Figure 19). These data suggest that Vms1p functions in parallel 
with several Cdc48p-associated proteins and helps mitigate the toxic effects of oxidative stress. 
 
Because loss of VMS1 led to a substrate-specific ERAD defect (see above), I reasoned 
that the simultaneous deletion of VMS1 and other Cdc48p partners would result in synthetic 
effects on ERAD. To date, the coordinated action of Cdc48p partners during ERAD has not been 
examined. Therefore, the degradation of CFTR, as a representative misfolded membrane protein 
was examined, and the turnover of CPY*, a model misfolded soluble ERAD substrate, was 
assessed in each of the tetratype progeny. The most striking example of a synergistic ERAD 
defect was observed when VMS1 and UFD2 were simultaneously deleted. Specifically, I found 
that CFTR was significantly stabilized when UFD2 was disrupted in vms1Δ cells (Figure 20A, 
open triangles). This strong effect is comparable to the CFTR degradation defect observed when 
Cdc48p function is disabled or when the Hrd1p and Doa10p ubiquitin ligases are both absent 
(GNANN et al. 2004).  Furthermore, I found that ufd2Δ yeast exhibit a modest delay during the 
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CFTR degradation time course (Figure 20A, compare closed triangles and closed squares), 
which is reminiscent of the ufd2Δ defect when Ste6p* degradation was assessed (NAKATSUKASA 
et al. 2008).  Finally, I discovered that vms1Δufd2Δ yeast proficiently degraded CPY* and robust 
growth was noted on stress-inducing media. One explanation for these data is that the ERAD 
defect in this mutant strain is confined to ERAD-C substrates.  A summary of the degradation 
assays for the ERAD substrates Ste6p* and CPY*, and the N-end rule substrate and Ub-Pro β-
galactosidase in these strains is provided in Table 6. 
 
That Vms1p contributes to the ERAD pathway in a substrate-specific manner was also 
evident in vms1Δubx4Δ yeast. Although CPY* degradation proceeded maximally when VMS1 
and UBX4 were individually deleted, the proteolysis of CPY* was slowed in the double mutant 
(Figure 20B).  In other cases, I observed that ERAD defects were notable in mutants lacking a 
single Cdc48p cofactor, but the absence of VMS1 had no further effect on ERAD efficiency. For 
example, the degradation of CPY* is significantly attenuated in ubx2Δ yeast (NEUBER et al. 
2005), but the magnitude of the defect was not exacerbated in vms1Δubx2Δ yeast (Figure 20C, 
Table 6).  This phenomenon was also apparent when the degradation of CPY* was examined in 
ubx1Δ and ubx1Δvms1Δ yeast (Figure 20D, Table 6): An ERAD defect in ubx1Δ yeast has, to 
our knowledge, not previously been reported, and the effect on the degradation of an ERAD-L 
substrate in the ubx1Δ strain is consistent with the tunicamycin sensitive growth phenotype 
observed in this strain (Table 5 and Figure 19).  
 
A variety of other vms1Δ combined mutants were also examined. In brief, I confirmed 
first that the deletion of UFD2 slows the degradation of Ste6p* (NAKATSUKASA et al. 2008) and 
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I found that the loss of VMS1 in the strain had no further effect on degradation. Second, I 
discovered the loss of both UBX1 and VMS1 slowed the degradation of Ste6p* (Table 6). 
Finally, as anticipated, loss of UBX1, UBX2, or UFD2 slowed degradation of Ub-Pro β-
galactosidase and that the deletion of VMS1 in these backgrounds was without an added effect on 
degradation. I observed no effect of VMS1 deletion on the degradation of the Deg1-LacZ 
substrate (Table 6). 
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Figure 19. VMS1 genetically interacts with genes encoding several Cdc48p partners 
Yeast cells with the indicated genotypes were grown to log-phase and harvested. The 
cells were then serially diluted and spot-plated on rich media (YPD) or rich media containing 
either tunicamycin (tuni) or cadmium (CdCl2). The plates were incubated at 30°C for 2-6 d.  The 
images are representative of several independent experiments. 
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Figure 20. ERAD defects are exacerbated in yeast lacking VMS1 and UFD2 or UBX4 but not UBX1 
or UBX2 
A. The stability of CFTR was examined by cycloheximide chase analysis as described for 
Figure 16. Anti-HA antibody was used to detect each epitope-tagged ERAD substrate and 
Sec61p served as a loading control. B-D. The ERAD of CPY* was assessed in the indicated 
strains. Anti-HA was used to detect the substrate and Sec61p was used as a loading control. For 
all graphs, wild type cells are represented by black squares and vms1Δ yeast is represented by 
white squares. Black triangles represent ufd2Δ in the graph seen in A., ubx4Δ in B., ubx2Δ in C., 
and ubx1Δ in D. The white triangles represent ufd2Δvms1Δ in the graph seen in A., ubx4Δvms1Δ 
in B., ubx2Δvms1Δ in C., and ubx1Δvms1Δ in D. The panels at the bottom of each graph are 
representative western blots. Data represent the means of at least three independent experiments, 
+SD. 
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Table 5. A summary of genetic interactions observed when double deletions between VMS1 and 
genes-encoding select Cdc48p cofactors were tested on chemical stressors 
The “+” indicates sensitivity, “++” indicates additive sensitivity and “-“ indicates no 
sensitivity. 
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Table 6. A summary of protein degradation assays for the indicated substrates 
The strains either lacked VMS1-only or lacked both VMS1 and a gene encoding a select 
Cdc48p cofactor. The “+” indicates a protein degradation defect and “-“ indicates no effect. 
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2.2.6 Substrate ubiquitination is proficient in yeast deleted for VMS1 
The results presented above implicate Vms1p as a contributing factor during the ERAD of 
specific substrates, and highlight the complex functional interplay amongst Cdc48p-associated 
factors.  One mechanism by which loss of Vms1p might inhibit ERAD is by impeding substrate 
ubiquitination.  However, because Cdc48p acts after ERAD substrates have been ubiquitinated, I 
instead predicted that the loss of Vms1p would have no effect on substrate ubiquitination, nor 
would the loss of VMS1 lead to synergistic effects on ubiquitination in mutant strains with 
known defects in the ubiquitin pathway.   
 
To test this hypothesis, I assessed the extent of CFTR ubiquitination in the ufd2Δvms1Δ 
strain due to the significant stabilization of this substrate in the double mutant (Figure 20A). I 
also wished to investigate whether the extent of CFTR ubiquitination decreased in ufd2Δ yeast 
because Ufd2p is required for ubiquitin chain extension, and the loss of UFD2 results in reduced 
Ste6p* ubiquitination (NAKATSUKASA et al. 2008). To this end, CFTR was immunoprecipitated 
from wild type cells and from vms1Δ, ufd2Δ, and ufd2Δvms1Δ yeast (Figure 21A). As a positive 
control for this experiment, the amount of ubiquitinated CFTR in doa10Δhrd1Δ yeast was also 
measured. As anticipated, I first noted that CFTR ubiquitination decreased in the 
doa10Δhrd1strain compared to wild type cells (compare lanes 1 and 3),Δ and that a signal 
corresponding to ubiquitinated CFTR was absent when immunoprecipitations in the absence of 
anti-HA antibody were performed (“Mock”, lane 2). In addition, I noted that the amount of 
polyubiquitinated CFTR decreased by ~30% and there appeared to be a shift to lower molecular 
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weight ubiquitinated species when CFTR was examined in ufd2Δ-derived lysates. As predicted, 
the loss of VMS1 did not decrease the extent of CFTR ubiquitination, consistent with Vms1p 
acting in the ERAD pathway after substrate ubiquitination. In fact, the loss of VMS1 led to a 
small but reproducible increase in the amount of ubiquitinated CFTR, in either the presence 
(compare lanes 3 and 4) or absence (compare lanes 5 and 6) of Ufd2p. Similar results were 
obtained when the ubiquitination of Ste6p* was monitored in these strains and in an in vitro 
ubiquitination assay (NAKATSUKASA et al. 2008). Together, these data are consistent with the 
notion that Vms1p acts in the ERAD pathway after substrate ubiquitination. 
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Figure 21. Increased levels of ubiquitinated proteins are associated with the Cdc48p complex in yeast 
lacking Vms1p 
A. The indicated yeast strains expressing CFTR-HA were grown to log-phase, collected 
and processed for immunoprecipitation. Immunoprecipitated material was resolved by SDS-
PAGE and subjected to anti-ubiquitin (top) and anti-HA (CFTR, bottom) western blotting. 
Polyubiquitinated CFTR resolves by SDS-PAGE as a smear ≥140 kDa, which is the approximate 
molecular mass of CFTR. B. Wild type (“WT”) and vms1Δ cells in which the PDR5 locus was 
also disrupted were transformed with either an untagged or HA-tagged version of Cdc48p. The 
vms1Δ strain was also transformed an HA-tagged version of Vms1p. Each indicated cell type 
was treated with MG132 (100μM) or an equal volume of DMSO for 1 h. ER fractions were 
isolated and the Cdc48p or Vms1p complexes were immunoprecipitated with anti-HA agarose 
after Triton X-100-solubilization. The isolated proteins were resolved by SDS-PAGE and 
processed for western blot analysis. The top panel depicts the results of the western blot with 
anti-ubiquitin antibody and the bottom panel depicts the results of the western blot with anti-HA 
antibody. 
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2.2.7 Polyubiquitinated species associated with Cdc48p increase in vms1Δ yeast 
Based on the data presented in Figure 21A, and because Vms1p associates with the Cdc48p 
complex (Figure 14B), I next asked whether Vms1p regulates the ability of the Cdc48p complex 
to bind ubiquitinated substrates or the ability of the complex to release substrates. If Vms1p is 
required for the association of ubiquitinated substrates with the Cdc48p complex, then decreased 
amounts of these substrates should be associated with the Cdc48p complex in the vms1Δ mutant. 
In contrast, if Vms1p aids in a post-ubiquitination step, then increased levels of ubiquitinated 
proteins should associate with the Cdc48p complex in vms1Δ yeast.   
 
To differentiate between these models I immunoprecipitated Cdc48p under native 
conditions from ER-enriched membranes. I then performed an anti-ubiquitin immunoblot to 
detect Cdc48p-associated ubiquitinated species. This protocol was conducted in a wild type and 
vms1Δ strain. In addition, to bias the analysis toward the spectrum of proteasome-targeted, 
Cdc48p substrates, the wild type and vms1Δ strains also lacked the gene encoding the multidrug 
resistance pump, PDR5, which sensitizes yeast to proteasome inhibitors (FLEMING et al. 2002). 
In a control experiment, a signal corresponding to ubiquitinated proteins was absent when an 
anti-HA immunoprecipitate from lysates containing an untagged version of Cdc48p was 
examined (Figure 21B, lanes 1 and 2).  Also, as expected, the addition of MG132 resulted in 
increased association of ubiquitinated species with the Cdc48p complex (compare lanes 3 and 4).  
Most striking, I observed an increase in the amount of ubiquitinated-species in association with 
Cdc48p when solubilized ER-enriched membranes from vms1Δ yeast were examined (compare 
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lanes 3 and 5), an effect that was significantly enhanced when proteasome-mediated degradation 
was blocked with MG132 (compare lanes 4 and 6). When the co-immunoprecipitation was 
performed in the presence of SDS, no ubiquitin signal was detected, indicating that the ubiquitin 
profile was not attributable to ubiquitin-modified Cdc48p. Additionally, I immunoprecipitated a 
carboxy terminus HA-tagged version of Vms1p under these same conditions and found that 
Vms1p was not detectably associated with ubiquitinated proteins (lanes 7 and 8). I therefore 
conclude that Vms1p plays a role in regulating the population of proteasome-targeted, 
ubiquitinated species in association with Cdc48p, but itself does not detectably associate with 
ubiquitinated proteins.  
2.3 DISCUSSION 
A large and increasing number of Cdc48p-associated partners in yeast have been identified, and 
with few exceptions the activities of most of these partners is not clear.  Notable partners with 
established activities include Otu1p, a DUB, Ufd2p, a ubiquitin extension enzyme (also referred 
to as an E4), and Ufd3p, which competes with Ufd2p and can consequently rescue ubiquitinated 
proteins from being destroyed (RICHLY et al. 2005; RUMPF and JENTSCH 2006). Ubx2p has been 
reported to help anchor the Cdc48p complex to the ER membrane, although the magnitude of 
Cdc48p release from the membrane in ubx2Δ yeast is variable (NEUBER et al. 2005; SCHUBERTH 
and BUCHBERGER 2005; WILSON et al. 2006). The Cdc48p complex has also been found in 
association with multi-protein membrane complexes that include Hrd1p and Doa10p (CARVALHO 
et al. 2006; DENIC et al. 2006; GAUSS et al. 2006). And, Ufd1p-Npl4p, which compete with 
Ubx1p/p47, aid in the binding of ubiquitinated substrates and designate Cdc48p function for 
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ERAD. In contrast, the functions of most other Cdc48p partners are ill-defined, and the list of 
Cdc48p/p97 partners is more complex in higher eukaryotes. 
2.3.1 Vms1p is linked to ERAD and protein quality control 
In this study, I report on the characterization of a new Cdc48p partner, the product of the 
YDR049W gene, which is now termed VMS1 (HEO et al. 2010). Vms1p is a conserved, soluble, 
cytosolic protein that exhibits limited residence on membranes in non-stressed cells and is found 
in the Cdc48p-containing complex. Heo and colleagues (2010) also found that Vms1p is 
localized throughout the cytosol, and partially relocalizes, under mitochondrial stress conditions, 
to the mitochondrial membrane where it plays a role in protein degradation (HEO et al. 2010).  
 
In my hands, the loss of VMS1 leads to a modest ERAD defect that is significantly 
enhanced when either UFD2 or UBX4 are deleted.  Based on the growth phenotypes of the 
vms1Δ allele in the context of mutations in the genes encoding diverse Cdc48p partners (i.e., 
UBX1, UBX2, UBX3, UBX4, and UFD3), I suggest that Vms1p participates in other quality 
control and stress-relief pathways in yeast, besides ERAD. Indeed, the recent discovery of 
Vms1p as a contributor to Cdc48p-associated mitochondrial protection under conditions of 
mitochondrial stress (HEO et al. 2010) is consistent with this hypothesis. Of note, an increasing 
body of data indicates that cellular quality control processes that operate under both stressed and 
unstressed conditions affect lifespan (BALCH et al. 2008).  
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2.3.2 VMS1 genetically interacts with genes encoding Cdc48p cofactors 
In accordance with this proposal, one UBX protein that was recently shown to contribute to 
Cdc48p function and to alter ERAD efficiency is Ubx4p.  Alberts and colleagues (2009) recently 
reported that ubx4Δ yeast exhibit a defect in the degradation of both CPY* and Ste6p* which 
results in a build-up of ubiquitinated proteins on Cdc48p (ALBERTS et al. 2009). Thus, Ubx4p 
may cooperate with Vms1p as a release factor. Notably, I observed a genetic interaction between 
VMS1 and UBX4, and a CPY* degradation defect was enhanced in the double mutant. However, 
I failed to observe an ERAD defect for CPY* or CFTR in the ubx4Δ mutant (Figure 20B), 
possibly because of the unique strain backgrounds used in this study and in the previously 
published report. The importance of strain background in analyzing the phenotypes in strains 
deleted for Cdc48p partners is highlighted by the fact UBX1 is an essential gene in the W303 
strain (CHENG and CHEN 2010), but the knock-out is viable in the BY background, as employed 
in this study. Additionally, the single deletion of UBX2 is not sensitive to cadmium in the BY 
background, but is sensitive in another genetic background (SCHUBERTH et al. 2004). 
 
In our hands, the strongest effect on ERAD was apparent in the vms1Δufd2Δ strain. The 
loss of VMS1 did not exacerbate the decrease in ubiquitinated proteins or alter the profile of 
ubiquitinated proteins observed in the ufd2Δ strain. However, the synergistic effect may best be 
explained by positing that Ufd2p and Vms1p regulate unique steps in the ERAD pathway. For 
example, Ufd2p is required for ubiquitin chain elongation, and consistent with its role as a 
processivity factor the absence of this enzyme does not alter the extent of ubiquitination but only 
the rate at which polyubiquitination is achieved. ERAD is, therefore, initially delayed in the 
ufd2Δ strain but over time the amount of degradation catches-up with that observed in wild type 
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yeast (Figure 20A) (NAKATSUKASA et al. 2008). If Vms1p also catalyzes a relatively slow but 
non-essential step in the ERAD pathway, then the combined effect of deleting VMS1 and UFD2 
may result in synergism. It is also formally possible that the loss of Vms1p reduces the cellular 
levels of Ufd2p, or that its absence prevents Ufd2p association with the Cdc48p complex. I have 
tested these hypotheses but observed wild type levels of Ufd2p in vms1Δ yeast and in the 
Cdc48p complex. 
2.3.3 Vms1p affects a post-ubiquitination event 
By developing new genetic and biochemical tools, I have also obtained data consistent with a 
role for Vms1p in a post-ubiquitination event. I find that: 1) there is a synthetic ERAD defect 
when both VMS1 and UFD2 are deleted and 2) that there is an increase in the amount of Cdc48p-
associated ubiquitinated proteins in vms1Δ cells (Figure 21B). Other factors that may contribute 
to this critical step are Rad23p and Dsk2p, which contain both ubiquitin-like domains and 
ubiquitin-binding domains (ELSASSER et al. 2002; RAO and SASTRY 2002) and help link the 
Cdc48p complex and the proteasome. Future efforts may indicate whether Vms1p functions in 
tandem with Rad23p-Dsk2p to affect the release of ubiquitinated substrates from the Cdc48p 
complex. The loss of VMS1 might lead to the absence of the bona fide release factor(s). In 
addition, future efforts may identify the spectrum of substrates that are enriched in complex with 
Cdc48p when the proteasome is disabled and Vms1p function is ablated. I suspect that ERAD 
substrates, as well as cytoplasmic substrates en route to the proteasome, will be present in 
association with the Cdc48p complex under these conditions.  
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In sum, I provide genetic evidence that a previously uncharacterized, Cdc48p partner 
performs an important house-keeping function during ER and cellular homeostasis.  Consistent 
with our genetic data that suggest a role for VMS1 in the ubiquitin-proteasome system, Costanzo 
and colleagues (2011) showed that VMS1, UBX1, UBX4, and UFD2 negatively interact with 
genes that encode non-essential components of the 19S proteasome particle and PRE9, the only 
nonessential component of the 20S core (COSTANZO et al. 2011). These data suggested that 
Vms1p, Ubx1p, Ubx4p and Ufd2p may play a role in substrate recognition, transfer of substrate 
to the proteasome, and/or deubiquitination. When combined with our genetic and biochemical 
data, we favor the view that Vms1p is a regulator of an important but poorly defined step in the 
ubiquitin-proteasome pathway. 
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3.0  VMS1 PROTEIN IS INVOLVED IN REGULATING THE PROTEASOME 
In Chapter 2, I showed that 1) loss of VMS1 affected the ERAD of a model substrate but not its 
ubiquitination, 2) Vms1p physically interacts with Cdc48p in both membrane and cytosolic 
fractions, 3) VMS1 genetically interacts with genes encoding Cdc48p cofactors, and that this led 
to additive ERAD defects and exaggerated sensitivity to stress agents, and 4) loss of VMS1 led to 
an accumulation of ubiquitinated proteins bound to Cdc48p. These data suggest that Vms1p 
functions at a post-ubiquitination step in the ERAD pathway. In this chapter, I demonstrate that 
loss of VMS1 increases the total cellular level of ubiquitinated proteins. Further, I provide 
evidence to indicate that this arises because the loss of VMS1 also decreases the amount of 
ubiquitin-processing 26S proteasome, and increases the free, inactive 20S proteasome core 
particle. Both of these phenomena can be restored to near wild-type levels, but only with a 
version of Vms1p that can interact with Cdc48p.  
3.1 EXPERIMENTAL PROCEDURES 
3.1.1 Yeast strains, growth conditions, and plasmids 
Yeast strains were from either the BY4741 or BY4742 genetic backgrounds and were grown at 
either room temperature (~24 ºC) or 30 ºC, as indicated. All strains used in this study are listed in 
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Table 7. Strain construction was identical to that described in Chapter 2. Plasmids used in this 
study are listed in Table 8. The construct expressing Vms1p-ΔVIM HA was a generous gift from 
Dr. Jared Rutter (University of Utah). 
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Table 7. List of strains used in this study. 
All strains were in BY4742 background, unless noted otherwise. 
Strain  Genotype Reference 
   
BY4742 MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15 Open Biosystems 
BY4741 MATA, his3Δ1, leu2Δ0, ura3Δ0, LYS2, met15Δ0 Open Biosystems 
KFY100 MATA, his4-619 leu2-3,112 ura3-52 Dr. Kai Uwe Frohlich 
KFY100-vms1Δ MATA, his4-619 leu2-3,112 ura3-52, vms1Δ::KanMX This study 
YPH500 MATα, his3Δ200, leu2Δ1, ura3-52, lys2-801, ade2-101, trp1Δ63 ATCC 
YPH500-vms1Δ MATα, his3Δ200, leu2Δ1, ura3-52, lys2-801, ade2-101, trp1Δ63, vms1Δ::KanMX This study 
vms1Δ::HIS3 MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3 This study 
vms1Δ::KanMX MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::KanMX Open Biosystems 
vms1Δ::KanMX MATA, his3Δ1, leu2Δ0, ura3Δ0, LYS2, met15Δ0, vms1Δ::KanMX Open Biosystems 
cdc48-3 MATα, his3Δ1, leu2, ura3, lys2Δ0, MET15, cdc48-3 This study 
vms1Δcdc48-3 MATα, his3Δ1, leu2, ura3, lys2Δ0, MET15, cdc48-3, vms1Δ::KanMX This study 
ubx2Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ubx2Δ::KanMX Open Biosystems 
ubx2Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ubx2Δ::KanMX This study 
rad23Δdsk2Δ MATA, his3Δ1, leu2Δ0, ura3Δ0, LYS2, met15Δ0, rad23Δ::KanMX, dsk2Δ::KanMX Dr. Susan Michaelis 
rad23Δdsk2Δvms1Δ MATA, his3Δ1, leu2Δ0, ura3Δ0, LYS2, met15Δ0, rad23Δ::KanMX, dsk2Δ::KanMX, vms1Δ::HIS3 This study 
rpn4Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, rpn4Δ::KanMX Open Biosystems 
rpn4Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, rpn4Δ::KanMX This study 
hsm3Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, hsm3Δ::KanMX Open Biosystems 
hsm3Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, hsm3Δ::KanMX This study 
ump1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ump1Δ::KanMX Open Biosystems 
ump1Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, ump1Δ::KanMX This study 
rpn10Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, rpn10Δ::KanMX Open Biosystems 
rpn10Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, rpn10Δ::KanMX This study 
rpn13Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, rpn13Δ::KanMX Open Biosystems 
rpn13Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, rpn13Δ::KanMX This study 
rpn14Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, rpn14Δ::KanMX Open Biosystems 
rpn14Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, rpn14Δ::KanMX This study 
otu1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, otu1Δ::KanMX Open Biosystems 
otu1Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, otu1Δ::KanMX This study 
cdc48Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48MYC This study 
cdc48Δvms1Δ MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, vms1Δ::HIS3, cdc48Δ::KanMX, pRS315-CDC48MYC This study 
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Table 8. Plasmids used in the study. 
Unless referenced, all plasmids were constructed by PCR amplification and cloning as 
detailed in the Materials and Methods section of Chapter 2. 
Plasmid name Description Reference 
   
pRS316-VMS1 Endogenous promoter, c-terminal 1xHA tagged VMS1, CEN This study 
pRS316-VMS1HA Endogenous promoter, c-terminal 1xHA tagged VMS1, CEN This study 
pRS416-VMS1-ΔVIM-HA Endogenous promoter, c-terminal 3xHA tagged VMS1-ΔVIM, CEN Dr. Jared Rutter 
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3.1.2 Measurements of total cellular ubiquitin levels 
The indicated yeast strains were grown overnight to log phase (OD600 = ~0.6-0.8). A total of 1ml 
was dispensed into 10mM sodium azide and harvested by centrifugation in a refrigerated 
tabletop centrifuge at 18000g for 2 min. The supernatant was aspirated and the pellets were snap-
frozen in liquid nitrogen. Thawed cell pellets were precipitated with 10% trichloroacetic acid, 
resuspended in SDS-sample buffer (80mM Tris-HCl, pH 8.0, 8mM EDTA, 3.5% SDS, 15% 
glycerol, 0.08% Tris base, 0.01% bromophenol blue) containing 100μM DTT to a final 
concentration of 10 OD600/ml and resolved by SDS-PAGE (10% or 12.5% polyacrylamide gels). 
Proteins were transferred onto a piece of nitrocellulose that was then sandwiched between two 
sheets of filter paper and placed in a boiling water bath for 30 min. Blots were probed with anti-
ubiquitin and anti-GPD antibodies and visualized as described in section 3.2.7, below. 
3.1.3 In gel proteasome assay 
An in gel proteasome assay was performed as described, but with minor modification (ELSASSER 
et al. 2005). All steps were performed on ice or at 4 ºC unless indicated otherwise. First, yeast 
were grown overnight in liquid culture (100ml) to log-phase (OD600 = 0.6-0.8) and harvested by 
centrifugation at 1000g for 5 min in a room temperature clinical centrifuge. Cell pellets were 
used immediately to prepare lysates, or snap frozen in liquid nitrogen and stored at -80 ºC. In 
each case, cell pellets were thoroughly resuspended in buffer containing 50mM Tris-Cl, pH 7.4, 
5mM MgCl2, 5mM ATP and 1mM DTT and disrupted by glass bead lysis (6 x 1 min pulses with 
1 min rests on ice) on a Vortex mixer. Unbroken cells were removed by centrifugation at 1000g 
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for 5 min, and the lysate as clarified by centrifugation in a refrigerated centrifuge at 18000g for 
30 min. The protein concentration of the final lysate was measured by BioRad assay. The typical 
protein concentration was ~10mg/ml, and the prepared lysates were immediately used.  
 
Native 3.5% polyacrylamide gels were prepared in 90mM Tris-base, pH 8.0, 90mM boric 
acid, 5mM MgCl2, 0.5mM EDTA, 5mM ATP, and 1mM DTT. Ammonium sulfate and TEMED 
were used to polymerize the gel. The gels were prepared at room temperature but were allowed 
to polymerize at 4 ºC. The running buffer was the same as the gel buffer, but lacked the 
polyacrylamide. A total of 60μg of lysate was mixed with an appropriate volume of 5x sample 
buffer (250mM Tris-Cl, pH 7.4, 50% glycerol, 60ng/ml xylene cyanol) and gels were loaded and 
run at 110V at 4 ºC until the ferritin (~440KDa) marker was three-fourths of the way to the 
bottom of the gel. The gel was then carefully transferred to a clean dish containing room 
temperature developer solution (50mM Tris-Cl, pH 7.4, 5mM MgCl2, 0.5mM EDTA, and 5mM 
ATP) and briefly incubated to bring the gel to room temperature. This solution was then 
carefully decanted and fresh developer solution containing 100μM of the proteasome substrate 
Suc-LLVY-AMC (Enzo) was added and the gel was incubated with gentle rocking for 30 min at 
37 ºC. Proteasome activity was visualized using a Kodak Image Station 440CF (Kodak). To 
visualize the activity of the 20S core particle, the gel was placed back into the developer 
solution, SDS was added to a final concentration of 0.02%, and the gel was incubated with gentle 
rocking at 37 ºC for 10-15 min. The activity was visualized as above. For western blot analysis, 
the native gels were preincubated with transfer buffer (0.025M Tris, 0.192M glycine pH 8.3, 
0.1% SDS, and 20% methanol) for 10-15 min and transferred overnight onto nitrocellulose. Gels 
were probed with the indicated antibodies and visualized as described in section 3.2.7. 
 108 
3.1.4 Real-time proteasome activity assay 
Cell growth conditions and lysate preparation were identical to that described in section 3.2.3. To 
measure proteasome activity in solution, 60μg of lysate/ml was brought to a final volume of 2ml 
with a buffer containing 50mM Tris-Cl, pH 7.4, 5mM MgCl2, 5mM ATP, 1mM DTT, and 10% 
glycerol. At this point, additives such as MG132 and SDS (0.02%) were added as indicated, to 
inhibit the proteasome or visualize the contribution of the 20S core particle, respectively. These 
lysates were preincubated at 30 ºC for 30 min. The fluorogenic proteasome substrate, Suc-
LLVY-AMC was next added to a final concentration of 100μM and fluorescence (excitation 
380nm, emission 460nm, bandpass = 4) was manually read using an Aminco-Bowman Series 2 
Luminescence Spectrometer over the course of 2 h. The reaction was kept at 30 ºC for the 
duration of the experiment. Data were plotted and analyzed in Microsoft Excel 2003. 
3.1.5 Glycerol gradient fractionation 
Cell growth conditions and lysate preparation was identical to those described in section 3.2.3 
and 3.2.4. To fractionate proteasomes, a 10-30% linear glycerol gradient was prepared in 50mM 
Tris-Cl, pH 7.5, 5mM MgCl2, and 5mM ATP using a Gradient Master (BioComp Instruments) 
according to the manufacturer’s instruction. The gradients were used either immediately, or 
stored overnight at 4 ºC before use. A total of 10mg of cell lysate was layered on top of the 
gradient and centrifuged at 83,000g for 24 h. Fractions (1ml) were collected from the top, and 
were TCA precipitated and resolved by SDS-PAGE as described above. Western blotting was 
performed using the indicated antibodies as described in 3.2.7, below. 
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3.1.6 Immunoprecipitation and Stable Isotopic Labeling by Amino acids in Cell culture 
(SILAC) analysis 
Immunoprecipitation of Cdc48p-Myc was performed as described in Chapter 2, section 2.1.5. 
Briefly, transformed cells were grown in selective media to log-phase, harvested by low-speed 
centrifugation, resuspended in Buffer 88 (20mM HEPES pH 6.8, 150mM KOAc, 250mM 
sorbitol, 5mM MgOAc) supplemented with 1mM PMSF, 1μg/ml leupeptin, 0.5μg/ml pepstatin 
A, and 10mM NEM. Cells were disrupted with glass beads by vigorous agitation on a Vortex 
mixer 10 times for 30 sec, followed by a 30 sec incubation on ice between each agitation. 
Unbroken cells were removed by centrifugation at 1,500g for 5 min at 4°C. Total lysate was 
separated into membrane and cytosol fractions by centrifugation at 150,000g for 20 min at 4ºC. 
The supernatant (cytosol) was collected and the protein concentration was estimated using the 
BioRad protein assay kit. The membrane fraction was washed one time with Buffer 88 and then 
resuspended in Buffer 88 such that the final A280 in 2% SDS was 40, which corresponds to a 
protein concentration of ~10mg/ml. Both fractions were stored at -80 ºC. To immunoprecipitate 
Cdc48p-Myc, 1mg of cytosol and resuspended membrane protein were treated as follows: The 
membrane fractions were solubilized on ice for 30 min in Buffer A (20mM HEPES, pH 7.4, 
150mM NaCl, 1% Triton X-100). Then, an equal amount of Buffer B (20mM HEPES pH 7.4, 
150mM NaCl) was added so that the final concentration of Triton X-100 was 0.5%. The 
cytosolic extract was treated on ice for 30 min by adding Triton X-100 to a final concentration of 
0.5%.  For each sample, insoluble material was removed by centrifugation at 16,000g for 10 min 
at 4°C and the volume was brought-up to 500μl with Buffer C (20mM HEPES, pH 7.4, 150mM 
NaCl, 0.5% Triton X-100) prior to immunoprecipitation with anti-HA- or anti-Myc-conjugated 
agarose (Santa Cruz). The immunoprecipitate was washed once with Buffer C, and three times 
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with Buffer D (20mM HEPES, pH 7.4, 300mM NaCl, 0.5% Triton X-100), and the bound 
proteins were released with SDS-PAGE sample buffer, as described above. 
 
For the Stable Isotopic Labeling with Amino acids in Culture (SILAC) experiment, wild-
type cells expressing Cdc48p-Myc from a low-copy plasmid were grown to log phase in standard 
minimal medium containing unlabeled L-Lysine-2HCl (Cambridge Isotope Labs) and vms1Δ 
cells expressing Cdc48p-Myc were grown in minimal medium containing L-Lysine-2HCl 
13
C6,
15
N2 (Cambridge Isotope Labs). Cells were processed and the immunoprecipitations were 
carried out as described above. Immunoprecipitated proteins were eluted by incubating the beads 
four times with 100μl of 0.1M glycine, pH 2.2 for 10 min at room temperature. The combined 
eluate was methanol/chloroform (4:1) extracted and lyophilized prior to mass spectrometry. The 
mass spectrometry was performed by our collaborators, Drs. Woong Kim and Steven Gygi 
(Harvard Medical School). 
3.1.7 Antibodies and western blot analysis  
Antibodies used in this study included: Anti-HA (Roche, USA), anti-Myc (Santa Cruz, USA), 
anti-FLAG M2 (Sigma), anti-Ubiquitin (Santa Cruz, USA), anti-Hsm3p (a generous gift from 
Dr. Daniel Finley, Harvard Medical School), anti-Blm10p (Enzo), anti-Rpt5p (Enzo), anti-
Rpn10p (a generous gift from Dr. Dorota Skowyra, St. Louis University), anti-Rpn3 (Abcam),  
anti-yeast alpha and beta 20S subunits (Enzo), and anti-GPD (Sigma). Bound antibodies were 
visualized with HRP-conjugated anti-mouse (Roche) or anti-rabbit (Roche) IgG. Western blot 
detection was performed as described in Chapter 2, section 2.1.7. 
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3.2 RESULTS 
3.2.1 Loss of VMS1 leads to the accumulation of cellular ubiquitinated proteins 
In Chapter 2, I showed that loss of VMS1 led to an increase in the amount of ubiquitinated 
species that was associated with an epitope-tagged version of Cdc48p (Figure 21B). In order to 
assess if the effect of Vms1p was specific for Cdc48p bound species, or represented a more 
global phenomenon, I compared the levels of ubiquitinated proteins found in total cellular 
extracts from a panel of strains possessing or lacking VMS1 and that were mutated for other 
genes. Specifically, these strains represent a range of defects at various stages of the ERAD 
pathway: ubx2Δ shows reduced recruitment of the Cdc48p complex to the ER membrane, the 
cdc48-3 mutant exhibits retrotranslocation defects, and rad23Δdsk2Δ has defects in shuttling 
ubiquitinated substrates to the 26S proteasome (ELSASSER et al. 2002; JAROSCH et al. 2002; RAO 
and SASTRY 2002; SCHUBERTH and BUCHBERGER 2005). As seen in Figure 22A, I found that 
strains lacking VMS1 consistently showed an increase in the amount of total cellular 
ubiquitinated protein regardless of genotype. This was evident regardless of strain background or 
mating type (Figure 22B and C). Select double mutants had pronounced levels of ubiquitin 
accumulation. For example, the ubx2Δvms1Δ accumulated ubiquitinated proteins to a greater 
extent than other combinations tested. On the other hand, the rad23Δdsk2Δvms1Δ strain showed 
only a modest accumulation. Regardless, this result suggests two things. First, it suggests that 
Vms1p functions in a parallel pathway with Ubx2p, Cdc48p, and Rad23p/Dsk2p. Second, it 
suggests that Vms1p may function in a pathway separate from its involvement in ERAD.  
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Based on these findings, I decided to test whether the accumulation of polyubiquitinated 
proteins required Vms1p-Cdc48p interaction by using a well-characterized mutant version of 
Vms1p that is unable to physically interact with Cdc48p. In this experiment, strains lacking 
VMS1 were supplemented with an empty vector and either a low-copy plasmid harboring a wild-
type, HA-epitope tagged version of Vms1p or an HA-epitope tagged version lacking the 
VCP/p97 Interacting Motif (VIM) (BALLAR et al. 2006; HEO et al. 2010; STAPF et al. 2011). The 
VMS1 deletion harboring an empty vector shows the expected increase in total ubiquitinated 
protein when compared to a wild-type strain, or to a vms1Δ strain harboring a wild-type copy of 
VMS1 (Figure 23B). However, when vms1Δ strains were supplied with a copy of Vms1p that 
cannot physically interact with Cdc48p (ΔVIM), the level of cellular ubiquitinated protein was 
similar to that seen in the vms1Δ strain harboring an empty vector. In addition, I examined 
whether protein expressed from these plasmids can also rescue the cycloheximide-sensitive 
phenotype of vms1Δ cells (PARSONS et al. 2006). I found that rescue also requires the VIM 
domain of VMS1 (Figure 23A). It is noteworthy to mention that I consistently observed that the 
level of “VIM-less” Vms1p appears to be somewhat higher than that of the wild-type version 
(Figure 23B), so that the inability to rescue this phenotype does not arise from poor protein 
expression. These data suggest that Vms1p interaction with Cdc48p is required to off-set the 
accumulation of ubiquitinated proteins in the cell.  
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Figure 22. Loss of VMS1 leads to an accumulation of ubiquitinated proteins in the cell 
A. Whole cell extracts from strains containing or lacking VMS1 were examined for total 
ubiquitinated proteins by western blotting with anti-ubiquitin antibody. Strains examined include 
those defective for various steps in the ERAD pathway, such as Cdc48p localization (ubx2Δ), 
retrotranslocation (cdc48-3), and ubiquitinated substrate escort (rad23ΔdskΔ). Anti-GPD was 
used as a loading control. B. Lysates from BY4741 (“a”) and BY4742 (“α”) were separated by 
SDS-PAGE and subjected to western blotting as described in part A. Ubiquitin levels in vms1Δ 
strains increased approximately 50%. C. Lysates from wild-type and vms1Δ strains from the 
KFY100 and YPH500 genetic backgrounds were resolved by SDS-PAGE and subject to western 
blotting with anti-ubiquitin and anti-GPD (loading control). D. Quantitation of polyubiquitin 
(>72KDa) signal from wild-type and vms1Δ strains. Sample size is 6. 
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Figure 23. Vms1p regulation of ubiquitinated protein homeostasis requires interaction with Cdc48p 
A. The function of the wild-type Vms1p-HA and Vms1p-ΔVIM-HA proteins was 
assessed by 10-fold serial dilution spot plating onto either YPD or YPD plus 0.1μg/ml 
cycloheximide. B. To assess whether Vms1p-Cdc48p interaction was required for the recovery 
of the ubiquitinated protein accumulation phenotype, whole cell extracts were prepared from 
strains harboring an empty vector, or a vector engineered for the expression of either wild-type 
Vms1p-HA or Vms1p-ΔVIM-HA (ΔVIM, a generous gift from Dr. Jared Rutter) and western 
blotted with anti-ubiquitin. Blots were also probed with anti-HA to detect the expression of the 
tagged forms of Vms1p and with anti-GPD as a loading control. C. Quantitation of ubiquitin 
signal (>72KDa) in B.  Sample size is 4. 
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3.2.2 Loss of VMS1 alters the distribution of proteasome subtypes 
The data from Chapter 2 and section 3.3.1 of this chapter suggest that Vms1p functions at a late 
stage (i.e., post-ubiquitination event) in protein degradation. Therefore, I examined the 
architecture and activity of the proteasome from total cell lysates using a previously established 
in gel proteasome activity assay (ELSASSER et al. 2005; HOUGH et al. 1987). As seen in Figure 
24A, lysates from vms1Δ cells showed a reproducible increase in the amount and activity of free 
20S core particles (CP) and a corresponding reduction in the amount and activity of capped 
proteasome particles (RPCP, RP2CP). The results of several experiments were quantified and 
these differences were found to be statistically significant (Figure 24B). To confirm these 
results, 20S CP activity was assessed in solution and over time using fluorometry and again there 
was a significant increase in the activity of the 20S CP (Figure 24C).  
 
Since there is more free 20S core particle in the vms1Δ, it is a formal possibility that 
vms1Δ mutant cells upregulate the protein levels of proteasome components, including the alpha 
and beta subunits of the 20S core particle, which in turn leads to a decrease in the relative 
amount of 26S particle. To rule out this possibility, I performed western blotting with a panel of 
antibodies against different components of the proteasome. As observed in Figure 25A, wild-
type and vms1Δ mutant cells have similar levels of all proteasome components tested. To further 
support these data, I compared the proteasome profile in rpn4Δ strains possessing or lacking 
VMS1 by the in gel proteasome overlay assay. Rpn4p is a transcription factor that regulates the 
expression of proteasome subunits, and in rpn4Δ cells there is a reduction in the amount of 
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proteasome subunits (XIE and VARSHAVSKY 2001). I observed that rpn4Δ strains show the 
expected reduction in the amount of total proteasome, but when rpn4Δ strains were also deleted 
for VMS1, lysates prepared from this strain again showed an increase in the amount and activity 
of the free 20S CP (Figure 25B and C). I conclude that the gene product of VMS1 plays a role in 
regulating the distribution of proteasome subtypes, but does not regulate the expression or 
translation of proteasome components.  
 
So far, I have shown in this chapter that loss of VMS1 leads to: 1) the accumulation of 
ubiquitinated proteins in total cell lysates and 2) a change in the distribution of proteasome 
subtypes. However, ubiquitin accumulation can be decreased back to approximate wild-type 
levels when the vms1Δ strain is supplied with a full-length copy of wild-type VMS1, but not with 
a version that fails to interact with Cdc48p. To examine whether the ubiquitin accumulation and 
proteasome distribution phenotypes correlated, I performed an in gel proteasome activity assay 
using lysates from vms1Δ strains that were supplemented with an empty vector or vectors for the 
expression of wild-type Vms1p-HA or Vms1p-HA lacking the VIM domain. As shown in 
Figure 26A and B, vms1Δ strains harboring an empty vector yielded the expected increase in the 
free 20S CP activity when compared to a wild-type strain. When vms1Δ strains were 
supplemented with a plasmid carrying wild-type Vms1p-HA, the amount of 20S CP activity 
decreased to near wild-type levels. However, vms1Δ strains expressing Vms1p-HA lacking the 
VIM domain did not show a significant decrease in 20S CP activity. These effects on the 
activities of the 20S CP were correlated to the levels of alpha and beta subunits by western 
blotting analysis.  
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Interestingly, a western blot against the HA-tag on Vms1p indicated that Vms1p-HA co-
migrates with capped proteasomes (Figure 26A, lower right). In addition, the Vms1p-HA 
mutant lacking the VIM domain showed a reproducible decrease in the amount of HA-signal co-
migrating with the capped proteasome. These results suggest that Vms1p is in a complex with 
the 26S proteasome and that the inability to interact with Cdc48p reduces the amount of 
associated Vms1p. Thus, Cdc48p may bridge Vms1p to the 26S proteasome. 
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Figure 24. The vms1Δ strain shows increased levels of 20S core particles 
A. Lysates from wild-type and vms1Δ cells (60μg) were resolved on a 3.5% native gel 
and the gels were incubated in a solution containing ATP and the fluorogenic chymotrypsin-like 
proteasome substrate, Suc-LLVY-AMC (100μM) to assess capped proteasomes. After imaging, 
the gels were incubated with the same solution, but with the addition of 0.02% SDS to visualize 
20S core activity. B. Wild-type and vms1Δ cell extracts were resolved on a 3.5% native gel and 
proteasome activity was visualized as described in A. Western blotting with antibodies against 
yeast 20S core alpha and beta particles and the 19S cap subunit, Rpt5p (bottom two panels, B). 
C. The left graph represents capped proteasome signal while the graph on the right represent 
signal corresponding to the 20S core. The units are arbitrary and the error bars represent + 
standard error (n ≥ 10). Quantitation was performed using ImageJ v4.16e. The activity from the 
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wild-type strain was set as 100%. D. The proteasome activity from lysates prepared from wild-
type or vms1Δ cells (60μg) were assessed in solution by fluorometry. Reactions were prepared in 
a buffer containing ATP and 100μM of the proteasome substrate Suc-LLVY-AMC. Where 
indicated, MG132 was added to a final concentration of 100μM. The error bars represent + 
standard error from at three independent experiments.  
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Figure 25. Maintenance of proteasome components are unaffected in vms1Δ strains 
A. Equal amounts of whole cell extracts from wild-type and vms1Δ strains were resolved 
by SDS-PAGE. Western blot analysis was used to detect the levels of the proteasomal activator 
(Blm10p), 19S cap components (Rpn3p, Rpt5p, and Rpt3p), a proteasome chaperone (Hsm3p), 
and the 20S core particle (alpha and beta Subunits). Anti-GPD was used as a loading control. B. 
In gel proteasome activity assay was performed to assess the effect of VMS1 deletion in strains 
lacking the proteasome transcription factor, Rpn4p. Wild-type, rpn4Δ, and rpn4Δvms1Δ yeast 
lysates were resolved by native gel. The gel was incubated in a solution containing ATP and 
Suc-LLVY-AMC (100μM) to assess capped proteasome activity (upper left panel, B). Next, the 
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gel was incubated in the same solution except 0.02% SDS was added to assess 20S core activity 
(right upper panel, B). Western blot analysis was performed with anti-yeast 20S CP and anti-
Rpt5p to assess the amount of 20S core and 19S cap, respectively. C. Quantitation of 20S CP 
activity (left) and anti-alpha and beta proteins corresponding to the 20S CP (right) from four 
independent experiments. The error bars indicate + standard error. The difference between rpn4Δ 
and rpn4Δvms1Δ in the in gel activity assays (corresponding to 20S core) was not statistically 
significant. The rpn4vms1 strain is being validated. Sample size is 4. 
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Figure 26. Proteasome architecture requires Vms1p-Cdc48p interaction 
A. Proteasome activity in lysates (60μg) from wild-type or vms1Δ cells containing an 
empty vector, or a vector expressing either wild-type Vms1p-HA or Vms1p-ΔVIM-HA (ΔVIM) 
were examined by native gel and Suc-LLVY-AMC (100μM) substrate overlay assay. The 
activity of the capped proteasome (RP2CP, RPCP, left panel A) and 20S core (CP, right panel A) 
were both assessed. Western blotting for Vms1p-HA (anti-HA) and 20S CP (alpha and beta) was 
also performed. B. Quantitation of 20S activity (top) and anti-20S CP signal (bottom) from four 
independent experiments in the indicated strains. The error bars represent + standard error of 
four independent experiments. Sample size is 4. “NS” means not significant.  
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3.2.3 VMS1 function appears to be independent of proteasome assembly chaperones 
To determine if Vms1p facilitates proteasome assembly or stability, I examined ubiquitinated 
protein levels and proteasome distribution phenotypes in a panel of double deletion mutants that 
lacked VMS1 and genes known to be involved in proteasome assembly/stability. The genes tested 
were: RPN10 – a ubiquitin receptor that is involved in connecting the base and lid of the 19S cap 
(GLICKMAN et al. 1998a), RPN13 – a ubiquitin receptor and core component of the 19S particle 
(HUSNJAK et al. 2008), RPN14 -  a chaperone of the 19S cap (FUNAKOSHI et al. 2009; LE TALLEC 
et al. 2009; PARK et al. 2009; ROELOFS et al. 2009; SAEKI et al. 2009), HSM3 – another 
chaperone of the 19S cap (FUNAKOSHI et al. 2009; LE TALLEC et al. 2009; PARK et al. 2009; 
ROELOFS et al. 2009; SAEKI et al. 2009), and UMP1 – a chaperone of the 20S core (RAMOS et al. 
1998). The analysis presented in Figure 27A revealed that loss of VMS1 resulted in an additive 
increase in ubiquitinated protein levels in most of the genotypes tested. This result suggests that 
Vms1p functions in parallel to Rpn13p, Rpn14p, Hsm3p, and Ump1p. The exception to this 
finding, however, was the rpn10Δ and rpn10Δvms1Δ strains, which both showed similar levels 
of ubiquitinated protein accumulation. Rpn10p is a ubiquitin receptor that also helps link the 19S 
base and lid (GLICKMAN et al. 1998a). This intriguing result suggests that these two gene 
products function in series. To further support this hypothesis, I examined the distribution of 
proteasome subtypes in these same mutants. As seen in Figure 27B, the accumulation of 20S CP 
was evident in all strains examined, as assessed with the fluorogenic substrate and by western 
blotting. Finally, I used glycerol gradient analysis to examine the distribution of proteasome 
components. Western blotting with antibodies against the 19S cap (Rpt5p), accessory proteins 
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(Blm10p), Cdc48p, 19S chaperone (Hsm3p) and the core components indicated that the 
sedimentation distribution was not significantly altered by the deletion of VMS1 (Figure 27C). 
On occasion, I have observed that both 20S core particle subunits and Rpn10p distributed 
differently (Figure 27D. see upward bracket). These data collectively suggest that Vms1p 
functions in a parallel and possibly independent proteasome assembly/stability pathway, and that 
Rpn10p and Vms1p may function in series. 
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Figure 27. Loss of VMS1 does not appear to affect proteasome assembly 
A. The effect of VMS1 deletion on ubiquitinated cellular proteins was assessed in 
different strains representing a panel of defects in proteasome stability (rpn10Δ, rpn13Δ) and 
assembly (hsm3Δ, ump1Δ, rpn14Δ). Wild-type and vms1Δ strains were also assessed. Equal 
amounts of whole cells extracts were resolved by SDS-PAGE and western blotted with anti-
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ubiquitin. Anti-GPD was used as a loading control. B. Proteasome activity from the strains used 
in (A) was assessed by native gel overlay assay with Suc-LLVY-AMC followed by the addition 
of 0.02% SDS to assess 20S core activity. The 20S core particle components were assessed by 
western blotting with an antibody against yeast 20S alpha and beta subunits. C. Whole cell 
extracts (5mg) from wild-type and vms1Δ strains were resolved on a glycerol gradient (10-30%). 
To examine the distribution of proteasome components, individual fractions were collected, 
precipitated and resolved by SDS-PAGE. Western blotting was performed with antibodies 
against the 19S cap (Rpt5p), the proteasome activator (Blm10p), Cdc48p, the proteasome 
chaperone (Hsm3p) and the 20S core (alpha and beta subunits). D. An independent example of 
the glycerol gradient analysis. The antibodies used in this experiment are Rpt5p (19S cap), 
Blm10p (proteasome activator), Cdc48p (ERAD-associated ATPase), Hsm3p (proteasome cap 
chaperone), alpha and beta subunits (20S core) and Rpn10p (ubiquitin receptor).  
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3.2.4 VMS1 does not significantly affect the Cdc48p association with the proteasome 
Based on the data presented in section 3.3.2, the Vms1p-ΔVIM mutant shows reduced co-
migration with capped proteasomes, which suggests two intriguing possibilities. 1) Cdc48p is at 
the proteasome at normal levels and the Vms1p-ΔVIM mutant shows reduced binding or 2) the 
Vms1p-ΔVIM mutant shows a reduced association and Cdc48p interaction with capped 
proteasomes is also lower. To begin to differentiate between these two possibilities, I performed 
immunoprecipitation experiments with an epitope-tagged version of Cdc48p from strains 
containing or lacking VMS1. I examined Cdc48p-Myc precipitates from both crude membrane 
and cytosolic fractions. The immunoprecipitated proteins were identified by mass spectrometry 
in collaboration with the laboratory of Dr. Steven Gygi (Harvard Medical School), and with the 
help of Dr. Kim Woong (Harvard Medical School). Cdc48p immunoprecipitations from the 
cytosolic fraction yielded ~400 interactors while material from the membrane fraction yielded 
~350 interactors (Table 9). Of these interactions, only 126 and 95 unique interactions were 
identified from the cytosol and membrane fractions, respectively. This indicates that the vast 
majority of interactors overlap. Additionally, I only observed 27 of the 79 (34.1%) known 
Cdc48p physical interactions annotated on the Saccharomyces Genome Database 
(www.yeastgenome.org, Biogrid) (STARK et al. 2006). Of the 79 known Cdc48p interactors, 54 
were identified by mass spectrometry. Thus, I was able to identify 50% of the known Cdc48p 
interactions that were detectable by mass spectrometry.  
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When I focused on specific UPS/ERAD relevant interactions and their peptide (spectral) 
counts, I noted that Cdc48p-Myc interactions with the 20S core appeared to be reduced in the 
cytosol of vms1Δ yeast (Table 10). In contrast, interactions with the 19S cap were largely 
similar. To test this possibility in a quantitative manner, I performed a Stable Isotope Lableing 
by Amino acids in Cell culture (SILAC) experiment, which is a form of quantitative mass 
spectrometry. In the SILAC experiment, wild-type cells were grown under normal conditions 
and vms1Δ yeast were grown in the presence of heavy, isotopic lysine. Cdc48p-Myc was 
immunoprecipitated from these the strains and again mass spectrometry was performed by the 
Gygi lab. The relative amount of “normal” (WT) and “heavy, isotopic” (vms1Δ) signal was 
compared between shared co-precipitating proteins. Unexpectedly, and in contrast to the spectral 
counting, I discovered that the interaction between Cdc48p and the proteasome was largely 
unaffected by the vms1Δ genotype (Figure 28). Rpt3p may be enriched in VMS1 mutants, but 
this is likely an outlier. Rpt3p has no known function outside of the proteasome. These data 
further support a model in which Cdc48p binds independent of Vms1p function to the 
proteasome, and most likely then recruits Vms1p.  
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Table 9. Complete list of membrane and cytosolic fraction Cdc48p interactors from wild-type and 
vms1Δ strains 
Cdc48p-Myc was immunoprecipitated from 2-3mg of cytosol or membrane from wild-
type and vms1Δ strains. The Cdc48p-Myc was the only copy of Cdc48p in these strains. The 
immunoprecipitated material was methanol/chloroform extracted, lyophilized and subject to 
mass spectrometry in collaboration with Drs. Steven Gygi and Woong Kim (Harvard Medical 
School). Included with the gene name are unique peptide counts, which represents how many 
different proteolyzed fragments of a protein were observed, and total peptide counts, which 
represents the absolute total number of peptides seen in the experiment. This is sorted by unique 
peptide counts and the most abundant are shown at the top.  
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                               CYTOSOL                                                              MEMBRANE                             
                WT                         vms1 Δ                                 WT                              vms1 Δ           
Gene Unique Total Gene Unique Total Gene Unique Total Gene Unique Total
CDC48 64 288 CDC48 77 319 CDC48 42 124 CDC48 54 133
SSA2 27 39 SSA2 33 54 SSA2 28 39 SSA2 27 32
CDC19 24 60 MET6 31 40 CDC19 21 26 HSP82 23 28
HSP82 22 28 HSP82 30 38 HSP82 20 24 KAR2 17 20
TFP1 21 27 MET10 30 37 ENO2 15 17 FKS1 15 17
THS1 20 25 THS1 29 34 KAR2 14 21 NPL4 15 17
ENO2 19 31 ECM17 29 31 NPL4 14 18 ENO2 14 20
PGK1 19 25 CDC19 28 58 EFT1 14 18 TDH2 13 17
DDR48 16 74 TFP1 27 31 PGK1 11 12 CDC19 13 15
NUP2 16 21 TDH2 22 41 TEF1 10 17 SSB2 13 14
MET6 16 17 FAS2 22 26 ADH1 10 10 PGK1 12 12
TDH2 15 39 RPO21 22 24 FKS1 9 16 EFT1 11 14
NPL4 15 22 ENO2 21 37 TDH2 9 13 ECM17 11 12
PAN1 15 18 ADH1 20 38 TIF1 9 10 PAB1 11 11
RPB2 15 18 YHR020W 20 26 SSA1 8 11 MET6 11 11
SHP1 14 53 PGK1 20 26 NUP2 8 10 SSA1 10 12
LEU2 14 31 PDC1 20 25 SSB2 8 9 TRM1 10 11
GPM1 14 23 ILS1 20 23 DEF1 7 11 PAN1 10 11
SPT5 14 19 CHC1 20 22 RPL3 7 11 DDR48 9 19
ADH1 14 19 LEU2 19 37 LEU2 7 9 DEF1 9 16
GPH1 14 17 VMA2 19 30 RPS6A 7 9 TFP1 9 11
ALA1 14 16 EFT1 18 22 GPM1 7 9 TEF1 9 11
EFT1 13 18 SHP1 17 30 URA2 7 8 SSE1 9 10
GSY2 13 17 HSP60 17 22 UBX2 7 7 SPT5 9 9
PAB1 13 15 MES1 17 19 HRD3 7 7 SSC1 8 10
PGI1 13 15 SSE1 17 19 RPS31 6 15 LEU2 8 9
PDC1 12 17 SPT5 17 19 PIL1 6 9 ADH1 8 9
HSP60 12 15 FAS1 17 18 ILV2 6 8 CBR1 8 9
SUP35 12 13 ALA1 17 18 PAB1 6 7 SUP35 8 8
SAH1 12 12 MET3 16 25 UFD1 6 7 CHC1 8 8
TPI1 11 13 GPM1 16 22 CHC1 6 6 CHS1 7 8
SES1 11 12 GSY2 16 21 RPL27A 6 6 ILV2 7 8
RPO21 11 12 GPH1 16 18 RPL19A 6 6 UFD1 7 8
CHC1 11 11 NPL4 16 17 SHP1 5 12 RPL1A 7 8
RPN2 11 11 DDR48 15 30 TPI1 5 7 HRD3 7 8
KAR2 10 13 DPS1 15 21 RVB1 5 7 PDI1 7 7
SSA1 10 12 CYS4 15 17 RPS18B 5 6 YEF3 7 7
HXK2 10 12 NUP2 15 16 PDC1 5 6 ACT1 7 7
TEF1 9 16 SES1 15 15 RPL25 5 6 SHP1 6 11
SSC1 9 12 CPA2 14 18 SPT5 5 5 VMA2 6 9
SSB2 9 11 PAB1 14 16 RPL4B 5 5 RPL3 6 8
MES1 9 11 RPB2 14 16 RPL7B 5 5 GPM1 6 8
HIS4 9 10 KAR2 14 15 RPL2B 5 5 RPS6A 6 7
CYS4 9 9 ADE3 14 15 PMA2 5 5 RPL8B 6 7
VMA2 8 23 VAS1 14 14 GCN20 5 5 PHO88 6 7
ILV5 8 11 ALD6 13 18 LSP1 5 5 TIF1 6 7
UFD1 8 11 PYC1 13 18 VMA2 4 8 FAA1 6 6
ACT1 8 11 SSA1 13 17 RPS14B 4 6 URA2 6 6
YHR020W 8 10 SSC1 13 17 SSC1 4 5 RPL7B 6 6
SHM1 8 10 PFK1 13 16 RPL1A 4 5 RPS31 5 13
BMH1 8 9 SSB2 13 15 PET9 4 5 HSC82 5 8
ADE3 8 9 HIS4 13 15 RPL6B 4 5 VMA4 5 7
URA2 8 9 SAH1 13 14 FAA1 4 4 BMH1 5 6
TIF1 8 9 GDB1 13 13 RPN1 4 4 PDC1 5 6
DEF1 7 15 RPN1 12 13 SEC21 4 4 TPI1 5 5
PSA1 7 12 RPA190 12 13 SUP35 4 4 NUP2 5 5
DPS1 7 12 ACT1 12 13 GCD11 4 4 GCN20 5 5
ATP1 7 9 CLC1 11 16 RPS3 4 4 RPL19A 5 5
ALD6 7 9 TEF1 11 16 PGA3 4 4 RPL2B 5 5
ATP3 7 7 SAM1 11 14 THS1 4 4 TRP5 5 5
SSE1 7 7 PGI1 11 14 CHO2 4 4 PET9 4 6
PYC1 7 7 GRS1 11 13 RPS4A 4 4 PIN4 4 5
PIN4 6 10 ATP2 11 13 RPL21B 4 4 RPS18B 4 5
RHR2 6 10 PAN1 11 12 ABP1 3 6 PMA2 4 5
RPS31 6 9 TRP3 11 12 FBA1 3 6 RPL20B 4 5
SAM1 6 8 HOM6 11 11 RPL17A 3 5 RPL10 4 5
IPP1 6 8 SHM1 11 11 USA1 3 5 RPS14B 4 5
GUS1 6 8 TPI1 10 12 RPL16B 3 5 RPL6B 4 5
ASN1 6 8 TRM1 10 11 URA7 3 4 STM1 4 5
CLC1 6 7 FRS2 10 10 RPT5 3 4 RPL16B 4 5
ILS1 6 7 TDH1 10 10 LCB1 3 4 RPL17A 4 4
RPN1 6 6 ENO1 9 18 RPL8B 3 4 TRX2 4 4
VAS1 6 6 ILV5 9 13 HSC82 3 4 POR1 4 4
TRP3 6 6 PSA1 9 12 PMA1 3 4 RPL4B 4 4  
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RPN7 6 6 DLD3 9 12 CBR1 3 4 RPN1 4 4
FBA1 5 10 GFA1 9 12 RPL20B 3 4 ERG6 4 4
APA1 5 9 DED81 9 11 RPL28 3 4 RPL12A 4 4
RTG2 5 9 PDI1 9 9 RPL13B 3 4 ERG11 4 4
RPT5 5 8 YDR341C 9 9 HRD1 3 3 RPS20 4 4
ALF1 5 8 APE2 9 9 SEC4 3 3 RPP0 4 4
DED81 5 7 LEU1 9 9 CDC33 3 3 YOS9 4 4
NAP1 5 7 DUG2 9 9 YOS9 3 3 UBX2 4 4
FAS1 5 7 FBA1 8 15 RPT2 3 3 RPO21 4 4
FAS2 5 7 ALF1 8 14 SGM1 3 3 THS1 4 4
GFA1 5 7 IPP1 8 11 ACT1 3 3 PSA1 4 4
CTS2 5 6 BMH1 8 10 POR1 3 3 GGC1 4 4
RPT6 5 6 UFD1 8 10 SRP1 3 3 SAM1 4 4
ABP1 5 6 GSY1 8 9 RPN2 3 3 MIR1 4 4
GSY1 5 6 TKL1 8 9 HSP60 3 3 RPL25 4 4
GCD11 5 6 PYC2 8 8 RPS12 3 3 SAH1 4 4
PYC2 5 6 PFK2 8 8 YEF3 3 3 RPS17A 4 4
PDI1 5 6 GDH1 8 8 YPR158W-B 3 3 RPS12 4 4
ENO1 5 6 CDC60 8 8 BMH1 3 3 RPL27A 4 4
TRM1 5 6 DEF1 7 9 RPL6A 3 3 RPL28 4 4
RPS18B 5 6 HXK2 7 9 RPS17A 3 3 RPL21B 4 4
LEU1 5 6 RPT5 7 8 TRP5 3 3 END3 4 4
TKL1 5 6 EFB1 7 8 RPL16A 3 3 RPL6A 4 4
GRS1 5 5 TAL1 7 8 RPL11A 3 3 ILV5 4 4
YDR341C 5 5 YGR117C 7 8 RPT6 3 3 GSY2 4 4
GDB1 5 5 PIN4 7 7 PFK2 3 3 PMR1 4 4
HOM6 5 5 YOL098C 7 7 GGC1 3 3 RPL13B 3 5
AAP1 5 5 RPT6 7 7 RPS19A 3 3 SEC4 3 4
YEF3 5 5 TRR1 7 7 RPG1 3 3 RPT5 3 4
RPA190 5 5 AAP1 7 7 RPN9 3 3 YPR158W-B 3 4
TAL1 5 5 ADO1 7 7 GUS1 3 3 RPL33A 3 4
GDH1 5 5 ATP3 7 7 RPS9A 3 3 UBX7 3 4
ERG13 5 5 END3 7 7 HTB1 3 3 CDC33 3 4
DLD3 5 5 URA2 7 7 IST2 2 4 RPL24B 3 4
ADH3 5 5 ADE13 7 7 RPL15B 2 4 PMA1 3 4
HSC82 4 6 ASC1 7 7 PHO84 2 3 GAS1 3 4
SAM2 4 5 RPN7 7 7 RPS20 2 3 RPL32 3 4
END3 4 5 GUS1 7 7 PGI1 2 3 TDH3 3 4
CDC60 4 5 ADH3 7 7 OLE1 2 3 RPL26A 3 4
YAK1 4 5 HSC82 6 10 ERG26 2 3 RPS1B 3 4
ADE13 4 5 CPR1 6 9 SSE1 2 3 SEC27 3 3
RPP2A 4 4 NAP1 6 8 DDR48 2 3 FBA1 3 3
FRS2 4 4 RHR2 6 8 RPL30 2 3 TRX1 3 3
GLE2 4 4 MET17 6 8 LEU1 2 3 RNR4 3 3
TRR1 4 4 TIF1 6 8 YPT1 2 3 RPP2A 3 3
ARO2 4 4 RNR2 6 7 RPL33A 2 3 SEC21 3 3
TRP2 4 4 THR4 6 7 SCS2 2 3 MET10 3 3
VMA4 4 4 ERG13 6 7 DFM1 2 3 CLC1 3 3
GLN4 4 4 SUP35 6 6 RPP0 2 3 GCD11 3 3
KAP123 4 4 SOD2 6 6 RPS1B 2 3 EFB1 3 3
ASC1 4 4 LYS4 6 6 ARO2 2 2 ARC1 3 3
ATP2 4 4 RPS6A 6 6 SEC26 2 2 ARO2 3 3
DAK1 4 4 YEF3 6 6 NAP1 2 2 RPB2 3 3
CPA2 4 4 YBR056W 6 6 SUB2 2 2 DED1 3 3
RPL27A 4 4 ATP1 6 6 KAP123 2 2 PIL1 3 3
RPS20 3 5 TYS1 6 6 RPS2 2 2 PGA3 3 3
RPS6A 3 5 ARO8 6 6 YDR341C 2 2 RPL11A 3 3
RNR4 3 5 ACC1 6 6 RTN1 2 2 HSP60 3 3
TUB3 3 5 SAM2 5 9 TMA19 2 2 SCS2 3 3
RPT2 3 4 RPS31 5 8 PHO88 2 2 RPL9B 3 3
TMA19 3 4 AAT2 5 7 RPP2A 2 2 ILV1 3 3
CPR1 3 4 RPT2 5 6 RPP2B 2 2 GUA1 3 3
RPL17A 3 4 RPS18B 5 6 RPN5 2 2 ERG26 3 3
AAH1 3 4 SGM1 5 6 BMH2 2 2 SEC63 3 3
PNC1 3 4 HEM1 5 6 RPL12A 2 2 RPL14A 3 3
RPN9 3 4 DUG3 5 6 YGR117C 2 2 LEU1 3 3
RPL25 3 4 DED1 5 6 RNA1 2 2 GSP2 3 3
YHB1 3 4 RPN6 5 6 ARC1 2 2 YKT6 3 3
ERG10 3 3 CTS2 5 5 RPN7 2 2 RPL5 3 3
FKS1 3 3 ERG10 5 5 YKT6 2 2 RPS4A 3 3
RPP2B 3 3 GCD11 5 5 SPF1 2 2 SHM2 3 3
LYS4 3 3 RPA135 5 5 TFP1 2 2 TEF4 3 3
CDC33 3 3 TRX2 5 5 UBX7 2 2 CCT8 3 3
SRP1 3 3 KRS1 5 5 RPL35A 2 2 TIF4631 3 3
TRX1 3 3 WTM1 5 5 RPS15 2 2 VMA13 3 3  
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EFB1 3 3 PGM1 5 5 RPL5 2 2 GUS1 3 3
ERG20 3 3 RTG2 5 5 GAS1 2 2 RPN2 3 3
HOM2 3 3 APA1 5 5 RPS8B 2 2 RPS11A 3 3
CYS3 3 3 RPN12 5 5 GSP2 2 2 ERV41 3 3
SHM2 3 3 UBA1 5 5 RPL32 2 2 CHO2 3 3
YOL098C 3 3 TRP5 5 5 WHI4 2 2 IST2 2 4
HIS1 3 3 RPN2 5 5 RVB2 2 2 RAS2 2 4
RPL3 3 3 TDH3 4 25 RVS161 2 2 OLE1 2 3
RNR2 3 3 LIA1 4 6 FAS2 2 2 SPF1 2 3
TRP5 3 3 AAH1 4 6 TDH3 2 2 ALF1 2 3
RPS3 3 3 SEC53 4 5 NDE1 2 2 PHO84 2 3
GSP2 3 3 NAB3 4 5 RPL9B 2 2 RPL15B 2 3
YGR117C 3 3 CYS3 4 5 TIF4631 2 2 SAM3 2 3
RPN6 3 3 HOM2 4 5 RPL42A 2 2 RPN7 2 3
GUA1 3 3 ARC1 4 5 RPS25B 2 2 SEC26 2 3
TYS1 3 3 GSP2 4 5 RPL26A 2 2 ATP1 2 3
URA5 3 3 GND1 4 5 ERG1 2 2 ALA1 2 3
RPL21B 3 3 RPP2A 4 4 RPL18A 2 2 SAM2 2 3
KRS1 3 3 RPP2B 4 4 PMR1 2 2 PEP4 2 2
PDC5 3 3 SSA4 4 4 FAA4 2 2 HYP2 2 2
BET4 3 3 YMR315W 4 4 ARF1 2 2 TOM70 2 2
RPT1 3 3 GUA1 4 4 YET3 1 2 HRD1 2 2
SEC13 3 3 RPP0 4 4 AHA1 1 2 SEC28 2 2
STI1 3 3 GLE2 4 4 RPS9B 1 2 ABP1 2 2
PRO2 3 3 ADK1 4 4 CHS1 1 2 RHR2 2 2
ACC1 3 3 ERG20 4 4 UGP1 1 2 YET3 2 2
RPS9A 3 3 PRO3 4 4 EGD2 1 2 SRV2 2 2
APE3 3 3 RPS12 4 4 HXT4 1 2 ASC1 2 2
HSP10 2 4 HIS7 4 4 RPL24B 1 2 NAP1 2 2
RPB4 2 4 ARG5 4 4 YJR015W 1 2 VMA5 2 2
THR4 2 4 STI1 4 4 RPL14A 1 2 RPL16A 2 2
PDC6 2 4 PRD1 4 4 SEC27 1 2 RPS7A 2 2
YMR226C 2 4 SHM2 4 4 USO1 1 2 LCB1 2 2
RPB11 2 4 GLN4 4 4 TRM1 1 2 RTN1 2 2
NUP100 2 3 IKI3 4 4 RPS24B 1 2 YDR341C 2 2
SGT2 2 3 MET13 4 4 PRS2 1 2 VAS1 2 2
ADK1 2 3 APE3 4 4 TOM70 1 1 YGR117C 2 2
ADO1 2 3 RPT1 4 4 MKT1 1 1 TSA1 2 2
HIS7 2 3 TUB3 4 4 STM1 1 1 GET1 2 2
RPL4B 2 3 AHP1 3 7 CLC1 1 1 NSP1 2 2
RPN3 2 3 TEF4 3 4 TSA1 1 1 TMA19 2 2
PRO3 2 3 SPE3 3 4 SUR4 1 1 AHA1 2 2
WTM1 2 3 MAE1 3 4 SUP45 1 1 YKL100C 2 2
NAB3 2 3 GCD10 3 4 PRE9 1 1 FAS2 2 2
UBA1 2 3 YMR226C 3 4 GET1 1 1 SUB2 2 2
AAT2 2 3 RPB5 3 3 ALG2 1 1 RPP2B 2 2
ARO8 2 3 HNT1 3 3 SEC11 1 1 RPT6 2 2
RPP0 2 3 RPB3 3 3 ASC1 1 1 YCP4 2 2
RPL16B 2 3 RNR4 3 3 CHS3 1 1 RPS15 2 2
RPP1B 2 2 BSP1 3 3 RPS5 1 1 CUE5 2 2
GUK1 2 2 YPL247C 3 3 RPS13 1 1 COF1 2 2
RPN5 2 2 TMA19 3 3 ALF1 1 1 GET3 2 2
NSP1 2 2 TRX1 3 3 ECM33 1 1 USA1 2 2
ARC1 2 2 HSP10 3 3 RPN13 1 1 ALD6 2 2
COF1 2 2 HSP26 3 3 RFA2 1 1 ARO4 2 2
LIA1 2 2 HEM2 3 3 UBX6 1 1 RPS3 2 2
TRX2 2 2 RPS20 3 3 MIR1 1 1 GSF2 2 2
NUP116 2 2 COF1 3 3 RAS2 1 1 FPR1 2 2
PRE9 2 2 NSP1 3 3 SCS7 1 1 RPS19A 2 2
VMA10 2 2 RPN5 3 3 ECM10 1 1 SUR4 2 2
ADE12 2 2 SRP1 3 3 RNR2 1 1 RNR2 2 2
MET17 2 2 TSA1 3 3 FEN1 1 1 RPL35A 2 2
EDE1 2 2 ILV3 3 3 CSE1 1 1 RVB2 2 2
SEC18 2 2 YLR301W 3 3 RHR2 1 1 PMT4 2 2
MMF1 2 2 DAK1 3 3 TRX2 1 1 RVB1 2 2
MDE1 2 2 HTS1 3 3 RPS7B 1 1 KAP123 2 2
RPS14B 2 2 YHB1 3 3 ATP3 1 1 NRP1 2 2
LYS21 2 2 LYS9 3 3 RPO21 1 1 MET17 2 2
PRT1 2 2 WHI4 3 3 GCN1 1 1 RPL36B 2 2
RPS15 2 2 RPS17A 3 3 SAM1 1 1 ERG9 2 2
SGM1 2 2 CCT8 3 3 PEP4 1 1 RPL37A 2 2
RNA1 2 2 DLD2 3 3 ADE3 1 1 RPN6 2 2
ARP3 2 2 RPN9 3 3 PIM1 1 1 RPS5 2 2
RVB2 2 2 BLM10 3 3 BFR1 1 1 WHI4 2 2
BMH2 2 2 ADE2 3 3 EDE1 1 1 YDJ1 2 2  
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RPS4A 2 2 CCT5 3 3 RPS10A 1 1 FAA4 2 2
ALD4 2 2 GUK1 3 3 RPL33B 1 1 PUB1 2 2
FPR1 2 2 MMF1 3 3 ITR1 1 1 PFK2 2 2
YKT6 2 2 LSC2 3 3 SEC63 1 1 DPS1 2 2
PRE1 2 2 BET4 3 3 YKL100C 1 1 ARF1 2 2
ARG5 2 2 HIS1 3 3 ZEO1 1 1 MRH1 2 2
ZEO1 2 2 IDI1 3 3 PSD1 1 1 DFM1 2 2
RPL32 2 2 UBX4 3 3 SOD1 1 1 FSF1 2 2
LYS9 2 2 FRS1 3 3 ACC1 1 1 RPS9A 2 2
ILV3 2 2 SUB2 3 3 RPL23B 1 1 RPL18A 2 2
GCD10 2 2 ARC35 3 3 FPR1 1 1 HXK2 2 2
WHI4 2 2 SEC13 3 3 PDR5 1 1 RAS1 2 2
RVB1 2 2 URA1 3 3 RPT1 1 1 ERG3 2 2
AHP1 2 2 ACO1 3 3 ERG11 1 1 TPO3 2 2
RPA135 2 2 PDC6 2 4 FSF1 1 1 LCB2 2 2
SPE3 2 2 VMA4 2 3 PDI1 1 1 ERG1 2 2
SPT6 2 2 TUB2 2 3 RPS26A 1 1 ANB1 2 2
RPS17A 2 2 RPB11 2 3 OLA1 1 1 RPS23B 2 2
YPL247C 2 2 GCD14 2 3 IRC22 1 1 ENO1 1 3
CCT8 2 2 IMD3 2 2 SEC28 1 1 RPP1B 1 2
RPL35A 2 2 SEC27 2 2 RPL10 1 1 RPL30 1 2
GPR1 2 2 RPP1B 2 2 TOM22 1 1 VPH1 1 2
APE2 2 2 ARO2 2 2 RPL22A 1 1 ALO1 1 2
TDH1 2 2 NUP116 2 2 ILV1 1 1 MNN2 1 2
YRB1 2 2 MDE1 2 2 RPB2 1 1 RPL8A 1 2
ASP1 2 2 RPN8 2 2 CTS2 1 1 PMT2 1 2
RPL9B 2 2 MAM33 2 2 TIF11 1 1 HSP26 1 1
CPR6 2 2 ADE5 2 2 HXK2 1 1 RPS2 1 1
HSP104 2 2 PNC1 2 2 RPL21A 1 1 YNL208W 1 1
RPS19A 2 2 YDL124W 2 2 MES1 1 1 NAB3 1 1
SOD2 2 2 ABP1 2 2 LYS20 1 1 KAP95 1 1
PMA2 2 2 CDC33 2 2 PTP2 1 1 RFA2 1 1
ARC35 2 2 YAK1 2 2 YPR158C-C 1 1 RPB5 1 1
RPL34B 2 2 BMH2 2 2 RPL7A 1 1 PGI1 1 1
TDH3 1 3 ILV2 2 2 TVP38 1 1 MET3 1 1
TUB2 1 2 YGL039W 2 2 PMT1 1 1 YEL007W 1 1
SNF7 1 2 DUG1 2 2 HTA1 1 1 YPT1 1 1
ECM10 1 2 RAD9 2 2 HCH1 1 1 ALG2 1 1
ENP1 1 2 RPS14B 2 2 ALA1 1 1 NPL3 1 1
RPL11A 1 2 URA7 2 2 ILV5 1 1 RPN5 1 1
TIF3 1 2 DYS1 2 2 RNR4 1 1 RPS9B 1 1
SSA4 1 2 YNL134C 2 2 RPS11A 1 1 CYS4 1 1
GAS1 1 2 PRT1 2 2 SMI1 1 1 EDE1 1 1
SEC4 1 2 YJR096W 2 2 CAM1 1 1 ECM33 1 1
TUB1 1 2 RPS15 2 2 SHM2 1 1 EPT1 1 1
YPR158W-B 1 2 KAP123 2 2 PDC6 1 1 SPT6 1 1
LSB3 1 2 ARO9 2 2 RRB1 1 1 VPS74 1 1
IMD3 1 1 TRP2 2 2 PYK2 1 1 TIF3 1 1
TSA1 1 1 ALD5 2 2 RPN12 1 1 EBP2 1 1
CDC53 1 1 URA4 2 2 MGM101 1 1 RPL33B 1 1
KAP95 1 1 ZEO1 2 2 ENO1 1 1 RPS13 1 1
SOD1 1 1 HEM13 2 2 RPS30B 1 1 SKG6 1 1
YJL055W 1 1 ARP2 2 2 ERG3 1 1 SEC17 1 1
RNR1 1 1 PMI40 2 2 YJR003C 1 1 UBP14 1 1
AHA1 1 1 RPS16A 2 2 RPL34B 1 1 DBP5 1 1
RPL16A 1 1 APT1 2 2 TEF4 1 1 PMT1 1 1
PIN3 1 1 ADE6 2 2 TPO3 1 1 SEC11 1 1
SUP45 1 1 HXK1 2 2 ATP1 1 1 RPS7B 1 1
RPL30 1 1 FPR1 2 2 ILV3 1 1 CAP2 1 1
YMR315W 1 1 RPS3 2 2 RPL15A 1 1 HYR1 1 1
NPL3 1 1 YGP1 2 2 HSP104 1 1 RPS16A 1 1
THR1 1 1 ASP1 2 2 GUA1 1 1 YJR015W 1 1
RPL33A 1 1 SVF1 2 2 YDJ1 1 1 RPN13 1 1
PAN5 1 1 RPS21A 2 2 CHL1 1 1 YOP1 1 1
YEL007W 1 1 UBP14 2 2 PDC5 1 1 ECM10 1 1
SEC26 1 1 RPS11A 2 2 FAS1 1 1 CHS3 1 1
YPT1 1 1 MET14 2 2 CPR1 1 1 TAF14 1 1
ACF4 1 1 ASN1 2 2 ARO1 1 1 SGM1 1 1
YBR056W 1 1 LEU9 2 2 RPS0B 1 1 ALG5 1 1
RPL24B 1 1 ARP3 2 2 TRX1 1 1 GNP1 1 1
HYR1 1 1 YPR158W-B 2 2 RPS16A 1 1 MBF1 1 1
EGD2 1 1 ARG4 2 2 ENP1 1 1 ACC1 1 1
NAM8 1 1 URA5 2 2 UBX3 1 1 GCN1 1 1
VPS74 1 1 PAA1 2 2 ACS2 1 1 VBA4 1 1
RPS12 1 1 ARO1 2 2 SAC1 1 1 VTC4 1 1  
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RPS12 1 1 ARO1 2 2 SAC1 1 1 VTC4 1 1
URA7 1 1 HOR2 2 2 ADK1 1 1 MES1 1 1
RPB3 1 1 CCT3 2 2 RPL24A 1 1 MNN5 1 1
RPS7B 1 1 HMF1 2 2 UBX4 1 1 CTS2 1 1
CAF16 1 1 CPR6 2 2 RPN6 1 1 IRC22 1 1
IDH2 1 1 ADH6 2 2 DHH1 1 1 TSC13 1 1
BSP1 1 1 RPS4A 2 2 ATP2 1 1 FEN1 1 1
IMD4 1 1 SUI3 2 2 MMF1 1 1 YMR046C 1 1
ECM33 1 1 RPL3 2 2 SEC13 1 1 TOM5 1 1
SEC21 1 1 PDX3 2 2 SUR2 1 1 RPT2 1 1
HNT1 1 1 RNA1 2 2 PSD1 1 1
RPS1A 1 1 YRB1 2 2 RPT1 1 1
RPL14A 1 1 RPL25 2 2 HTB1 1 1
OLA1 1 1 LSP1 2 2 MET14 1 1
ADE5 1 1 HIS2 2 2 ARB1 1 1
TIF34 1 1 ELP3 2 2 SCD6 1 1
RPS21A 1 1 RPS9A 2 2 TIF11 1 1
MED2 1 1 ARF1 2 2 DIC1 1 1
CRM1 1 1 HEF3 2 2 ENT2 1 1
PHO3 1 1 YNL010W 2 2 VMA8 1 1
RPS13 1 1 RPN11 2 2 YMR124W 1 1
DUG3 1 1 PDC5 1 3 NUP100 1 1
YER156C 1 1 YEL007W 1 2 APT1 1 1
RPN13 1 1 TAF14 1 2 FRE1 1 1
PFK1 1 1 PIL1 1 2 MNN9 1 1
HEM1 1 1 AHA1 1 2 YGR001C 1 1
RDI1 1 1 ARO4 1 2 ERG25 1 1
ADE6 1 1 NRD1 1 2 RPS25B 1 1
ADE17 1 1 LAP3 1 1 SAC1 1 1
SCS2 1 1 RPB4 1 1 DBP2 1 1
FBP26 1 1 RNR1 1 1 SES1 1 1
LSC2 1 1 NAM8 1 1 RPS24B 1 1
RPN12 1 1 BNA3 1 1 SSA4 1 1
NUP60 1 1 PIN3 1 1 PYK2 1 1
SUB2 1 1 MDH1 1 1 ADE5 1 1
RPL12A 1 1 PRE9 1 1 CPR1 1 1
MET10 1 1 KAP95 1 1 ZRT1 1 1
YPR1 1 1 HAM1 1 1 RFA1 1 1
NRP1 1 1 PEP4 1 1 RPB3 1 1
UBX7 1 1 RPS9B 1 1 ERV46 1 1
UBP14 1 1 RPL24B 1 1 RPL24A 1 1
ARB1 1 1 NPL3 1 1 RPN8 1 1
RPL1A 1 1 CCP1 1 1 BMH2 1 1
SAP185 1 1 EDE1 1 1 RPL37B 1 1
SIT4 1 1 CAF16 1 1 RPS25A 1 1
DED1 1 1 CAP2 1 1 RPS29A 1 1
BNA1 1 1 DOA1 1 1 TIM44 1 1
RPS11A 1 1 RTN1 1 1 KRE9 1 1
SAC6 1 1 RPL11A 1 1 MAE1 1 1
MAM33 1 1 ZWF1 1 1 ZRT2 1 1
APT1 1 1 HYR1 1 1 BUG1 1 1
PMI40 1 1 GET3 1 1 HCH1 1 1
PYK2 1 1 THR1 1 1 YPT7 1 1
CTS1 1 1 RPT3 1 1 EMC4 1 1
TOM1 1 1 SUP45 1 1 CAM1 1 1
YMR099C 1 1 PAN5 1 1 ARP2 1 1
LYS20 1 1 ECM10 1 1 LAG1 1 1
RPS5 1 1 TUB1 1 1 YPR158C-C 1 1
PTC3 1 1 SNF7 1 1 TUB3 1 1
RPL8B 1 1 RPS1A 1 1 PRE9 1 1
RPL6A 1 1 PRE10 1 1 TAL1 1 1
GRE3 1 1 TIF4631 1 1 DED81 1 1
HXK1 1 1 RPS13 1 1 TFC4 1 1
HMF1 1 1 ACO2 1 1 PIS1 1 1
RPC40 1 1 SOD1 1 1 GND1 1 1
HAT2 1 1 BAT1 1 1 RPB11 1 1
YJR096W 1 1 ECM33 1 1 SCM4 1 1
ASF1 1 1 UBX7 1 1 NDE1 1 1
RPL2B 1 1 CIA1 1 1 TRR1 1 1
PFK2 1 1 RPA12 1 1 APE3 1 1
PTP2 1 1 RPS7A 1 1 CPR6 1 1
ACS2 1 1 RVB2 1 1 HSP104 1 1
PIL1 1 1 SGT2 1 1 APA1 1 1
NPA3 1 1 RPG1 1 1 ELO1 1 1
RPS29A 1 1 PRO1 1 1 SSZ1 1 1  
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FRS1 1 1 SER33 1 1 FAS1 1 1
NGL2 1 1 RPN13 1 1 SER1 1 1
OYE2 1 1 SSZ1 1 1 RPL26B 1 1
FUR1 1 1 YPR1 1 1 FKS3 1 1
DBP2 1 1 GCY1 1 1 SSM4 1 1
HCH1 1 1 SIT4 1 1 NUP116 1 1
CIC1 1 1 YJL055W 1 1 ATP2 1 1
PAA1 1 1 MGE1 1 1 SNL1 1 1
TEF4 1 1 RPL14A 1 1 CCT5 1 1
UBR1 1 1 RPL16B 1 1 YOR342C 1 1
RPL10 1 1 CPS1 1 1 CCC1 1 1
RPL20B 1 1 VPS74 1 1 YTA12 1 1
HTB1 1 1 ARG1 1 1 GBP2 1 1
ILV2 1 1 YLR179C 1 1 RPN12 1 1
RPS24B 1 1 BNA1 1 1 COP1 1 1
YLR301W 1 1 YMR099C 1 1 BNA1 1 1
NFU1 1 1 RPS25A 1 1 WTM1 1 1
RPS16A 1 1 PRE8 1 1 RPL23B 1 1
PPH22 1 1 SAM4 1 1 ARV1 1 1
PMA1 1 1 RVB1 1 1 RPS0B 1 1
MAE1 1 1 GCN20 1 1 PRO2 1 1
RPS0B 1 1 CPR3 1 1 RNA1 1 1
RPS30B 1 1 PRI1 1 1 CCT6 1 1
VMA7 1 1 NRP1 1 1 GLE2 1 1
RPS25B 1 1 ATP15 1 1 GFA1 1 1
PAN3 1 1 UBP15 1 1
RPC10 1 1 RPC10 1 1
RPL6B 1 1 MET8 1 1
RPL42A 1 1 YKR070W 1 1
ARO9 1 1 NUP100 1 1
CHL1 1 1 ILV1 1 1
IDI1 1 1 RPN10 1 1
CAM1 1 1 SER1 1 1
RPT4 1 1 PKP1 1 1
SEC53 1 1 SCW4 1 1
RPL24A 1 1 RIB4 1 1
UBX4 1 1 VMA7 1 1
FAA4 1 1 GLY1 1 1
RPL7B 1 1 SEC21 1 1
RPL15B 1 1 YKL215C 1 1
FET4 1 1 TUF1 1 1
CCT5 1 1 LSM4 1 1
ASN2 1 1 PYK2 1 1
HTA1 1 1 LSC1 1 1
DHH1 1 1 BUD14 1 1
CPR3 1 1 LSB1 1 1
RPL28 1 1 RPS19A 1 1
URA1 1 1 QCR2 1 1
MOT3 1 1 CAM1 1 1
SEC27 1 1 PRS2 1 1
ASN2 1 1
PPH22 1 1
RPC19 1 1
MEU1 1 1
FUR1 1 1
FRE1 1 1
PRE1 1 1
RPC40 1 1
RPL6A 1 1
PGM2 1 1
PRC1 1 1
MRH1 1 1
POR1 1 1
NOP58 1 1
OYE2 1 1
GLC7 1 1
CFT2 1 1
ADE12 1 1
SPT6 1 1
RPP1A 1 1
TFC4 1 1
PRO2 1 1
TRM7 1 1
RPL21B 1 1
MOT3 1 1  
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Table 10. Select ERAD/UPS-related interactions found in Table 9 
Data from Table 8 were mined for relevant interactions related to ERAD/UPS process. 
Included with the gene name are unique and total peptide counts. 
                          CYTOSOL                                                    MEMBRANE                  
               WT                       vms1 Δ                        WT                     vms1 Δ     
Gene Unique Total Gene Unique Total Gene Unique Total Gene Unique Total
CDC48 64 288 CDC48 77 319 CDC48 42 124 CDC48 54 133 Cdc48p
NPL4 15 22 NPL4 16 17 NPL4 14 18 NPL4 15 17 complex
UFD1 8 11 UFD1 8 10 UFD1 6 7 UFD1 7 8
SHP1 14 53 SHP1 17 30 SHP1 5 12 SHP1 6 11 UBX
UBX2 UBX2 UBX2 7 7 UBX2 4 4
UBX3 UBX3 UBX3 1 1 UBX3
UBX4 1 1 UBX4 3 3 UBX4 1 1 UBX4
UBX5 UBX5 UBX5 UBX5
UBX6 UBX6 UBX6 1 1 UBX6
UBX7 1 1 UBX7 1 1 UBX7 2 2 UBX7 3 4
RPT1 3 3 RPT1 4 4 RPT1 1 1 RPT1 1 1 19S base
RPT2 3 4 RPT2 5 6 RPT2 3 3 RPT2 1 1
RPT3 1 1 RPT3 1 1 RPT3 1 1 RPT3
RPT4 1 1 RPT4 RPT4 2 2 RPT4
RPT5 5 8 RPT5 7 8 RPT5 3 4 RPT5 3 4
RPT6 5 6 RPT6 7 7 RPT6 3 3 RPT6 2 2
RPN1 6 6 RPN1 12 13 RPN1 4 4 RPN1 4 4
RPN2 11 11 RPN2 5 5 RPN2 3 3 RPN2 3 3
RPN10 RPN10 1 1 RPN10 RPN10
RPN3 2 3 RPN3 RPN3 RPN3 19S lid
RPN5 2 2 RPN5 3 3 RPN5 2 2 RPN5 1 1
RPN6 3 3 RPN6 5 6 RPN6 1 1 RPN6 2 2
RPN7 6 6 RPN7 7 7 RPN7 2 2 RPN7 2 3
RPN8 RPN8 2 2 RPN8 RPN8 1 1
RPN9 3 4 RPN9 3 3 RPN9 3 3 RPN9
RPN11 RPN11 2 2 RPN11 RPN11
RPN12 1 1 RPN12 5 5 RPN12 1 1 RPN12 1 1
RPN13 1 1 RPN13 1 1 RPN13 1 1 RPN13 1 1
SCL1 6 8 SCL1 SCL1 SCL1 20S
PRE8 2 4 PRE8 1 1 PRE8 PRE8 (alpha)
PRE9 2 2 PRE9 1 1 PRE9 1 1 PRE9 1 1
PRE6 2 2 PRE6 PRE6 PRE6
PRE2 2 2 PRE2 PRE2 PRE2
PRE5 7 7 PRE5 PRE5 1 1 PRE5
PRE10 3 5 PRE10 1 1 PRE10 PRE10
PUP1 2 2 PUP1 PUP1 PUP1 20S
PUP3 2 3 PUP3 PUP3 PUP3 (beta)
PRE1 2 2 PRE1 1 1 PRE1 PRE1
PRE2 2 2 PRE2 PRE2 PRE2
BLM10 BLM10 3 3 BLM10 BLM10
CIC1 1 1 CIC1 CIC1 CIC1
SIT4 1 1 SIT4 1 1 SIT4 SIT4
HRD1 3 3 HRD1 2 2 HRD1 HRD1 ERAD
HRD3 7 7 HRD3 7 8 HRD3 HRD3
YOS9 3 3 YOS9 4 4 YOS9 YOS9
USA1 3 5 USA1 2 2 USA1 USA1
CUE1 1 1 CUE1 CUE1 CUE1
SSM4 SSM4 1 1 SSM4 SSM4
DFM1 2 3 DFM1 2 2 DFM1 DFM1
UBA1 2 3 UBA1 5 5 UBA1 UBA1 Misc UPS
UBA3 1 1 UBA3 UBA3 UBA3
UBR1 1 1 UBR1 UBR1 UBR1
UBP14 1 1 UBP14 2 2 UBP14 UBP14 1 1
UBP15 UBP15 1 1 UBP15 UBP15
CDC53 1 1 CDC53 CDC53 1 1 CDC53
DOA1 DOA1 1 1 DOA1 DOA1
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Figure 28. Cdc48p interaction with the proteasome is unaltered by the loss of VMS1 
Wild-type and vms1Δ strains expressing Cdc48p-myc as their sole version of Cdc48p 
were grown in media containing standard and heavy (
13
C6,
15
N2) lysine, respectively. Extracts 
were prepared and Cdc48p-myc was immunoprecipitated with myc-agarose. Precipitated 
material was methanol/chloroform extracted and mass spectrometry was performed. The data 
from this SILAC analysis are presented as a ratio of WT (light) to vms1Δ (heavy). Ratios below 
“1” (horizontal red line) represent enrichment in vms1Δ (heavy-labeled) strain. Ratios above “1” 
represent enrichment in the wild-type (standard) strain. 
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3.3 DISCUSSION 
3.3.1 Loss of VMS1 increases cellular ubiquitinated proteins 
As discussed in Chapter 2, loss of VMS1 results in the accumulation of ubiquitinated proteins 
associated with Cdc48p. In this chapter, I report that the loss of VMS1 also results in the 
accumulation of total cellular ubiquitinated proteins. This finding suggests that ubiquitinated 
protein homeostasis represents one of Vms1p’s functions. Two apparent models can explain 
these data. In the first model, Vms1p modulates Cdc48p (or a Cdc48p cofactor) so that it 
promotes the efficient transfer or processing of ubiquitinated substrates. The second possibility is 
that Vms1p affects a downstream process such as proteasome function, which will in general 
increase the amount of ubiquitinated proteins in the cell. Using a panel of yeast strains mutated 
for various steps in the ERAD pathway, I discovered that the additional loss of VMS1 
consistently resulted in a further increase in ubiquitinated proteins (Figure 22A). This suggests 
that Vms1p functions in a largely additive parallel pathway with the tested genes. Interestingly, 
the level of ubiquitinated protein accumulation does not correlate with the presence of synthetic 
growth defects. For instance, ubx2Δvms1Δ accumulate far more ubiquitin than cdc48-3,vms1Δ 
strains, yet the latter has a severe growth defect on rich media (see Figure 14C, Chapter 2). 
This likely reflects the additional functions of Cdc48p. Moreover, I found that loss of VMS1 
results in accumulation of total ubiquitinated proteins irrespective of strain background and 
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mating type (Figure 22B and C). This strongly suggests that ubiquitinated protein homeostasis 
is the conserved function of Vms1p. 
3.3.2 Vms1p regulates proteasome subtype distribution 
There are at least three scenarios which would result in the accumulation of total ubiquitinated 
protein: 1) defects in deubiquitinating enzymes, 2) aberrant regulation of ubiquitinated substrate 
transfer to the proteasome and 3) defects in proteasome function. While it is still possible that 
Vms1p plays a role in deubiquitination (but see Figure 29, in which no growth defect was 
observed in strains deleted for VMS1 and the Cdc48p-associated DUB, OTU1) or substrate 
transfer, I chose to examine proteasome activity because this system was readily testable. In fact, 
I discovered that the distribution of proteasome subtypes was altered in vms1Δ mutants. The 
most prominent effect was with regard to the increase in the amount and activity of the 20S core 
as measured by both western blot analysis and Suc-LLVY AMC activity observed in the vms1Δ 
strain (Figure 24A-C). This was partially restored when the vms1Δ strain was supplied with a 
vector expressing wild-type Vms1p (Figure 26A). I also observed a significant decrease in 
proteasome activity associated with capped proteasomes in vms1Δ mutant cells, which is 
consistent with data showing an accumulation of ubiquitinated proteins. The former phenomenon 
was observed in 14 different experiments, without exception (Figure 30, left). By contrast, the 
decrease in 26S capped proteasome activity was observed in 8 out of 10 experiments (Figure 30, 
right). This might reflect the technically demanding nature of these experiments.  
 
Surprisingly, I did not observe a decrease in the signal corresponding to 19S capped 
proteasomes when I compared wild-type and vms1Δ strains harboring an empty vector (grown in 
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a minimal media). In fact, the levels of capped proteasomes from vms1Δ cells expressing wild-
type Vms1p-HA or the VIM mutant all appeared to increase. This phenomenon may be due in 
part to the effect of growth in minimal selective media. It is known that proteasomes play an 
important role in cell growth in minimal media (HEINEMEYER et al. 1991), where amino acids are 
limiting, but whether or not minimal media affects the distribution of proteasomes has not been 
tested, at least to my knowledge. At the most basic level, these data suggest that Vms1p affects 
the assembly or stability of the 26S proteasome.  
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Figure 29. VMS1 does not genetically interact with the gene encoding the deubiquitinating enzyme, 
OTU1 
A genetic cross was performed between Mat alpha (BY4742) vms1Δ and Mat a 
(BY4741) otu1Δ strains. Diploid cells were sporulated and tetrads were dissected. White circles 
represent wild-type, black circles represent vms1Δ, grey circles represent otu1Δ, and red circles 
represent otu1Δvms1Δ. The plate was incubated at 30°C. 
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Figure 30. Individual experiments from Figure 24B 
The individual experiments from Figure 24B are displayed as a scatter plot. The left plot 
is an assessment of 20S CP (Suc-LLVY-AMC) signal whereas the right plot is an assessment of 
26S capped proteasome. In both examples, the strains used are wild-type and vms1Δ. The 
activity seen in the wild-type strain was set to 100%. 
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3.3.3 Vms1p most likely functions in proteasome stability 
As mentioned above, my data can not rule out the possibility of defects in substrate transfer or 
DUB activity. I found that a strain double deleted for the genes encoding the ERAD DUB, 
OTU1, and VMS1 showed no apparent growth defect (Figure 29). However, two other very 
prominent proteasome-associated DUBs exist (Ubp6p and Rpn11p), and these need to be tested. 
This could be done by: 1) examining the expression levels of these DUBs and 2) testing for the 
association of these DUBs with capped proteasomes in WT and vms1Δ yeast.  
 
A defect in substrate transfer, due to loss of VMS1, was suggested in Chapter 2, and is 
based on the accumulation of ubiquitinated proteins associated with Cdc48p. This brings up the 
possibility that Vms1p serves as an escort factor or receptor for Cdc48p-ubiquitinated substrate 
complexes. This idea is further supported by the observation that both wild-type and a ΔVIM 
version of Vms1p co-migrated with the capped forms of the proteasome (Figure 26A). However, 
I have never been able to show association between Vms1p and ubiquitinated substrates as 
assessed by Vms1p immunoprecipitation followed by western blotting with antibodies against 
ubiquitin. Furthermore, the decrease in the amount of co-migrating Vms1p-ΔVIM with the 
proteasome suggests that Cdc48p may be required to link Vms1p with the proteasome, and this is 
further supported by the mass spectrometry data from (Figure 28) which indicates that the 
amount of Cdc48p-associated with the proteasome is unchanged in the vms1Δ background. This 
supports the possibility that Vms1p is recruited to the proteasome by Cdc48p, where Vms1p 
functions to maintain 26S proteasome homeostasis. The analysis of Vms1p-interaction partners 
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could validate this notion, especially if Vms1p is found in complex with Cdc48p and the 
proteasome, which is then reduced by a VIM mutant. Additionally, it would be interesting to see 
if gross overexpression of the Vms1p-ΔVIM mutant leads to any additional effects on the 
architecture of the 26S proteasome.  
 
The co-migration of Vms1p with the 26S proteasome raises two exciting possibilities: 1) 
Vms1p plays a role in stabilizing the 26S proteasome, or 2) Vms1p helps assemble the 26S 
proteasome. Data from section 3.3.3 (Figures 27A, B) showed that there was no effect of doubly 
deleting between VMS1 and select genes involved in proteasome assembly. While this result 
argues against a role in proteasome assembly, these experiments need to be further expanded to 
cover all possible proteasome chaperones (e.g., Pba1p-4p, Nas2, Nas6, Ecm29p) (FUNAKOSHI et 
al. 2009; KUSMIERCZYK et al. 2008; LE TALLEC et al. 2009; LEHMANN et al. 2010; LI and 
DEMARTINO 2009; PARK et al. 2009; ROELOFS et al. 2009; SAEKI et al. 2009; SCOTT et al. 2007). 
An alternative approach is to examine the proteins associated with Vms1p by 
immunoprecipitation under conditions that maintain proteasome stability (i.e., in the presence of 
ATP), or by yeast-two-hybrid. To date, there are no identified physical interactions between 
Vms1p and proteasome assembly chaperones, but these large-scale studies have relied on the 
bulky TAP tag for purification and conditions that deplete ATP (Biogrid) (STARK et al. 2006).  
 
Notably, some mutants like rpn10Δ cells already showed very high levels of ubiquitin 
accumulation, and a further increase in ubiquitin accumulation caused by VMS1 loss was modest 
(Figure 27A). The rpn10Δvms1Δ double mutant, however, showed a pronounced increase in 
free 20S core particle. These data suggest that Vms1p functions in series with Rpn10p. In this 
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scenario, Rpn10p loss cripples ubiquitinated protein homeostasis because of the accumulation of 
non-, or partially functional proteasome intermediates that have the 19S base attached to the 20S 
CP. Vms1p loss further reduces the stability of the 19S base-20S CP intermediate, but the 
severity of the ubiquitin degradation defect is already maximal because the proteasome in 
RPN10 mutants is defective. There is also evidence that overexpressed Dsk2p competes with 
Rpn10p for binding to substrate and this leads to the accumulation of ubiquitinated proteins 
(MATIUHIN et al. 2008). One possibility is that vms1Δ leads to Dsk2p overproduction, or 
prevents substrate association with Rpn10p. I have observed, on occasion, that Rpn10p 
distribution in a glycerol gradient is altered in vms1Δ lysates (see lower panel Figure 27D for 
one example). 
3.3.4 Additional considerations 
It is notable that mutations in genes encoding many proteasome-related factors showed a 
decrease in the amount of the di-ubiquitin signal (Figure 27A, Ub x 2). The relevance of this is 
not known.  
 
Cdc48p immunoprecipitations yielded approximately 400 cytosolic and 350 membrane 
interactors (Table 8). However, only ~34% previously known interactors were identified. While 
the data from spectral counting and from the SILAC experiment differ, this is not uncommon and 
reflects the inaccuracy of using spectral counting for proteomic quantitation. I am currently 
working on improving the analysis of the SILAC data sets in collaboration with Dr. Woong Kim 
from the Gygi lab. The current hypothesis, which is based on the SILAC data, is that Cdc48p is 
at the proteasome at equal levels in WT and vms1Δ yeast. This can be examined by performing 
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the in gel proteasome substrate overlay assay, and then western blotting for Cdc48p and possibly 
other relevant cofactors such as Ufd1p. Finally, I have shown in Chapter 2 that VMS1 genetically 
interacts with members of the UBX domain family. It would be interesting to see if the UBX 
family members, on their own, have any effect on the distribution of proteasome subtypes, as 
observed in this chapter for vms1Δ.  
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4.0  CONCLUSIONS AND FUTURE DIRECTIONS 
4.1 CONCLUSIONS 
In Chapters 2 and 3, I showed that the Vms1 protein, which was previously uncharacterized, 
functions in the ubiquitin proteasome system. Specifically, co-immunoprecipitation experiments 
show that Vms1p is a Cdc48p-interacting partner that resides in the cytoplasm and at 
intracellular membranes. I demonstrate that loss of VMS1 results in an ERAD defect that is 
further exaggerated by the additional loss of select Cdc48p cofactors. Additionally, select double 
mutant combinations showed sensitivity to cellular stressors such as cadmium and tunicamycin. I 
showed that VMS1 mutants accumulate total cellular ubiquitinated proteins, and accumulation 
was also evident in the population that is associated with Cdc48p. I also found that the 
accumulation of ubiquitinated proteins observed in the VMS1 mutants can be mimicked by a 
yeast strain expressing only a version of Vms1p lacking its VIM domain, a Cdc48p interacting 
motif. These results indicate that ubiquitinated protein homeostasis requires the formation of the 
Cdc48p-Vms1p complex. Furthermore, I found that the ubiquitinated protein accumulation 
phenotype in vms1Δ yeast correlates with the accumulation of the latent 20S proteasome. I then 
showed that Vms1p co-migrates with the 26S proteasome and that the VIM mutant showed a 
reduced signal. Finally, I observed that the effect of vms1Δ on the proteasome was not due to 
changes in subunit expression, and did not appear to be the result of defects in the proteasome 
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assembly pathway. My data suggest, for the first time, that a complex of Cdc48p and Vms1p 
regulates the stability of the 26S proteasome.  It is curious that the loss of VMS1 leads to 
selective degradation defect of CFTR. This may imply that CFTR is hypersensitive to changes in 
proteasome levels in yeast.  
4.2 FUTURE DIRECTIONS 
4.2.1 Cycloheximide sensitivity 
I have shown that the loss of VMS1 on its own has only modest effects on protein degradation. 
Virtually all substrates tested to date had little to no detectable impairment in their degradation. 
A potential issue in these experiments is the use of the protein translation inhibitor, 
cycloheximide. VMS1 mutant cells are extremely sensitive to cycloheximide. And, while this 
phenotype was not enough to occlude the ERAD defect for CFTR, it is evident that the effect of 
vms1Δ on CFTR degradation was better assessed in a pulse chase experiment (Figure 16A and 
B). One possible remedy would be to examine additional ERAD substrates, for instance, the 
ERAD-L substrate CPY* by pulse chase analysis. I would also be interested in performing a 
pulse chase, without cycloheximide, for the N-end rule substrate, Ub-pro-beta-gal. Alternatively, 
it is possible to define in vivo substrates that are dependent upon Vms1p for efficient degradation 
by mass spectrometry. This is currently under consideration and could be performed as a SILAC 
experiment using whole cell extracts, or isolated cellular fractions from wild-type and vms1Δ 
cells. Defining the in vivo substrates by this method is in theory applicable to any ERAD/UPS 
mutant, and would help characterize overlapping and unique pathways of protein degradation.  
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A prominent phenotype of VMS1 loss is hypersensitivity to the protein translation 
inhibitor, cycloheximide. Cycloheximide exposure results in the depletion of ubiquitin and is 
suppressed by proteasome mutants (Figure 31A) (GERLINGER et al. 1997; HANNA et al. 2003). 
In my hands, vms1Δ yeast plated onto a low concentration of cycloheximide yielded suppressors 
of this phenotype, and indeed these suppressors accumulate ubiquitinated protein to a greater 
extent than the original mutants (Figure 22C, Figure 31B). This strongly suggests that 
cycloheximide sensitivity suppression is the result of proteasomal inactivation. My data indicate 
that proteasome instability is a relevant feature in the vms1Δ strain. It would be interesting to 
analyze proteasome distribution in vms1Δ strains that are sensitive and resistant to 
cycloheximide. If there is no effect, whole genome sequencing could be used to determine if 
these suppressors harbor mutations in additional proteasome components, or perhaps in novel 
genes that regulate the UPS. As an alternative to the whole genome approach, sequencing genes-
encoding known proteasome genes could be performed. The spontaneous rescue of this 
phenotype has the potential to reveal much about regulation of proteasome function. 
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Figure 31. Suppressor mutants of the vms1Δ cycloheximide sensitive phenotype accumulate higher 
levels of ubiquitinated proteins 
A. Cycloheximide depletes ubiquitin and ubiquitinated proteins in wild-type and vms1Δ 
yeast. Wild-type and vms1Δ cells were grown to log-phase and treated with 100μg of 
cycloheximide for 2.5 h. Cells before or after treatment were processed for western blot analysis 
with anti-ubiquitin antibodies. B. As seen in Figure 22C, vms1Δ yeast plated on cycloheximide 
show suppressor mutants. Suppressors (#3 and #4) were isolated and total protein was prepared 
by TCA precipitation. The protein extract was resolved by SDS-PAGE and subject to western 
blotting with anti-ubiquitin.  
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4.2.2 Cdc48p ATPase activity 
VMS1 genetically interacts with many members of the UBX family of Cdc48p cofactors (Table 
5). UBX family members from a diverse number of organisms have been shown to modulate 
Cdc48p/p97 ATPase activity (see section 1.4.2). In addition, VMS1 genetically interacts with two 
different temperature sensitive CDC48 alleles (cdc48-2 and cdc48-3). The mutations have been 
partially characterized (see Figure 11), and affect the function of the first AAA-ATPase domain 
(D1). While the first ATPase domain is thought to be largely involved in hexamerization, there is 
evidence indicating that the ATPase domains communicate with each other during the hydrolysis 
cycle (DELABARRE and BRUNGER 2003; LI et al. 2012). It would be interesting to see if purified 
Vms1p can modulate the ATPase activity of Cdc48p in an in vitro assay. Currently, I have 
obtained purified Vms1p from our collaborator, Dr. Angela Gronenborn and with assistance 
from Dr. Leonardus Koharudin. Additionally, the Brodsky lab is well equipped to perform these 
assays as the lab routinely performs ATP- hydrolysis experiments for the HSP70s.  
4.2.3 The Cdc48p-Vms1p complex at the proteasome 
Recently, the Cdc48 hexamer was shown to form a tight functional complex with the 20S core 
particle in Archaea (BARTHELME and SAUER 2012). Three conclusions could be drawn from this 
elegant study. First, the Cdc48 complex dramatically increases 20S-mediated peptide 
degradation, suggesting that the peptide is being channeled into the 20S core by this ATPase. 
Second, the Cdc48 hexamer interaction with the 20S is not entirely dependent upon the HbYX 
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motif (see section 1.2.4). This result indicates that the Cdc48 hexamer has additional physical 
contacts with the proteasome that can stimulate the opening of the gate, and also alludes to the 
presence of additional bridging factors between the Cdc48 hexamer and the 20S core 
proteasome. Third, ATP, but not ADP binding to Cdc48 supported interaction with the 20S 
particle. This raises the possibility that UBX proteins, which are known to decrease the ATPase 
activity of yeast Cdc48p and genetically interact with VMS1, may be involved in modulation this 
type of interaction, or the interaction of the 19S cap and 20S core. 
 
I have shown that Vms1p and a mutant version lacking the VIM domain co-migrate with 
the 26S proteasome (Figure 26A). Most interestingly, the Vms1-ΔVIM protein showed reduced 
co-migration compared to the wild-type version. This implies that Cdc48p may, in part, help 
recruit Vms1p to the proteasome to maintain proteasome stability. Further support for this 
hypothesis comes from the SILAC experiment, which showed that Cdc48p-association with 
proteasomal components was largely unaffected in the vms1Δ background (Figure 28). 
However, a major caveat with the SILAC data is that there are many different Cdc48p-
complexes. It was simply not possible to determine whether Cdc48p-complexes were associated 
with the 19S cap and 20S core particle as a single entity or individually. Further, the conditions 
for the SILAC experiment were not optimal for maintaining the 26S proteasome complex and 
this apparent because the beta7 (Pre4p) subunit of the proteasome was never identified in any of 
my mass spectrometry experiment. It is likely then that Cdc48p interacts with the 19S and 20S 
particles individually.  
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Taking all these data into account, two formal possibilities exist: 1) Cdc48p may recruit 
Vms1p to the proteasome, and 2) Vms1p is recruited to the proteasome independent of the 
Cdc48p hexamer, and then recruits Cdc48p. The reason that the bulk of the Vms1-ΔVIM protein 
is reduced may be that the Cdc48p interaction prevents its degradation. To distinguish between 
these two possibilities, I would like to perform the native gel proteasome activity assay with 
lysates from wild-type and vms1Δ yeast expressing Cdc48p-myc followed by western blotting 
with the anti-myc serum. My expectation is that Cdc48p will co-migrate with the 20S core 
particle, and the interaction will be entirely unaffected by the vms1Δ genetic background. This 
would imply that the Cdc48p complex is at the proteasome to recruit Vms1p is a 26S stabilizing 
factor. 
4.2.4 Testing additional fluorogenic substrates 
I have shown that VMS1 deletion leads to an increase in the amount of 20S activity for a 
fluorogenic substrate, Suc-LLVY-AMC. This substrate is specific only for the chymotryptic-like 
activity of the beta5 subunit of the proteasome. There are other substrates that can be used to test 
the additional activities of the proteasome. For instance, the Z-LLE-AMC substrate measures the 
PGPH-like activity and the BOC-RRL-AMC assesses the trypsin-like activity. I have recently 
purchased these substrates and plan on testing the affect of VMS1 loss on their degradation.  
4.2.5 An in vitro system for proteasome function 
My work indicates that proteasome function is ultimately hampered by the loss of the VMS1 
gene. To further test this model, I would like to develop an in vitro assay for protein degradation. 
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The assay is based on a protocol originally developed to measure the in vitro degradation of a 
Cyclin inhibitor, Sic1p (SAEKI et al. 2005). Cdc48p complexed to ubiquitinated species can be 
purified from both wild-type and vms1Δ mutant yeast and can be used as a starting material, 
instead of the isolated ubiquitinated Sic1p (see Figure 21B). The precipitate can be mixed with 
purified 26S proteasome in the presence or absence of ATP to stimulate degradation (Figure 
32A). In fact, I have attempted this assay. In Figure 32B, I found that mixing these components 
results in a reduction in the ubiquitinated signal (compare lanes 1-3 and 4-6). This might 
represent true substrate degradation, but I can not rule out DUB activity in this assay at the 
moment. Additionally, it is uncertain whether or not the ubiquitinated species are derived from 
Cdc48p or from the pool associated with the proteasome. To address this issue, I could in 
practice express an epitope-tagged form of ubiquitin (HA-tagged) along with Cdc48p-Myc, and 
purify the Cdc48-Myc complex as the starting material. This would let me monitor the 
ubiquitinated proteins specifically associated with Cdc48p. Regardless this is a very promising 
first step, and may allow the community to reconstitute the last steps prior to degradation in the 
ERAD pathway. 
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Figure 32. Development of an in vitro degradation assay 
A. Lysates from yeast strains expressing Rpn11p-FLAG were prepared for affinity 
purification with FLAG-agarose. Affinity purified 26S proteasome was resolved, in duplicate, by 
SDS-PAGE and silver stained. B. In vitro degradation assay. Cdc48p-ubiquitinated protein 
complexes were purified as in Figure 21B. Affinity purified proteasome from (A) and either ATP 
or a cocktail of Apyrase/NEM was added to the Cdc48p-ubiquitinated protein precipitate, and the 
reaction was allowed to proceed at 30°C for the indicated times. The reaction was quenched by 
adding SDS-PAGE sample buffer, and resolved by SDS-PAGE for western blotting with anti-
ubiquitin antibody. 
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Appendix A 
MODELING IBMPFD MUTATIONS IN YEAST 
The human homolog of Cdc48p, VCP/p97, has been linked to several diseases including a 
number of neuromuscular disorders (see section 1.4.1). A commonality among these diseases is 
the presence protein aggregates, suggesting that the pathology of the disease is caused by 
aberrant protein quality control (JU et al. 2009; WEIHL et al. 2006).  
 
In this study, I used yeast to model the molecular pathology associated with the human 
disease, Inclusion Body Myopathy associated with Paget’s disease of bone and Frontotemporal 
Dementia (IBMPFD). Specifically, I constructed several CDC48 yeast mutants that corresponded 
to the most common IBMPFD mutations, R95G, R155H, and A232E (WATTS et al. 2004). I 
found that R95G and the A232E mutations caused temperature sensitivity in yeast and an 
autophagy-related defect. However, a more detailed analysis, which was done with the help of 
Bill Glassford (graduate rotation student, University of Pittsburgh), revealed that the temperature 
sensitivity of the R95G and R155H alleles were the result of the HA-epitope tag at the end of 
carboxy terminus of Cdc48p. A Myc-tagged version of these alleles displayed no temperature 
sensitivity and no defect in autophagy. Further, the Myc-tagged alleles showed no growth 
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phenotypes on various stress agents and no ERAD defects. This study, however, does reveal that 
epitope tagged versions of Cdc48p are very stable and thus the differences between these two 
versions of Cdc48p are likely related to some aspect of Cdc48p function. In fact, I discovered 
that there are differences in the apparent migration of the Cdc48p hexamer, depending upon the 
epitope tag used. Additionally, I show for the first time that a classic temperature sensitive allele 
of CDC48, cdc48-3, is devoid of detectable free hexamer. I conclude that the yeast model of 
IBMPFD might be used in the future to study basic Cdc48p function such as hexamer assembly 
and cofactor binding. (This study was started as a collaboration between the Brodsky lab and the 
lab of Dr. John Paul Taylor at St. Jude’s Childrens Hospital (Memphis, Tennessee)).  
A.1 EXPERIMENTAL PROCEDURES 
A.1.1 Yeast strains, oligos, plasmids, and growth assays 
Yeast strains used in this study are listed in Table 10. Strain construction and growth 
assays were performed as described in Chapter 2 section 2.1.1. A notable exception is that cells 
were selected on media lacking uracil to maintain the CDC48 encoding plasmid. Schematic for 
creating yeast harboring IBMPFD mutations is shown in Figure 33. Plasmids and 
oligonucleotides used in this study are listed in Table 11 and 12. 
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Table 11. List of strains used in this study 
Strain  Genotype Reference 
   
BY4742 MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15 Open Biosystems 
cdc48-3 MATα, his3Δ1, leu2, ura3, lys2Δ0, MET15, cdc48-3 Tran, et al., 2011 
cdc48ΔWTMyc MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48Myc This study 
cdc48ΔR95GMyc MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48Myc(R95G) This study 
cdc48ΔR155HMyc MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48Myc(R155H) This study 
cdc48ΔA232EMyc MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48Myc(A232E) This study 
cdc48ΔWTHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48HA This study 
cdc48ΔR95GHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48HA(R95G) This study 
cdc48ΔR155HHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48HA(R155H) This study 
cdc48ΔA232EHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, cdc48Δ::KanMX, pRS315-CDC48HA(A232E) This study 
ufd2Δcdc48ΔWTHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::HIS3MX, cdc48Δ::KanMX, pRS315-CDC48HA This study 
ufd2Δcdc48ΔR95GHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::HIS3MX, cdc48Δ::KanMX, pRS315-CDC48HA(R95G) This study 
ufd2Δcdc48ΔR155HHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::HIS3MX, cdc48Δ::KanMX, pRS315-CDC48HA(R155H) This study 
ufd2Δcdc48ΔA232EHA MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::HIS3MX, cdc48Δ::KanMX, pRS315-CDC48HA(A232E) This study 
ufd2Δ::HIS3MX MATα, his3Δ1, leu2Δ0, ura3Δ0, lys2Δ0, MET15, ufd2Δ::HIS3MX This study 
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Table 12. Plasmids used in this study 
Plasmid name Description Reference 
   
pSM1911 PGK1 promoter, Ste6p*-HA expression plasmid, 2 micron Huyer, et al., 2006 
CPY*-3xHA Endogenous promoter, CPY* 3xHA expression plasmid, CEN Bhamidipati, et al., 2005 
pRS315-CDC48myc Endogenous promoter, c-terminal 1xmyc CDC48, CEN Tran, et al., 2011 
pRS315-CDC48myc(R95G) Endogenous promoter, c-terminal 1xmyc CDC48 (R95G), CEN This study 
pRS315-CDC48myc(R155H) Endogenous promoter, c-terminal 1xmyc CDC48 (R155H), CEN This study 
pRS315-CDC48myc(A232E) Endogenous promoter, c-terminal 1xmyc CDC48 (A232E), CEN This study 
pRS316-CDC48HA Endogenous promoter, c-terminal 1xHA tagged CDC48, CEN Tran, et al., 2011 
pRS316-CDC48HA(R95G) Endogenous promoter, c-terminal 1xHA tagged CDC48 (R95G), CEN This study 
pRS316-CDC48HA(R155H) Endogenous promoter, c-terminal 1xHA tagged CDC48 (R155H), CEN This study 
pRS316-CDC48HA(A232E) Endogenous promoter, c-terminal 1xHA tagged CDC48 (A232E), CEN This study 
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Table 13. List of oligonucleotides used in this study 
Name  Sequence 
  
R95G-F agttcgtaacaatttacgtattgggctgggtgatttagttacaattcatc 
R95G-R gatgaattgtaactaaatcacccagcccaatacgtaaattgttacgaact 
R155H-F gaaaggcgaccattttgttgtccatggcggtatgagacaagtcgaattca 
R155H-R tgaattcgacttgtctcataccgccatggacaacaaaatggtcgcctttc 
A232E-F tgagacatcctcagttgttcaaggagatcggtatcaagccaccaagaggt 
A232E-R acctcttggtggcttgataccgatctccttgaacaactgaggatgtctca 
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Figure 33. The general scheme used to model IBMPFD mutations in yeast 
Diploid strains heterozygous for the deletion of CDC48 (cdc48Δ::KanMX) were transformed 
with the indicated plasmids and grown on selective media. Diploids were then sporulated and 
tetrads were dissected on selective media to force the maintenance of the plasmid. Strains 
positive for growth on both G418 and the plasmid selective marker were saved. Total DNA was 
extracted from these strains and the CDC48 gene was amplified and sequenced to ensure that the 
only allele present was from the plasmid. 
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A.1.2 Cycloheximide chase assay 
Cycloheximide chase assays were performed as described in Chapter 2 section 2.1.2. 
A.1.3 Assays to measure autophagy  
Autophagy and CVT pathways were assessed using the assays described in Chapter 2 section 
2.1.6. 
A.1.4 Immunoprecipiation  
Immunoprecipitation of the Cdc48p-HA and Cdc48p-Myc tagged constructs was done as 
described in Chapter 2 section 2.1.5.  
A.1.5 Native PAGE 
Cdc48p hexamers were analyzed using native PAGE. Briefly, 100ml of log-phase cells were 
harvested, resuspended in Buffer 88 (20mM HEPES pH 6.8, 150mM KOAc, 250mM sorbitol, 
5mM MgOAc) supplemented with 1mM PMSF, 1μg/ml leupeptin, and 0.5μg/ml pepstatin A, 
and disrupted by glass bead lysis at 4°C. The unbroken cells were removed by low-speed 
centrifugation, and the resulting crude supernatant was centrifuged at 18,000g for 20 min in a 
refrigerated table top centrifuge to obtain the cytosolic fraction. The cytosolic fraction (25μg) 
was resuspended in native PAGE sample buffer (80mM Tris-HCl, pH 8.0, 8mM EDTA, 15% 
glycerol, 0.08% Tris base, 0.01% bromophenol blue) and resolved on a 6% native 
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polyacrylamide gel (8.5 x 10 cm). To denature select samples, SDS was added to a final 
concentration of 0.5% and the mixture was incubated at 75°C for 10 minutes. The samples were 
cooled on ice prior to loading. Proteins were then transferred on nitrocellulose and western blot 
analysis was performed with the indicated antibodies. 
A.1.6 Gel filtration analysis 
Gel filtration analysis was used to analyze the distribution of Cdc48p complexes. The source 
material was cytosolic extracts prepared as described in section 5.1.5. Sephacryl S300HR gel 
filtration media resuspended in Buffer 88 (~80ml) was packed by gravity in a 2.5 x 50 cm 
column. The column was flushed with 5-6 volumes of Buffer 88 prior to use, and stored in 10% 
ethanol. To fractionate the Cdc48p complex, 10mg of cytosol was applied to the column. A 
peristaltic pump (1mm tubing) was used at a setting of 150ml/h to flush the column with Buffer 
88. Fractions were collected with an automated fraction collector at a setting of 1.5 min/fraction. 
The total protein from each fraction was isolated by TCA precipitation and resolved by SDS-
PAGE. Western blotting was performed with the indicated antibodies.  
A.1.7 Antibodies and western blot analysis 
Antibodies used in this study included: Anti-HA (Roche, USA), anti-Myc (Santa Cruz, USA), 
anti-GFP (Roche, USA), anti-Ape1p (a kind gift from Dr. Daniel Klionsky), anti-Cdc48p (a kind 
gift from Dr. Rasmus Hartmann-Petersen) and Ubx1p (a kind gift from Dr. Alexander 
Buchberger). Western blots were decorated with the indicated primary antibodies and 
appropriate HRP-conjugated anti-mouse or anti-rabbit IgG secondary antibodies. The HRP-
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chemiluminescent signal was visualized by enhanced chemiluminescence (Pierce, USA). Images 
were captured on a Kodak Image Station 440CF (Kodak, USA) and were analyzed using ImageJ 
v1.42q (Abramoff). 
A.2 RESULTS  
A.2.1 Yeast strains carrying IBMPFD mutations do not exhibit growth defects at 
permissive temperatures 
The indicated IBMPFD mutation was introduced at the corresponding location in the yeast 
CDC48 gene by site directed mutagenesis (Figure 34A). The mutagenized version of CDC48 
was cloned into a low-copy CEN plasmid and introduced into a diploid strain heterozygous for 
the deletion of CDC48. A single HA-epitope tag was also introduced at the carboxy terminus of 
the Cdc48 protein to facilitate detection. Haploid strains containing both a deletion of the CDC48 
chromosomal locus and the plasmid containing CDC48 were selected for by the scheme seen in 
Figure 33. For convenience, the human nomenclature is used for the yeast-modeled IBMPFD 
alleles. 
 
As seen in Figure 34B and 34C, yeast strains harboring the IBMPFD mutations in their 
only copy of Cdc48p displayed no obvious growth defect. Additionally, the expression level of 
Cdc48p-HA from the CEN plasmid in these strains was unaffected by the presence of the 
IMBPFD mutations, and comparable to a wild-type construct (Figure 34B, bottom panel). This 
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indicates that the IBMPFD mutations, under standard growing conditions, are not detrimental to 
cell viability and growth.  
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Figure 34. IBMPFD mutations modeled in the CDC48-HA gene show no viability or growth defects 
under standard growth conditions 
A. The three different IBMPFD mutations selected are indicated by the upward pointing 
arrowheads. The alignment between human and yeast p97 and Cdc48p, respectively, was done 
using Vector NTI. These three mutations represent the most common IBMPFD mutations. B. 
Tetrads carrying the individual IBMPFD alleles were dissected and grown at 30ºC (top). Western 
blot analysis (anti-HA and anti-Sec61p) was performed on total protein from the indicated strains 
to determine their relative expression levels (bottom). C. Growth of the indicated strains was 
measured (OD600) in liquid culture. The doubling times were calculated and plotted using 
Microsoft Excel.  
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A.2.2 Yeast strains carrying IBMPFD mutations are temperature 
To test if IBMPFD mutations in the CDC48-HA gene compromise tolerance to general cell 
stress, 10-fold serial dilutions of the indicated strains were spot plated and grown at permissive 
(30ºC) and at high temperature (38ºC). The IBMPFD alleles R95G and A232E displayed a 
pronounced and reproducible temperature sensitive phenotype at high temperature (Figure 35A, 
right). High temperature is known to induce, among other things, the autophagic pathway 
(MELENDEZ and NEUFELD 2008). IBMPFD mutations in humans have also been shown to cause 
defects in the autophagic pathway (JU et al. 2009). I therefore analyzed the processing of an 
autophagic/CVT marker in IBMPFD-modeled CDC48-HA mutants. Consistent with the 
temperature sensitive phenotype, both the R95G and A232E mutants showed an increase in the 
processing of Ape1p, which indicated that the autophagic/CVT pathways were activated (Figure 
35B, compare lanes 2 and 4). Interestingly, when these strains were challenged at higher 
temperature, the processing of Ape1p was reduced in both the R95G and A232E mutants (Figure 
35B, compare lanes 6 and 8). This suggests that the temperature sensitivity observed in these 
select IBMPFD strains could be due to an autophagic defect.  
 
One possible explanation for the temperature sensitivity seen in R95G and A232E 
CDC48-HA mutants is protein instability. Elevated temperature is known to exacerbate the 
misfolding of some proteins and promote their degradation (ZHANG et al. 2002). To test protein 
stability, I performed a cycloheximide chase analysis of the IBMPFD CDC48-HA mutants. As 
seen in Figure 36A and B, the IBMPFD mutants were not grossly unstable when compared to 
wild-type Cdc48p-HA. Thus, it is more likely that the observations of temperature sensitivity and 
the mild autophagic defect are due to the altered function of Cdc48p.  
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Figure 35. Select IBMPFD mutations modeled in the CDC48-HA gene show temperature sensitivity 
and autophagic defects 
A. The indicated yeast stains were spot tested (10-fold serial dilutions) on the appropriate media 
and the plates were incubated at the indicated temperatures. B. Autophagic/CVT pathway was 
assessed as described in the Experimental Procedures section. Total TCA precipitated protein 
from the indicated strains was resolved by SDS-PAGE and western blotting was performed with 
the indicated antibodies. 
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Figure 36. Cdc48p-HA is a stable protein 
A and B. The stability of Cdc48p-HA was assessed by cycloheximide chase assay as described 
in the Experimental Procedures sections. A. represents the quantitation of two independent 
experiments and B. are representative figures from the experiment.  
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A.2.3 Temperature sensitive IBMPFD mutants are due to a genetic interaction between 
the mutant allele and the epitope tag 
To ensure that effects seen in the IBMPFD mutations were due solely to the mutation, a graduate 
rotation student, Bill Glassford and I tested the recoverability of the temperature sensitive 
phenotype. This assessment was important because epitope tagging at the carboxy terminus of 
Cdc48p might impair the binding of select cofactors, such as (BOHM et al. 2011; RUMPF and 
JENTSCH 2006). In this experiment, the temperature sensitive R95G and A232E strains were 
transformed with an empty vector, or a vector designed to express wild-type versions of Cdc48p 
that were untagged, HA-tagged or Myc-tagged at the carboxy terminus. As seen in Figure 37, all 
strains grew normally at the permissive temperature (30ºC). However, when the strains were 
incubated at high temperature (38ºC), only the strains expressing the untagged or Myc-tagged 
versions of Cdc48p recovered the temperature sensitive phenotype of the R95G and A232E 
mutations. This result was quite surprising and suggested that the phenotype of the R95G and 
A232E CDC48-HA mutant constructs was due to a combined effect of the mutant allele and the 
epitope tag.   
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Figure 37. The temperature sensitivity seen in select IBMPFD-CDC48-HA alleles is the result of a 
compound effect of the mutant allele and the HA-epitope tag 
The indicated strains (left of the vertical bar) were transformed with the indicated plasmids (right 
of the bar). The strains were spot plated (10-fold serial dilutions) and selective media and 
incubated at the indicated temperatures.  
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A.2.4 Cdc48p-HA hexamers exhibit slower migration than Cdc48p-Myc hexamers 
Many IBMPFD mutations affect the amino-terminus and the first AAA ATPase domain of 
p97/Cdc48p (HALAWANI et al. 2009). A classic temperature sensitive of CDC48, cdc48-3, 
possesses mutations in the first AAA ATPase domain (see Figure 11 in Chapter 1). During the 
course of my studies, I discovered that the cdc48-3 mutant, when incubated at a permissive 
temperature, lacked detectable free hexamers as assessed by native PAGE (Figure 38). Thus, one 
possible explanation for the temperature sensitivity of Cdc48p-HA is that free hexamers may be 
depleted. To test examine this, a graduate rotation student, Bill Glassford and I performed a 
native gel assay using lysates from yeast expressing Cdc48p-HA or Cdc48p-Myc alone, or both 
Cdc48p-HA and Cdc48p-Myc. We also assessed the effect of temperature on Cdc48p-HA and 
Cdc48p-Myc hexamers. As observed in Figure 39A, Cdc48p-HA hexamers showed a slower 
apparent migration when compared to Cdc48p-Myc hexamers (compare lanes 3, 4, 7, 8, 11-14 in 
Figure 39A). The signal corresponding to the Cdc48p-Myc hexamer consistently migrated faster 
than Cdc48p-HA hexamers (compare lanes 3 and 4 with 11 and 12 in Figure 39A). Cdc48p-HA 
and Cdc48p-Myc also displayed altered gel filtration profiles (Figure 39B). Interestingly, mixed 
Cdc48p-HA and Cdc48p-Myc hexamers also migrated with the same apparent mobility as the 
Cdc48p-Myc hexamer alone (compare lanes 7 and 8 with 11-14 in Figure 39A). The presence of 
mixed Cdc48p-HA and Cdc48p-Myc hexamers was confirmed by reciprocal immunoprecipation 
experiments (Figure 39C). These results indicate that Cdc48p-Myc confers this type of hexamer 
mobility even in the presence of temperature sensitive Cdc48p-HA subunits.  
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The incubation of cells at 38ºC led to a noticeable decrease in Cdc48p-HA hexamers 
(compare lanes 3 and 4 in Figure 39A), whereas Cdc48p-Myc hexamers appeared to increase 
with high temperature exposure (Figure 39A, lanes 11 and 12). Intriguingly, these two 
aforementioned properties were quite apparent when strains expressed both Cdc48p-HA and 
Cdc48p-Myc (compared the upper and lower bands seen in lanes 7 and 8 of Figure 39A). These 
data collectively suggest that temperature sensitivity of Cdc48p-HA may be caused by the loss of 
free hexamers, and that the R95G and A232E IBMPFD mutations further compromise a Cdc48p-
HA hexamer-associated process.  
 
In Figure 38, I found that the loss of UFD2 results in faster Cdc48p hexamer migration. 
Given that Ufd2p binds to the carboxy terminus of Cdc48p, I wondered if the slower migration 
of the Cdc48p-HA hexamer was caused by the tight binding of Ufd2p to the carboxy terminus. 
The tight binding of Ufd2p to Cdc48p-HA would exclude the binding of the DUB, Otu1p 
(RUMPF and JENTSCH 2006). Thus the HA tag may lead to an overrepresentation of pro-
degradative Cdc48p-Ufd2p within the cell. To test this idea, I deleted the UFD2 gene in the 
different IBMPFD mutant CDC48-HA backgrounds and tested for the recovery of temperature 
sensitivity. As seen in Figure 40, the deletion of UFD2 did not rescue temperature sensitivity in 
any of these strains tested.   
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Figure 38. The cdc48-3 allele causes the loss of free hexamer 
Cytosolic extracts were prepared from the indicated strains. A total of 25μg of protein was 
resolved by native PAGE as described in the Experimental Procedures section. Western blotting 
was performed with the anti-Cdc48p antibody (a kind gift from Dr. Rasmus Hartman-Petersen). 
For SDS treatment, SDS was added to a final concentration of 0.5% and the sample was 
incubated at 75ºC. 
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Figure 39. Cdc48p-HA hexamers display a different migration pattern than Cdc48p-Myc hexamers 
A. The indicated cells were grown at either permissive (30ºC) or non-permissive (38ºC for 2-4 h) 
temperatures. Cytosolic extracts were prepared from the indicated strains and 25μg of the 
cytosolic extract was resolved by native PAGE as described in the Experimental Procedures 
section. Western blotting was performed with antibodies against the epitope tags found at the 
carboxy terminus of Cdc48p. B. A total of 10mg of cytosolic extract from wild-type Cdc48p-HA 
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and Cdc48p-Myc was separated by gel filtration (Sephacryl S300HR) column chromatography 
as described in the Experimental Procedures section. Total protein from each fraction was TCA 
precipitated and resolved by SDS-PAGE. Western blotting was performed with the indicated 
antibodies to assess the distribution of Cdc48p complexes. C. Immunoprecipitation experiments 
were performed to assess the formation of mixed hexamers and were done as described in the 
Experimental Procedures section. Immunoprecipitated proteins were resolved by SDS-PAGE 
and western blotted with the indicated antibodies.  
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Figure 40. The loss of UFD2 does not rescue the temperature sensitive IBMPFD-CDC48-HA alleles 
The indicated strains were spot tested (10-fold serial dilution) for sensitivity at permissive (30ºC) 
or non-permissive (38ºC) temperatures, and also for sensitivity towards the indicated chemical 
stress agents.  
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A.2.5 IBMPFD mutations modeled into CDC48-MYC are not temperature sensitive 
Given that the original goal of this project was to model IBMPFD disease-causing mutations in 
yeast, I created a second series of strains containing IBMPFD mutations in a CDC48-Myc gene 
and tested for the expression of these alleles. The strategy was identical to that used to create the 
IBMPFD CDC48-HA strains (Figure 33). Like their IBMPFD CDC48-HA counterparts, the 
Cdc48p-Myc versions all expressed the mutant proteins to levels comparable to that of the wild-
type protein (Figure 41A). To see if the IBMPFD CDC48-Myc strains had compromised stress 
tolerance, I performed the serial dilution spot test at permissive (30ºC) and non-permissive 
(38ºC) temperatures, and also on media containing different chemical stress agents. As observed 
in Figure 41B, the modeling of IBMPFD mutations in the CDC48-Myc gene did not lead to 
sensitivity at higher temperature or on any tested chemical stressors. Additionally, the IBMPFD-
CDC48-Myc alleles displayed no apparent ERAD defect for two different substrates (Figure 42A 
and B) and no defect in autophagy (Figure 43). Thus, I conclude that select IBMPFD mutations 
when combined with the HA epitope tag at the carboxy terminus, mimic some aspects of the 
molecular pathology of IBMPFD.    
 179 
 
Figure 41. IBMPFD mutations modeled in the CDC48-Myc gene is not temperature sensitive 
A. IBMPFD mutants were constructed as described in the Experimental Procedures section. The 
procedure is illustrated in Figure 1. Western blot was performed from total protein extracts from 
the indicated strains to assess the level of protein expression between the various IBMPFD 
alleles. B. The indicated strains were spot tested (10-fold serial dilution) for sensitivity at 
permissive (30ºC) or non-permissive (38ºC) temperatures, and also for sensitivity towards the 
indicated chemical stress agents.  
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Figure 42. IBMPFD mutations modeled in the CDC48-Myc gene do not negatively affect the ERAD 
of two model substrates 
A. and B. The ERAD of Ste6p*, a transmembrane substrate and CPY*, a soluble ER-lumenal 
substrate was assessed by cycloheximide chase as described in the Experimental Procedures 
section. A. Quantitation of protein levels from three independent experiments. Representative 
figures are shown in B.  
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Figure 43. IBMPFD mutations modeled in the CDC48-Myc gene do not show autophagy defects 
The indicated strains were transformed with a vector designed to express GFP-ATG8, a reporter 
of autophagy. The induction of autophagy was performed as a time-course experiment as 
described in the Experimental Procedures section. Total protein was precipitated and resolved by 
SDS-PAGE and western blotting was performed with the indicated antibodies. Ponceau S red 
staining is included as an indicator of relative protein loading.  
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A.3 DISCUSSION 
 
The modeling of IBMPFD mutations in epitope tagged versions of the yeast CDC48 gene has led 
to a number of insights. First, the HA-, but not the Myc-epitope tag compounds the effects of the 
R95G and A232E alleles to cause temperature sensitivity and autophagic defects. This finding is 
remarkable given the fact that the HA tag (amino acids sequence: YPYDVPDYA) is a single 
HA, which was presumed to be minimally obstructive to Cdc48p function. The Myc-tag (amino 
acid sequence: EQKLISEEDL) is also present as a single copy. The observed difference in 
temperature sensitivity is likely due to the sequence of the HA tag.  
 
Incubating “wild-type” Cdc48p-HA yeast at high temperature led to a noticeable decrease 
in the amount of free hexamer (Figure 39A, lanes 3, 4, 7, 8). The classic temperature sensitive 
allele, cdc48-3, which possesses a pair of mutations in the first AAA ATPase domain, is largely 
devoid of free hexamers. Wild-type Cdc48p-HA, when incubated at high temperature, may 
mimic the cdc48-3 allele at permissive temperature. This is conceptually interesting since the HA 
tag and cdc48-3 allele reside on opposite ends of the protein. Given that the first AAA ATPase 
domain, which is the domain mutated in cdc48-3, is involved in hexamerization, this implies that 
the carboxy terminus affects the hexamerization domain. This is further supported by the fact 
that the R95G and A232E IBMPFD alleles and HA tag are on opposite ends the Cdc48p protein. 
Intriguingly, the R95G temperature sensitivity is less severe than that caused by the A232E 
allele, but more severe than the non-mutated version of CDC48-HA. The R95G mutation is in the 
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amino-terminus domain which binds cofactors. It is formally possible that the effects seen in the 
R95G mutant/HA-tag combination is due to changes in cofactor binding in addition to whatever 
effect the HA tag causes. One suggested experiment would be to immunoprecipitate the different 
mutant proteins and perform mass spectrometry. The expectation is that the R95G/HA-tag 
combination will show a different spectrum of associated cofactors.  
 
Additionally, performing the native gel assay with both HA- and Myc- tagged versions of 
IBMPFD mutants might prove insightful. A comparison between the IBMPFD mutants and other 
temperature sensitive alleles of CDC48, such as cdc48-1, 2 and 10, and mutants defective in 
nucleotide binding and hydrolysis would be most interesting. Further, assessing the distribution 
of hexamers in the UFD2/IBMPFD double mutants could shed light on the anomalous hexamer 
migration observed in yeast expressing Cdc48p-HA. In addition, overexpressing UFD2 may be 
insightful.  
 
The anomalous migration of Cdc48p-HA hexamer is particularly intriguing because it 
appears that incubation at high temperature causes a loss of free hexamer (Figure 39A lanes 3 
and 4). I believe that this is a result of protein aggregation, which is supported by the following 
two reasons. First, the high temperature incubation does not lead to an increase in monomer or 
HA-reactive signal found in the loading well of the native gel. Second, the extracts are clarified 
cytosolic extracts, so insoluble material is largely removed. This notion could be easily tested by 
comparing the total Cdc48p-HA levels in insoluble and cytosolic fractions by SDS-PAGE.  
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